Hidden Drivers of Health, From Gut to Brain

A narrative review of what actually shapes young minds found that nutrition, sleep, physical activity, and parenting can all meaningfully improve intelligence and executive function during the school years, when the brain is especially plastic [1]. In Hispanic and African American children, the salivary microbiome and household socioeconomic status each contributed comparably to cognitive test scores, together accounting for about 10% of the variance [2]. A meta-analysis of 22 studies found that compared to normal-weight peers, children and teens with obesity scored measurably lower on working memory (effect size −0.65), attention, cognitive flexibility, and verbal fluency [3]. Diet quality leaves fingerprints on the brain into adulthood too — in a cross-sectional imaging study of over 23,000 UK Biobank participants, an unhealthy plant-based diet (think refined grains and sugary drinks) was linked to nearly 300 brain structural and white-matter differences, far more than a healthy plant-based pattern [4]. A large Japanese cohort followed for nearly 19 years found that the highest fiber consumers had a 35% lower suicide risk, but this advantage disappeared after adjusting for folate, B vitamins, magnesium, and iron — suggesting the full nutrient package deserves credit rather than fiber alone [5]. And an ecological analysis of up to 204 populations found that national animal protein supply tracked higher dementia rates in a non-linear curve, though the researchers interpret this as a marker of broader nutritional and economic transitions rather than a direct effect of dietary protein [6].

For older adults, a cluster of findings maps out what nudges the brain toward or away from dementia. In more than 51,000 UK Biobank participants followed for over a decade, having both vision and hearing loss more than doubled the risk of developing dementia even after accounting for depression, social isolation, and baseline cognition [7]; a small imaging study also found that older adults with hyperlipidemia showed lower cognitive processing speed alongside altered resting-state activity in frontal and cerebellar regions [8]. An umbrella review in hemodialysis patients found that higher education was associated with roughly 80% lower odds of cognitive impairment, while depression, stroke history, and low-flux dialysis were among the strongest risk factors for cognitive frailty [9]. A review on obstetric history and dementia found that hypertensive disorders of pregnancy most clearly link to later vascular brain injury and vascular dementia, while parity alone doesn't appear to track amyloid or tau pathology [10]. On the encouraging side, a 28-day RCT found that just 3g/day of creatine improved reaction time, working memory, and inhibitory control in both young and older women versus placebo, with exploratory evidence of particular benefit in older adults [11]. In a longitudinal study of MCI patients, automatically extracted speech features from verbal fluency tests predicted two-year dementia conversion with reasonable accuracy, approaching but not quite matching full cognitive composite batteries — a potentially scalable, low-burden screening tool [12]. Beyond the aging brain, a nationally representative survey found that food insecurity in Hispanic/Latino adults was consistently tied to serious psychological distress, anxiety, depression, and loneliness even after adjusting for demographics [13]; among active-duty soldiers, nearly 39% screened positive for probable disordered eating, with anxiety and older age as the only independent predictors after adjustment [14]. A two-week wearable study in anorexia nervosa found that self-reported negative mood predicted dietary restriction better than any physiological sensor signal, with a mood-ratings-only model outperforming every combination of wearable metrics [15]; and a fidelity evaluation of a telehealth food addiction program found dietitians delivered content at 82–87% fidelity, with summarizing sessions and eliciting clients' main food intake concerns as the least consistently covered elements [16].

Zooming into the brain's cellular machinery, a review described how microglia shift their metabolism under the chronic stress of neurodegeneration — initially adapting but eventually impairing their own debris-clearance and driving neurotoxic lipid secretion — with genetic risk factors for both Alzheimer's and Parkinson's disease encoding metabolic vulnerabilities in exactly these pathways [17]. A related review described intercellular nanotubes, thin membranous bridges connecting neurons, microglia, astrocytes, and other brain cells, that can either rescue stressed cells by transferring mitochondria or betray them by spreading toxic protein aggregates [18]. The hypothalamus features prominently in two new frameworks: one review argued that AgRP and POMC neurons are a central hub linking metabolic signals to reward, learning, and social behavior, and that rigidifying these signals through aging or overnutrition may drive cognitive decline [19], while another detailed how the paraventricular nucleus integrates circadian, stress, and metabolic signals, with rodent models linking its disruption to neurodegeneration and metabolic disease (though direct human evidence remains limited) [20]. A less-familiar receptor, TAAR5 — expressed mainly in the olfactory epithelium and sensing the microbiota-derived compound trimethylamine — is gaining attention because it appears to modulate both serotonin and dopamine signaling, with possible links to mood and circadian regulation [21]. In neurodevelopmental conditions, a review found IGF1 has the strongest clinical evidence as a treatment target in Rett and Phelan-McDermid syndromes, while IGF2 shows promise for learning and memory in Fragile X, Angelman syndrome, and schizophrenia, though small samples and inconsistent biomarkers remain major hurdles [22]. A review of epilepsy — affecting over 50 million people worldwide, with nearly one-third refractory to current treatments — surveyed emerging options including gene therapy, neuromodulation, and the ketogenic diet [23]. A case-control study in women with PCOS found that alarin levels were elevated regardless of depression status and correlated with insulin resistance and LH rather than mood, pointing this neuropeptide toward the metabolic rather than psychiatric features of the condition [24]. Sports concussion guidelines now favor brief relative rest followed by early, symptom-guided return to activity in both general and adolescent populations [25] [26], though nutritional and dietary supplements still lack sufficient clinical evidence for routine recommendation in concussion recovery [25]. A 12-week RCT found that targeted use of kudzu extract on anticipated drinking days reduced binge-drinking frequency by roughly 27% versus placebo, with stronger effects among the most consistent users [27]. Focus groups with ALS patients and clinicians identified a persistent gap between knowing what good nutrition looks like and actually implementing it, with calls for clearer communication about the dietitian's role in proactive care [28]. A review on chronic pain in the Indian context argued that the prevailing opioid-constrained model is biochemically inadequate for the maladaptive pathophysiology of chronic pain, calling for investigation of glial modulators, cytokine inhibitors, sodium-channel blockers, and validated Ayurvedic phytochemicals alongside drug policy reform [29]. And an opinion piece on brain imaging flagged that up to 40% of the signal near the cerebellum in fMRI studies can be explained by heart rate and breathing noise — a methodological caution worth keeping in mind when reading cerebellar research on cognition and mood [30].

A picture is emerging of how the brain responds to what we do — and don't do — day to day. A meta-analysis of 17 RCTs found that mind-body exercise improved global cognition (SMD = 0.82) and episodic memory in older adults with mild cognitive impairment, with Tai Chi and programs longer than 12 weeks showing the largest gains [31]; a small pilot RCT of an 8-week multidomain program combining nutrition, exercise, cognitive training, and social engagement showed high adherence and a significant cognitive advantage over a health-education control in MCI patients [32]. Keeping the mind active matters too: in a large longitudinal study spanning the COVID-19 pandemic, reduced engagement in cognitively stimulating activities was the strongest predictor of cognitive decline among older Chinese adults, with urban women showing the steepest drop — while moderate physical activity showed no significant effect [33]. Self-reported central fatigue was consistently linked to lower cognitive scores and higher odds of impairment across three large cohorts (UK Biobank, CHARLS, and NHANES), with the clearest signal for processing speed and executive function [34]. Environment shapes the developing brain too: in nearly 9,400 children followed from ages 9–10 to 13–14, growing up in a high-opportunity neighborhood was associated with larger amygdala volumes and meaningfully higher memory scores, with effects that persisted or grew over four years [35]. Even heat takes a toll: in military students monitored across training weeks, higher wet-bulb globe temperatures were associated with worse spatial memory and slower reaction times, with metabolomics showing an early shift from amino acid stress to lipid disruption over time [36]. And for habitual coffee drinkers, overnight abstinence specifically slowed reaction times without touching working memory or executive function in a study of 30 regular consumers — a finding worth keeping in mind when interpreting any reaction-time-based cognitive study that uses an abstinence protocol [37].

On the biology side, several papers illuminate how the brain ages — and hint at where intervention might matter. A brain-imaging study of 557 dementia-free adults found that those in the highest quartile of CSF p62/SQSTM1 — a marker of impaired cellular waste clearance — had a 78% higher risk of incident dementia, with tau pathology and reduced brain volumes partly explaining the connection [38]. An ALE meta-analysis of 21 fMRI studies pinpointed the bilateral fusiform and parahippocampal gyri as the most reliably activated regions during object-location memory encoding, with the left cluster holding up across every leave-one-out iteration [REF:5bc327ec-db1c-4b63-adf4-7b0aece811e2]. In 60 older adults at risk for type 2 diabetes, higher HbA1c correlated with larger dentate gyrus and CA2 hippocampal subfield volumes, while spatial memory tracked with CA1 and subiculum size — suggesting metabolic risk begins reshaping hippocampal structure before diabetes is diagnosed [39]. A review frames the contact zone between the ER and mitochondria — called the mitochondria-associated membrane — as a unifying pathological hub for Alzheimer's, Parkinson's, ALS, Huntington's, and stroke, linking both too-much and too-little coupling to five recognized aging hallmarks [40]. Separately, preclinical work shows that astrocytes and microglia can physically donate mitochondria to energy-depleted neurons via tunneling nanotubes and extracellular vesicles, though whether this is a primary repair mechanism or a compensatory response — and how to harness it clinically — remains unresolved [41]. In dopaminergic neurons, aging appears to erode the cell's ability to clear reactive aldehydes — byproducts of lipid peroxidation including 4-HNE and acrolein — leaving neurons increasingly vulnerable in Parkinson's disease; a review argues the focus should shift from antioxidant approaches toward restoring aldehyde clearance via Nrf2 or ALDH2 pathways [42]. Mendelian randomization adds a surprising structural link: dry age-related macular degeneration causally increases Alzheimer's risk (OR = 1.14), with bioinformatics pointing to shared complement, MAPK, and lipid metabolism pathways and no evidence of reverse causality [43]. For cancer patients, a review proposes a three-hit model of chemotherapy-induced cognitive impairment — gut dysbiosis and systemic inflammation first, then blood-brain barrier disruption, then epigenetic reprogramming and white matter damage — each stage pointing to a different intervention window [44]. GLP-1 receptor agonists have generated excitement as potential neurorepair drugs, but both pivotal phase 3 trials testing this hypothesis in Alzheimer's and Parkinson's disease (EVOKE/EVOKE+ and Exenatide-PD3) failed to meet their primary clinical endpoints despite promising biomarker signals [45]; a companion review proposes a four-level cognitive framework — from food perception to executive decision-making — to guide more targeted mechanistic studies on how GLP-1RAs modulate food-related thinking [46]. A review of traditional Chinese medicine bioactive compounds found experimental evidence for activity across multiple ischemic cascade pathways including AMPK/SIRT1, Nrf2/HO-1, and NLRP3, while carefully noting that hitting many targets simultaneously does not establish pharmacological synergy or superiority over single-target drugs, and human translation remains limited [47].

The connections between the mouth, the gut, mood, and brain round out this batch. In 568 older US adults, those with both tooth loss and cognitive impairment had sharply reduced oral microbiome diversity, and mediation analysis showed that microbiome diversity partly explained the link between tooth loss and cognitive decline [48]; a perspective piece extends this into a proposed "brain-tooth axis," arguing that tooth loss and poor chewing function may drive neuroinflammation and amyloid accumulation via inflammatory, microbial, and trigeminal pathways while early neurodegeneration in turn impairs oral self-care [49]. The flavonoid icariin shows relatively strong experimental support for intestinal barrier protection and gut microbiome remodeling, with more speculative evidence for downstream brain effects via SCFAs and vagal signaling; a review notes that limited brain penetration means icariin may work partly through gut-derived metabolites rather than the parent compound [50]. In adolescents, a lipidomic study of 75 cases of major depressive disorder versus 75 controls found 82 differentially abundant lipid species, with a logistic regression model achieving an AUC of 0.85; after 8 weeks of fluoxetine, 21 of those species shifted [51]. Mendelian randomization found that depression causally increases breast cancer risk by boosting tumor norepinephrine and suppressing PPARγ, which in turn reduces immune cell infiltration — and in cell and animal models, quercetin reversed these effects [52]. Looking even earlier in life, a prospective study of 196 children found that serum metabolite patterns at age 6 — spanning amino acids, acylcarnitines, and gut microbiota-related metabolites — predicted higher internalizing and externalizing behavioral traits through adolescence, with the internalizing association remaining stable over time [53]. In cirrhosis, a one-year cohort study showed that brain atrophy and impaired memory independently predicted overt hepatic encephalopathy far better than ammonia levels, underscoring that brain reserve — not just liver disease severity — determines who develops this complication [54]. A multi-omics study of spinal cord injury identified a candidate metabolic signature in CSF — downregulated mitochondrial aspartate aminotransferase co-occurring with reduced methionine — across 13 acute patients and an independent cohort of 16 [55]. In a non-randomized cohort, oral taurine (3 g/day for 6 months) was associated with a large drop in serum TNF-α and substantially higher functional independence scores in spinal cord injury patients compared to conventional treatment, though the absence of randomization means this result is hypothesis-generating [56]. Despite olfactory dysfunction being measurable in nearly 11% of adults over 40 in NHANES, the standard symptom question caught fewer than one in five cases — and after correcting for multiple testing, no dietary pattern significantly differed between those with and without measured dysfunction [57]. A case report describes the first use of ketogenic parenteral nutrition in a diet-naive toddler with refractory epilepsy who could not tolerate enteral feeds after bowel surgery, suggesting this route is feasible while noting the lack of standardized protocols as a barrier [58]. And in three elderly women whose severe body-perception disturbance tied to major depression had led to dangerous reductions in food intake, electroconvulsive therapy resolved symptoms within 3–6 sessions, with full courses of 8–15 sessions restoring nutritional status in all cases [59].

One of the most striking supplement stories comes from a meta-analysis of 14 randomized trials showing that every 30 mg per day increase in crocin — the active pigment in saffron — was linked to a 3.37-point drop in depression scores and a 2.73-point drop in anxiety, with the effect scaling in a clear dose-response curve [60]. Probiotics also showed up for mood: a 20-trial meta-analysis found they meaningfully reduced depression scores and improved sleep quality in healthy adults, though they didn't move the needle on anxiety [61]. Caffeine cuts the other way — a meta-analysis found no reliable effect on depression but found anxiety scores were higher on average after caffeine exposure, with the effect appearing larger above 200 mg per day, though certainty was very low [62]. On the dietary side, a review of vitamins for Alzheimer's disease concluded that folic acid and B12 carry the most consistent, if still limited, signal for cognitive benefit — especially in people with high homocysteine — and that vitamin D deficiency is worth correcting when documented, while vitamins A, C, and E don't yet clear the bar for routine use [63]. In over 2,400 U.S. adults aged 60 and older, greater Mediterranean diet adherence tracked with better verbal fluency and processing speed, particularly among those with normal BMI [64]; a narrative review similarly found that the Mediterranean, ketogenic, and MIND diets each show potential in Parkinson's disease, though direct evidence from PD-focused trials is still thin [65]. A case-control study in Iranian children found that higher total and low-fat dairy intake were each associated with lower odds of an ADHD diagnosis [66]. And for people living with severe mental illness, a co-design study found that those with lived experience prioritized plain language, short videos, and simple navigation when shaping a web-based nutrition tool — with early usability testing returning high scores [67].

A lot of this research ultimately points to the machinery underneath. The brain's waste-clearance plumbing — called the glymphatic system — appears sensitive to poor sleep, aging, high-fat diet, diabetes, and gut dysbiosis, all of which impair the channels that flush amyloid-beta and tau; neuroimaging can now detect this dysfunction, though treatments to restore it remain at an early translational stage [68]. Reviews applying AI to gut microbiome datasets are beginning to identify microbial signatures linked to Alzheimer's progression, connecting gut dysbiosis to neuroinflammation and amyloid deposition via the gut-brain axis — a rapidly expanding field still awaiting clinical validation [69]. A bibliometric analysis of 15 years of research on obesity and psychiatric conditions confirms that gut-brain connections, neuroinflammation, and high-fat diet now dominate the conversation, with the field surging after 2021 [70]. A mechanistic review traced how heavy metals including lead, cadmium, arsenic, manganese, and mercury drive sustained neuroinflammation by activating microglia and suppressing the brain's antioxidant defenses — with metal mixtures showing evidence of greater-than-additive harm [71]. In bipolar disorder, a review finds consistent evidence of impaired mitochondrial energy production in both brain and body — reduced ATP and phosphocreatine, elevated oxidative and inflammatory markers — with early interest in supplements like creatine, CoQ10, and NAC, as well as the ketogenic diet [72]; mitochondria also take center stage in Leber hereditary optic neuropathy, where a natural history study of 402 patients found that only about 1 in 5 affected eyes achieved meaningful spontaneous visual recovery at 12 months [73]. Exercise adds a different lever: a review describes how muscles and liver release circulating molecules called exerkines that cross into the brain and support cognition, framing the mental benefits of exercise as a coordinated whole-body response rather than something confined to the central nervous system [74]. A theoretical model offers a fresh take on why effort feels costly, proposing that the brain's willingness to work is fundamentally governed by arousal costs — how much activation is needed to gear up for, execute, and recover from a task — with effort-based decisions functioning to minimize those costs [75].

Risk for cognitive trouble reaches far back in time and across many systems. In a study of nearly 9,300 Chinese adults aged 65–99, childhood hunger was associated with roughly 23% higher odds of cognitive impairment in late life [76]. A cross-sectional study in almost 14,000 U.S. adults found that a history of periodontal disease tracked with lower cognitive scores and higher levels of phosphorylated tau, though most associations didn't survive correction for multiple comparisons [77]. In Vietnam War veterans, a traumatic brain injury history moderated the relationship between age and memory decline — older TBI-exposed veterans showed steeper episodic memory drops — with no such effect seen for executive function or language [78]. Among Filipino patients with mild cognitive impairment or dementia, physical inactivity was associated with nearly four times the odds of a dementia diagnosis [79]. In a nationally representative South African sample of older adults, having at least one non-communicable disease significantly raised the odds of psychological distress, while disability in turn raised the odds of having an NCD [80]. Higher digital health literacy in Chinese adults aged 50 and older was linked to fewer depressive symptoms — mediated through physical activity and perceived stress — but only among middle- and higher-income individuals, not those with lower incomes [81]. A graph neural network trained on over 14,000 brain scans mapped local brain aging at fine spatial resolution and found that in Alzheimer's disease, the medial temporal regions age most rapidly, with cortical curvature and gray/white matter intensity ratio identified as the features most sensitive to AD pathology [82]. In a study of cognitively healthy middle-aged adults, personality profile clusters interacted with Alzheimer's risk genes to predict cognitive outcomes — but only in women: in certain female profiles, models incorporating APOE and PICALM together explained 55–70% of the variance in fluid intelligence [83]. For people already living with cognitive impairment, a meta-analysis found that group-based interventions produced significantly greater cognitive gains than individually delivered care, and multicomponent programs specifically drove improvements in both cognitive and psychosocial outcomes [84]. A narrative review of stroke rehabilitation found that interdisciplinary teams with neuropsychologist involvement were associated with better survival and functional independence, and with a threefold improvement in cost-benefit ratio compared with conventional care [85], and an ongoing multicenter trial is now testing whether acupuncture synchronized with active swallowing tasks can improve swallowing after stroke — with results anticipated in September 2027 [86]. In Chinese nursing homes, a study of nearly 575 people with dementia identified four distinct care-resistance profiles, with eating and bathing resistance each linked to lower cognitive function and absent communication from care workers [87]. A survey of Brazilian care facility staff found that more than three-quarters believed tube feeding was the only nutritional option in advanced dementia — a view contradicted by current evidence — with similarly widespread misconceptions about aspiration risk and comfort feeding [88]. Finally, a published correction to a review of biomarkers and neuroprotective treatments in neurodegeneration updated several citations and in-text attributions without altering the original study's conclusions [89].

One of the more concrete pieces of good news comes from a carefully designed trial: in a double-blind RCT of 60 older adults aged 65 to 89, three months of freeze-dried blueberry powder — roughly equivalent to one cup a day — meaningfully increased cerebral blood flow in key brain regions compared to placebo [90]. The anterior cingulate cortex, an area tied to attention and decision-making, saw a 7% increase (P = 0.03), and the caudate and putamen showed within-group gains of 7% and 6% respectively. Notably, brain glutathione levels didn't change, which points toward vascular modulation — improved blood vessel function — rather than a direct antioxidant effect in the brain tissue itself.

On a more experimental front, researchers have registered a double-blind, sham-controlled trial testing transcutaneous auricular vagus nerve stimulation (taVNS) in 40 post-stroke patients experiencing swallowing difficulties [91]. Recruitment began in March 2025, with results expected in winter 2026, so there is nothing yet to report on effectiveness — but the trial is well-structured and the question it's asking, whether gentle nerve stimulation near the ear can aid stroke recovery, is worth following.

Zooming out to the landscape these interventions inhabit, a think-tank of 24 scholars raised a pointed concern: today's digital health tools tend to carve wellbeing into narrow biomedical silos and are frequently shaped by commercial incentives that favor user engagement over genuine flourishing [92]. The group's consensus was that real wellbeing spans physical, mental, emotional, social, spiritual, and nutritional dimensions simultaneously, and that the tools meant to support it should be personalized, human-centered, and designed to augment rather than replace human relationships — with equity across resource settings built in from the start, not bolted on later.

The biggest caveat running through almost everything here is that "linked to" is not "causes" — most of these are observational studies, and the GLP-1 drug trials are a sharp reminder that even the most exciting biomarker signals can fail to move real clinical outcomes. Worth watching: the saffron (crocin) dose-response finding is unusually tidy for nutrition research, and if you or someone you know is managing depression alongside conventional treatment, it's worth raising with a clinician.

Obese children in a 70-patient pediatric study averaged nearly an hour less sleep each night and about 50 more minutes of daily screen time than their non-obese peers, with screen exposure alone linked to a more than three-fold higher odds of obesity after adjusting for confounders [1]. The scope of undetected metabolic burden becomes starker when you look beyond body weight: FibroScan screening of asymptomatic South Indian adults found nearly 65% had metabolic liver disease (MASLD), more than half of them under 46, and nearly a third with a normal ultrasound, meaning standard imaging missed them entirely [2]. Excess fat also reaches into unexpected corners: across 33,310 Korean adults, virtually every adiposity measure was tied to worse periodontal disease, with relative fat mass showing the largest effect and the association consistently stronger in women [3]. Access to treatment is its own barrier; in a Taiwanese real-world cohort, nearly half of patients who never reached the therapeutic liraglutide dose cited medication cost, not tolerability, as the reason [4], while a US pragmatic RCT is currently testing whether roughly $80 a month in grocery support can improve food security and downstream health outcomes in low-income people with chronic disease [5]. A review of polysaccharides from plant, animal, and microbial sources shows they can curb obesity through gut microbiota, lipid and glucose metabolism, and anti-inflammatory pathways, with molecular structure (weight, monosaccharide composition, sulfation) determining potency [6]. Fat cells also generate heat through more routes than the classic UCP1 protein: the futile creatine cycle has been validated through loss-of-function, reconstitution, and genetic interaction experiments as an independently contributing thermogenic pathway running in parallel with UCP1 [7]. Obesity's relationship with cancer therapy depends heavily on sex and hormonal status: a pan-cancer analysis found higher BMI associated with better survival after immune checkpoint inhibitors only in male patients and women over 55, while preclinical work in diet-induced obese female mice showed estrogen-driven M2 macrophage polarization blunting anti-tumor responses, effects that reversed after ovariectomy [8]. One year after sleeve gastrectomy, women achieved greater uric acid reductions than men despite starting from lower baseline levels, with a C-peptide-mediated pathway accounting for about 9% of that effect and kidney function change as an independent predictor [REF:ea0bcaf0-db1b-4c1a-9ca6-0f9615d6b5aa].

Diabetes keeps revealing less obvious faces. Among nearly 700 Hong Kong children newly diagnosed with type 2 diabetes, 35% were non-obese, and those lean children had worse beta-cell function, higher HbA1c, and nearly triple the DKA rate at presentation; obese children dominated for insulin resistance, liver disease, hypertension, and sleep apnoea [9]. A letter on lean young-onset diabetes in Bangladesh raises the possibility that some of these cases fit a Type 5 Diabetes profile, but also cautions that severe hyperglycemia (median HbA1c 11.6%) may be artificially inflating apparent insulin resistance, and that repeat measurements after glycemic correction are needed before drawing firm conclusions [10]. For people already managing type 2 diabetes, a 104-week post hoc analysis found that starting three drugs at once (metformin, dapagliflozin, and saxagliptin) achieved the same HbA1c reduction as a stepwise approach, but hypoglycemia hit 23.7% of the stepwise group versus zero in the triple combination group [11]. Sleep adds another layer: in a cross-sectional study of adults with long-standing type 1 diabetes, shorter REM sleep correlated with higher HbA1c and worse glucose variability, and those with two or more carotid plaques averaged about 10 fewer minutes of REM per night [12]. In the SWAN cohort followed for over 11 years, greater cumulative depressive symptoms during the menopausal transition were linked to incident type 2 diabetes, with central obesity mediating roughly one-fifth of that association and the somatic subscale of depression showing the strongest signal [13]. At the acute end of the glycemic spectrum, a US national analysis of over 330,000 hypoglycemia hospitalizations found in-hospital mortality of 1.6%, but adjusted mortality odds were 30–44% higher in 2020–2022 than in 2017, even as admission volumes dipped during the pandemic, with heart failure and atrial fibrillation as the strongest independent predictors [14]. A narrative review of perioperative dysglycemia in GI surgery flags standard intermittent monitoring as inadequate, while noting that evidence linking newer digital tools (continuous glucose monitors, EHR alerts, and closed-loop insulin systems) to actual improvements in surgical outcomes beyond glucose metrics remains limited [15]. Among 196 South Indian women with PCOS, cluster analysis identified three biologically distinct subtypes (gonadotrophin-predominant, BMI-predominant, and intermediate) that differed in blood pressure and endometrial thickness but not in AMH or HbA1c [16]; a separate narrative review cautions that nutraceuticals and herbal interventions in PCOS show variable effects on insulin resistance and inflammation markers, and that biochemical gains shouldn't be read as evidence of reduced cardiovascular risk or improved fertility without adequately powered RCT data [17]. A large NHANES analysis found no independent association between HOMA-IR and overall cancer history after adjusting for age, sex, and BMI, with no synergistic effect from systemic inflammation, suggesting any such link may be limited to specific high-risk subgroups [18]. A review of age subgroup analyses, frailty analyses, meta-analyses, and real-world data concludes that SGLT2 inhibitors' cardiovascular and heart failure benefits are largely preserved in patients 75 and older, even though volume depletion, falls, and polypharmacy need to be weighed individually [19].

Zooming in on molecular mechanisms, a Voices commentary highlights how lipid organizational dysregulation (not just lipid levels, but the spatial arrangement of lipids across organelles, cell types, and organs) is a shared mechanism driving neurodegeneration, cardiovascular disease, and inflammation [20]. In diabetic retinopathy specifically, a review describes how dysregulated lipid metabolism, oxidative stress, and chronic inflammation form a self-amplifying pathogenic loop, with PPARα and PPARγ as master transcriptional regulators, and nano-drug delivery systems targeting these pathways proposed as a way past the limitations of traditional PPAR agonists [21]. There is also the concept of metabolic memory: persistent epigenetic reprogramming (through DNA methylation, histone modifications, and noncoding RNAs) that sustains chronic oral inflammation and impaired wound healing even after blood sugar and lipid levels normalize, by locking in dysregulated immune responses and altered host-microbiota interactions [22]. An unexpected route of metabolic harm came to light in experiments with healthy volunteers: aripiprazole significantly raised circulating small extracellular vesicles that then impaired hepatocyte insulin signaling, and macrophage-derived vesicles from antipsychotic-treated cells also induced hepatocyte insulin resistance, pointing to vesicle-mediated inter-organ crosstalk as a novel mechanism behind antipsychotic-associated metabolic dysfunction [23]. On the rarer end, a case report and systematic review describes clopidogrel triggering insulin autoimmune syndrome, a hypoglycemic condition that resolved after switching to ticagrelor, dietary modification, and voglibose [24]. NMR metabolomics distinguished acute myocardial infarction from stable coronary artery disease via elevated lactic acid and hypoxanthine, two metabolites proposed as potential diagnostic and prognostic biomarkers pending validation in larger studies [25]. Among hypertensive US adults, current smoking, cardiovascular disease history, and Medicaid coverage each independently predicted stroke history, with Medicaid carrying over three times the odds, though racial and ethnic differences in stroke prevalence across antihypertensive medication categories did not reach a statistically significant interaction [26]. In rural Nepal, a cross-sectional study of 197 hypertensive outpatients found prescribers averaging four drugs per prescription against a WHO target of fewer than two, with generic prescribing reaching only 34% [27]. Among Indonesian children hospitalized with dilated cardiomyopathy, one-third died in-hospital, and a seven-variable bedside risk score achieved an AUC of 0.932 for predicting mortality, a result that held up under internal validation [28]. A 129-person RCT of Transcendental Meditation in Australian university staff found only a small diastolic blood pressure reduction (−1.18 mmHg) and no significant effects on fasting glucose, insulin resistance, lipids, cortisol, or heart rate variability, with burnout and sex subgroup findings described as hypothesis-generating since no multiplicity correction was applied [29].

A striking cluster of findings maps the upstream drivers of insulin resistance. In a Malawian study, each 0.1-unit rise in waist-to-hip ratio was linked to a 58% higher HOMA-IR, while each 0.1 kg/kg increase in relative grip strength tracked with nearly 20% lower insulin resistance — together those two measures explained roughly a quarter of the variance in HOMA-IR [30]. Elevated sclerostin is another signal worth watching: in a study comparing obese and control women, obese participants had significantly higher sclerostin levels that correlated tightly with fasting insulin, HOMA-IR, and epicardial fat, with an AUC of 0.89 for discriminating insulin resistance, though BMI rather than sclerostin proved the independent predictor of thicker epicardial fat [31]. Looking downstream, a UK Biobank cohort of over 429,000 people followed for a median 13.4 years found that better insulin sensitivity (estimated glucose disposal rate) was linked to a 13% lower age-related macular degeneration risk per standard deviation, with systemic inflammation accounting for less than 7% of that association [32]. Perimenopause accelerates cardiometabolic risk in its own right: a review concluded that the hormonal transition worsens lipid profiles, insulin sensitivity, body composition, and vascular function beyond what aging alone predicts, with vasomotor symptoms and sleep disruption independently linked to worse cardiometabolic profiles through autonomic, inflammatory, and neuroendocrine pathways [33]. Thyroid status matters too — a comparison study found hypothyroid patients had significantly higher total cholesterol, LDL, triglycerides, and HbA1c than hyperthyroid patients, along with elevated atherogenic indices [34], while carotid imaging showed T2DM patients averaging 0.72 mm intima-media thickness versus 0.61 mm in controls with nearly three times the plaque prevalence [35]. Zooming further out, adverse social determinants — economic conditions, poor built environment, and limited educational opportunity — are independently linked to greater cardiovascular-kidney-metabolic syndrome burden, with proposed mechanisms including glucocorticoid resistance, chronic sympathetic activation, and accelerated biological aging from cumulative stress [36].

The evidence supporting semaglutide continues to build: a meta-analysis of seven RCTs in over 38,000 patients found it reduced cardiovascular death by 17% versus placebo, with consistent benefit across T2DM, obesity without diabetes, and obesity-related HFpEF regardless of administration route or baseline HbA1c [37]. A review of the broader incretin landscape shows GLP-1 receptor agonists (especially semaglutide) improving weight, adiposity, and insulin resistance in people with PMOS, with emerging reproductive benefits, while dual GIP/GLP-1 agonism (tirzepatide) and triple GIP/GLP-1/glucagon agonism (retatrutide) may offer even greater reductions in body weight and visceral fat — though PMOS-specific reproductive evidence for the multi-incretin agents is limited and whether benefits persist after withdrawal remains unknown [38]. For triple oral therapy, a Phase III Indian trial found the fixed-dose combination of dapagliflozin, glimepiride, and metformin reduced HbA1c by more than 2 percentage points at 16 weeks, with significantly more patients reaching HbA1c below 7% compared to the two-drug regimen [39]. Beyond pharmacology, a propensity-matched cohort found that enrolling T2DM patients in an online co-care management program brought HbA1c from 7.40% to 6.59% at six months, versus minimal change in usual care, with improvements in BMI, blood pressure, and lipids alongside [40]. Even periodontal care has a metabolic angle: a 120-patient RCT found that adding Nd:YAG laser therapy to conventional gum treatment in T2DM patients produced a 0.26% lower HbA1c and 0.62 mmol/L lower fasting glucose compared to conventional treatment alone [41]. Genetics may one day personalise therapy, though a 32-SNP pharmacogenomic analysis in T2DM found no variants surviving false-discovery-rate correction, with only suggestive signals around FTO and metformin transporter variants (SLC22A1, SLC22A2) [42]. Complications tell a sobering story: a Nigerian tertiary hospital study found musculoskeletal disorders in 48% of T2DM patients versus 18% of controls, with disease duration over five years and poor glycemic control as independent predictors [43], and nearly 80% of adults with diabetic retinopathy showed suboptimal foot care, with female sex and higher education as the only independent predictors of adequate practice [44]. In a counterintuitive finding, adiponectin was significantly higher in T2DM patients with peripheral neuropathy than in those without, suggesting a compensatory rather than protective elevation, with only diabetes duration independently predicting neuropathy [45]. For hypoglycemia recovery, a small crossover study found that a beta-hydroxybutyrate-plus-glucose drink was preferred over standard glucose gel in 13 of 14 patient-reported domains, with 92% rating it highly effective and 92% reporting near-absence of the post-hypoglycemia hangover [46]. A trial worth watching is EVOID-AS, a 580-patient randomized trial testing whether the DPP-4 inhibitor evogliptin slows aortic valve calcification and hemodynamic progression in mild-to-moderate calcific aortic stenosis, with results expected in 2028 [47]. In Germany's first real-world acoramidis cohort for ATTR cardiomyopathy — 289 patients with a median age of 82 — 74% were also on SGLT2 inhibitors, with marked increases in loop diuretics, MRAs, and anticoagulants in the months before starting the new therapy [48].

Lifestyle choices remain stubbornly predictive of long-term cardiovascular outcomes: a six-year study of law enforcement officers found that physically inactive officers had a seven-fold higher incidence of dyslipidemia than active peers, and eating fewer than five daily servings of fruit and vegetables was linked to higher rates of both hypertension and dyslipidemia [49]. Meanwhile, about 11% of U.S. adults use heart health or cholesterol supplements — including nearly 20% of those already on lipid-lowering therapy — but supplement use didn't differ across dietary misalignment categories, suggesting people aren't trading a poor diet for a supplement [50]. A WhatsApp-based telehealth pilot in hypertensive adults showed notable within-group improvements in systolic blood pressure, medication adherence, and hypertension knowledge, though without a control group causality cannot be established [51]. Women with a history of preeclampsia or gestational hypertension carry a heavy cardiometabolic load a year postpartum: in one cohort, 31% met criteria for arterial hypertension, 18% for prediabetes, and over half had LDL above 100 mg/dL, with 21% of preeclampsia women showing low-grade albuminuria [52]. Obesity's reach keeps extending — a review frames hidradenitis suppurativa as an immunometabolic disorder driven by pro-inflammatory adipokine imbalance and skin barrier disruption, with weight loss, bariatric surgery, and metabolism-directed therapies showing potential to reduce disease burden [53]. In a small crossover study, instant brown rice produced modestly lower peak glucose and glycemic excursion than instant white rice, though people with postprandial distress syndrome had greater fullness after brown rice — a potential symptom trade-off worth knowing [54]. At the molecular level, a family-and-cell study identified a novel truncating VEGFB mutation that disrupts AMPK-mediated lipid oxidation and causes triglyceride accumulation in liver cells, flagging VEGFB as a candidate gene for primary hyperlipidemia [55]. A review drawing on single-cell omics and metabolomics recasts hepatic stellate cells as metabolic and immune signaling hubs, not just fibrosis drivers, with roles in intestinal barrier function, myocardial energy metabolism, and bone remodeling through glycolytic reprogramming, vitamin A metabolism, and receptor signaling [56]. The microRNA miR-29a adds another layer of complexity, modulating oxidative metabolism, inflammatory signaling, and mitochondrial adaptation across skeletal muscle, adipose tissue, liver, and pancreatic cells through the PPARδ/PGC-1α axis — but a key translational hurdle is that therapeutically lowering it carries oncogenic risk [57]. A PRISMA-guided review of Himalayan medicinal plants identified five species — including Rhododendron arboreum, Centella asiatica, and Ophiocordyceps sinensis — as mechanistically validated for cardioprotective effects in myocardial injury models via mitochondrial stability and AMPK signaling, while calling for pharmacokinetic and disease-relevant human studies before clinical translation [58]. And on the longest time horizon, a review of geroscience evidence concludes that biological aging is increasingly modifiable: genetic, pharmacological, and dietary interventions extend healthspan in animals, and cardiovascular-specific aging clocks estimating the biological age of the heart and vasculature may serve as surrogate endpoints in future human trials of caloric restriction, rapamycin, taurine, and plasma exchange [59].

A 90,807-person Japanese cohort followed for nearly 19 years found no link between saturated or trans fat intake and cardiovascular or all-cause mortality, though higher PUFA intake showed a modest association with lower mortality in women [60]. Where fat is stored adds another layer: a Danish case-cohort study found that people with the highest levels of EPA in their adipose tissue had a 36% lower risk of hemorrhagic stroke, while high adipose ALA was linked to 32% higher risk [61]. Beyond diet, air pollution reaches metabolic health too — in a cross-sectional study of women in a heavily polluted Iranian city, each standard-deviation rise in fine particulate matter was associated with 22–23% higher prevalence of PCOS metabolic syndrome [62]. A review of salt sensitivity reminds us that roughly half of people with hypertension experience arterial stiffening and blood vessel damage from high-salt diets even before their blood pressure budges [63]. From a very different angle, a study in rural Madagascar found that two hookworm species had opposite effects on the body: Necator americanus infection was associated with lower BMI and blood pressure, while Ancylostoma ceylanicum was tied to higher blood pressure independent of body weight [64]. On the risk-screening front, a 9-year longitudinal study showed a simple three-variable index combining cholesterol, HDL, and fasting glucose independently predicted new-onset hypertension, especially in men and in people with diabetes [65], and in a large U.S. sample of hypertensive adults, a higher platelet-to-white blood cell ratio was associated with 10–12% lower mortality [66]. Among over 400 hypertensive patients in one Chinese city, more than 85% had elevated homocysteine and in a larger hospital dataset over 60% had dyslipidemia [67]. In Chinese adults with type 2 diabetes, only 1 in 20 simultaneously hit their blood sugar, blood pressure, and LDL targets — with obesity the biggest barrier [68]. Among people with HIV on stable antiretroviral therapy, nearly 1 in 3 had metabolic syndrome, and a body-composition index (TyG-WHtR) matched the accuracy of a full clinical model for identifying it [69]; in a separate Chinese cohort of middle-aged and older adults, combining high TyG-ABSI with a higher frailty trajectory more than doubled CVD incidence [70].

For people already managing cardiometabolic disease, the treatment picture is filling in quickly. A head-to-head trial in 54 MASLD patients found saroglitazar and dapagliflozin reduced liver fat and fibrosis similarly over 25 weeks, but saroglitazar produced significantly greater HbA1c reduction — a potential edge when both liver health and blood sugar need addressing at once [71]. A small but striking trial showed that 14 weeks of mindfulness-based CBT cut HbA1c by nearly 2 percentage points in adults with diabetes and depression (from 9.0% to 7.2%), while controls' blood sugar worsened, and all four quality-of-life domains improved in the intervention arm [72]. A review of combined aerobic and resistance exercise in type 2 diabetes points to real benefits for heart function, insulin sensitivity, and vascular health — though it notes that well-powered trials in people with established diabetic cardiomyopathy are still lacking [73]. In pre-diabetic Indian adults, 3 months of 2,000 IU/day of vitamin D3 combined with lifestyle advice normalized blood sugar in 40% of participants, versus 11% in the lifestyle-only group [74]. On GLP-1 receptor agonists and eye safety, a review concludes there is no class-wide ocular toxicity, but flags early diabetic retinopathy worsening during rapid blood sugar normalization and identifies nonarteritic anterior ischemic optic neuropathy as a semaglutide-specific signal supported by regulatory action [75]. SGLT2 inhibitors leave their own metabolic trace: urinary volatile organic compounds — particularly acetone — rise measurably during treatment, and a review proposes this as a pharmacodynamic biomarker and an early warning signal for euglycemic diabetic ketoacidosis [76]. Metabolic syndrome also showed up as an obstacle in an unexpected context: in adults receiving allergen immunotherapy for rhinitis, type 2 diabetes was associated with 78% lower odds of overall symptom improvement [77]. And qualitative interviews with rural elderly Chinese patients with coronary disease identified limited disease awareness, distrust of local healthcare, and weak community support as the dominant hurdles to self-management [78].

The research also keeps surfacing connections between cardiometabolic health and systems you might not expect. Retinal blood vessel changes detectable by eye-scan imaging may offer an early, non-invasive window into simultaneous damage in the kidneys and heart — a review notes these vessels share developmental origins with both organs and may even reflect real-time responses to cardiometabolic drugs [79]. Ferroptosis — an iron-dependent form of cell death — is increasingly implicated in cardiovascular disease, with mitochondria-associated membranes proposed as a central coordinating hub [80]. A molecular target called PAK4 is emerging as a potential metabolic node regulating fat breakdown, liver metabolism, and muscle glucose uptake, though its essential role in embryonic heart development means inhibiting it carries uncharacterized cardiac risk [81]. Metabolomics is opening another door for precision medicine: a study of newly diagnosed type 1 diabetes patients identified 15 baseline blood metabolites that predicted teplizumab response with 76.9% accuracy [82]. In systemic sclerosis, nearly 30% of patients had insulin resistance, and those with more advanced capillary damage in nail-fold imaging were more likely to have it, suggesting metabolic dysfunction may contribute to the disease's microvascular complications [83]. After pheochromocytoma surgery, half of patients in a small monitoring study experienced postoperative hypoglycemia, with blood sugar spending 22–37% of the time below range overall and even more during overnight hours [84]. In MASLD, people with better overall physical capacity were significantly less likely to have poor sleep efficiency — an association that held in women but not men [85]. Among physically active young adults, those eating the highest dietary insulin load actually had slightly better metabolic scores, hinting that regular exercise may blunt adverse metabolic responses to insulinogenic foods [86]. Obesity alone does not disqualify someone from living liver donation — a review argues that body composition predicts risk better than BMI, and targeted weight loss can move borderline candidates into an acceptable range [87]. A case report rounded out the picture with something genuinely rare: a 24-year-old with obesity and metabolic syndrome was found to have hepatic tumoral calcinosis — an extremely uncommon condition usually seen near joints in adolescents, not in liver tissue — resolved with surgery [88]. And a 10-year longitudinal study of older partnered adults with diabetes found that being sexually active was associated with more favorable HbA1c trajectories over time, with emotional sexual satisfaction showing a gendered split in its relationship to blood sugar control [89].

Drugs that work on weight and blood sugar continue to generate compelling data. A meta-analysis of 10 trials found semaglutide trimmed body weight by more than 12% on average in people with overweight or obesity who didn't have diabetes—though adverse events causing people to drop out ran nearly double those on placebo [90]. Across 30 trials, adding a GLP-1 receptor agonist to basal insulin in a fixed-ratio combination consistently pushed HbA1c and weight lower than insulin alone, with the biggest weight drops exceeding 3 kg [91]. Who benefits most from tirzepatide may partly depend on biology: in 90 people switching to it from other GLP-1 drugs, those with higher levels of a particular receptor on their immune cells lost more weight and saw better liver-health scores, with lab work suggesting the drug may directly calm inflammation [92]. For type 1 diabetes, a Japanese 55-year modelling study found the MiniMed 780G closed-loop insulin system cost-effective, projecting close to 3 extra quality-adjusted life-years at a cost per QALY below Japan's accepted threshold [93]. In 265 people with type 1 diabetes tracked by CGM, the early-morning "dawn phenomenon" glucose rise was more common in men and in those with higher HbA1c, while pump users experienced it less often [94]. A small cross-sectional pilot of 29 CGM users with type 2 diabetes found 72% reported the monitor helped them take their oral medications more consistently, though the study was too small to draw firm conclusions [95]. GBD 2023 data across 34 Asian countries found type 2 diabetes burden grew across most regions between 1990 and 2023, most sharply in South Asia where age-standardized prevalence rose 66.5%—with a diet low in fruit the leading dietary culprit there, and air pollution topping all risk factors continent-wide [96]. For measuring who's at risk, an analysis of over 133,000 Women's Health Initiative participants found that combining waist circumference with BMI widened the range of diabetes hazard ratios (up to 4.43) compared to BMI alone (up to 3.30), though both approaches showed similarly modest prediction accuracy overall [97].

On the diet and lifestyle side, some findings reinforce familiar advice—and a few push back on assumptions. A meta-analysis of 19 trials found oral potassium supplementation cut clinic systolic blood pressure by 5.3 mmHg in people with untreated primary hypertension, with smaller drops in 24-hour readings and more frequent side effects than placebo [98]. Omega-3 fats at everyday dietary levels (up to 1,500 mg EPA+DHA per day) appear to lower—not raise—atrial fibrillation and cardiovascular risk; a modest increase in absolute AF risk only appeared at high pharmacological doses in people already at elevated CVD risk, where the overall risk-benefit picture still looked favorable [99]. Hard cheese keeps its surprisingly good reputation: a review of current evidence concludes the whole food's matrix—its bioactive proteins, bacteria, and micronutrients—appears to blunt the cardiovascular harm you'd expect from its saturated fat and sodium if you ate those nutrients another way, though which components are responsible hasn't been pinned down [100]. In a cross-sectional study of Korean adults, sugar-sweetened beverage intake was independently linked to higher BMI after adjusting for lifestyle factors, while breakfast frequency was not once confounders were controlled [101]. A crossover trial in 30 healthy adults found monk fruit–based sweeteners produced lower glucose and insulin spikes than sucrose without affecting appetite or calorie intake, though diarrhea was more common and one formulation scored lower for palatability [102]. In a cross-sectional NHANES analysis of adults with diabetes, sticking to HEI-2020, DASH, or a Mediterranean-style diet was each associated with significantly lower odds of having gout alongside their diabetes, with insulin resistance markers mediating a meaningful portion of those associations [103]. A culturally adapted nutrition approach tested across six world regions—combining calorie targets, glycemic index guidance, and behavioral counseling—improved blood sugar control, body weight, and eating confidence over 6–12 months in an RCT of people with type 2 diabetes [104]. Fitness itself may reshape artery health: in 208 adults at risk for diabetes, every standard-deviation gain in cardiorespiratory fitness over a 9-month program was linked to 13-fold higher odds of carotid-artery wall thickness regressing [105]. A 100-day online Japanese workplace program produced statistically significant improvements in 7 of 9 metabolic syndrome indicators among men in the intensive group—including a 0.8 cm waist reduction—though the absence of a control group means regression to the mean can't be excluded [106]. Food insecurity is an underappreciated driver: 18.4% of US households with children face it, and food-secure adolescents had 40% lower odds of early cardiovascular-kidney-metabolic syndrome stages, with chronic stress, gut changes, and epigenetic effects compounding purely dietary pathways [107]. A review positions SGLT2 inhibitors as particularly well-suited across the full cardiovascular-kidney-metabolic syndrome continuum—contextualizing the AHA's CKM framework for Turkish epidemiology—while noting that identifying and stratifying patients remains a practical challenge [108]. In a cohort of 802 adult childhood cancer survivors, Western-style diets dominated but showed no significant link to cardiovascular disease or CVD risk factors, with sociodemographic factors appearing to shape diet quality more than health outcomes did in this population [109].

Several threads here point toward biology that's still being mapped. Fatty liver disease (MASLD) is appearing in an unexpected setting: after major pancreatic surgery, limited observational data link it to poorer survival and reduced ability to tolerate chemotherapy, driven by digestive and hormonal insufficiency rather than the usual metabolic risk factors—though prospective data are lacking [110]. MASLD is now also the fastest-growing contributor to liver cancer globally, and a review describes how non-coding RNA molecules regulate the full chain from fat accumulation to malignancy, making them active targets for early detection and treatment research [111]. Genetics can stack the deck considerably: a Moroccan case-control study found that a particular APOA5 gene variant (rs3135506 GG genotype) was associated with over 7-fold higher odds of metabolic syndrome, while a CETP variant also raised risk in unadjusted analyses [112]. A cross-sectional NHANES analysis found a higher platelet-to-HDL cholesterol ratio was associated with adult asthma prevalence, with risk running roughly 19–20% higher in upper quartiles compared to the lowest—pointing toward possible metabolic-inflammatory links worth investigating further [113]. On the drug-discovery side, a machine learning virtual screening study flagged seven already-approved drugs as candidate PPARδ modulators—relevant to metabolic and fibrotic disease—though lab confirmation of actual activity is still needed [114]. A review of soluble epoxide hydrolase inhibitors explains how blocking this enzyme preserves anti-inflammatory signaling molecules relevant to heart, metabolic, and brain disease, covering design strategies and the challenges of making such drugs viable in humans [115]. Reversing a Roux-en-Y gastric bypass—most often attempted when severe post-surgical low blood sugar becomes unmanageable—carries real short-term risk: a systematic review of 12 studies found a 39% complication rate and 15% reoperation rate within 30 days, with evidence certainty rated very low throughout [116]. PCOS is coming into sharper focus as a metabolic condition as much as a reproductive one: research including single-cell and transcriptomic studies indicates it impairs the uterine lining's ability to support implantation through hormonal, inflammatory, and metabolic mechanisms, though the full picture remains incompletely characterized [117]. A review of epigenetic evidence finds that DNA methylation of steroidogenesis genes, histone changes, and non-coding RNAs each contribute to PCOS's hormonal and metabolic disruption, with environmental exposures including endocrine-disrupting chemicals capable of triggering these modifications [118]. GLP-1 receptor agonists show consistent metabolic benefits in women with PCOS and related hyperandrogenic conditions, but a systematic review found hormonal and reproductive outcomes—including menstrual regularity—improved inconsistently across studies, underscoring the need for phenotype-specific trials [119].

BMI is a blunt tool for cardiometabolic risk. In a study of over 163,000 normal-weight Spanish workers, nearly half had at least one cardiometabolic abnormality (high blood pressure, elevated cholesterol, or high blood sugar), with men faring worse than women and the burden climbing in step with unhealthy habits like smoking, low physical activity, and poor diet [120]. Indian youth face a similar stacking of risks: a cross-sectional survey of 12,000 people aged 10 to 30 found that more than 15% used smokeless tobacco, nearly a third weren't physically active enough, and three-quarters reported moderate psychological stress, with daily salt and sugar intake both exceeding recommended limits [121]. The American Heart Association now bundles these overlapping problems under "cardiovascular-kidney-metabolic (CKM) syndrome," tracing the roots of heart disease through kidney and metabolic dysfunction all the way back to preconception; a review proposes multidisciplinary pediatric care built around this framework from early life, with dietitians, pharmacists, and community coaches working together [122]. In a Chinese cohort of older adults, cognitive health turned out to predict future CKM risk in unexpected ways: both reversible and potentially reversible cognitive frailty were independently associated with higher CKM risk (HRs 2.74 and 2.51), while improving to robust cognitive status was linked to more than halving that risk [123]. A decade-long watch on healthcare workers found metabolic syndrome prevalence rising from 20% to over 26%, with blood sugar climbing throughout even as some risk components briefly dipped during the COVID-19 years [124]. For people already deep in cardiac risk, coronary artery calcium (CAC) scoring is reshaping care: in a study of 215 patients, more than 40% of those with a CAC above 1,000 had actual myocardial ischemia, calcium score was the only independent predictor, and imaging results drove medication changes in over a third of patients [125]. In a general population cohort, epicardial adipose tissue (fat around the heart) independently predicted heart attacks in women but not men, with the strongest effect in women under 55 and a modest but significant improvement in predictive accuracy over standard risk tools [126]. A broad review reframes atherosclerosis as a whole-body inflammatory disease involving the immune system, the nervous system, the microbiome, and cellular adaptability, which partly explains why meaningful cardiovascular risk persists even with today's best therapies and why sex differences in how plaques behave remain so difficult to address [127]. At the genetic level, a genome-wide analysis in more than 480,000 people found moderate genetic overlap between PTSD and cardiovascular risk factors, particularly through lipid metabolism, vascular tone, and immune pathways, though the actual genetic correlation with cardiovascular disease outcomes was surprisingly small, with Chromosome 6 emerging as a convergence point for both [128]. Type 1 diabetes may be less uniform than it looks: machine learning on 600 adults with recent-onset T1D identified three distinct subtypes, with the "mixed" form (higher BMI, lower insulin sensitivity) carrying nearly five times the retinopathy risk of classic T1D and sitting roughly six years earlier on the beta-cell decline trajectory [129]. Sleep patterns interact with genetics to shape blood sugar in direction-specific ways: a genome-wide interaction study across more than 480,000 people found 16 loci where short or long sleep duration intersects with genetic variants to affect blood glucose and insulin, with the two sleep extremes implicating entirely different biological mechanisms [130].

The treatment picture for cardiometabolic disease is changing fast. SGLT2 inhibitors, validated across four major outcome trials in diabetic kidney disease, reduce cardiovascular and kidney complications largely independent of blood sugar control, with KDIGO, ADA, and ESC now listing them as foundational therapy; genital infections are the main downside, with rare but real risks of euglycemic ketoacidosis [131]. Empagliflozin reduces cardiovascular events, heart failure hospitalizations, and kidney disease progression across people with or without type 2 diabetes, with a safety profile low enough in hypoglycemia risk to be used safely during Ramadan fasting [132]. GLP-1 receptor agonists keep expanding their reach: in a real-world propensity-matched study of adults over 80 with heart failure, type 2 diabetes, and obesity, once-weekly semaglutide was associated with dramatically better daily functioning and heart failure health status at two years, alongside fewer hospitalizations and cardiovascular deaths [133]. The oral GLP-1 agent orforglipron produced mean body weight reductions of roughly 6 to 9% in a 72-week Japanese phase 3 trial, with gastrointestinal side effects consistent with the drug class [134]. A review cautions that these agents deserve extra scrutiny in older adults, as a substantial portion of the weight loss may come from lean mass rather than fat, raising frailty and malnutrition risks; when the drug is stopped, fat tends to return faster than muscle, making resistance training and adequate protein essential co-interventions [135]. Tracking food purchases among people starting GLP-1 treatment found early encouraging shifts toward more protein, fiber, and produce, but by ten months those patterns had largely reverted, with high and low weight-loss responders showing similar shopping behavior except for greater salt increases among low responders at five months [136]. For people with diabetes after total pancreatectomy, switching to an advanced hybrid closed-loop insulin system raised median time-in-range from 54% to 72%, cut hypoglycemia duration, and meaningfully eased anxiety about low blood sugar, with improvements stable over six months [137]. Standard HbA1c testing misses a lot in advanced kidney disease: an Italian health technology assessment found glycated albumin flagged poor glycemic control in 52% of patients versus only 19% with HbA1c, with healthcare professionals rating it higher on safety, effectiveness, and care pathway management [138]. Potassium balance carries serious cardiovascular stakes at both extremes: low potassium appears in up to 20% of hospitalized patients and raises the risk of dangerous arrhythmias, while high potassium complicates chronic kidney disease and heart failure management; a review notes that dietary sources like bananas are insufficient to correct hypokalemia, which requires supplementation under continuous ECG monitoring [139]. One meta-analysis on verapamil and type 2 diabetes risk illustrates the limits of observational data: two cohort studies suggested a possible 22% lower risk, but the result was statistically imprecise, heavily method-dependent, and both studies carried serious risk of bias from residual confounding [140]. Adding probiotics to caloric restriction did not significantly improve weight, BMI, body fat, or waist circumference compared with energy restriction alone in a meta-analysis of 16 randomized trials; a small reduction in fat mass reached statistical significance, but its clinical relevance remains uncertain [141]. A small quasi-experimental study of enriched Golden Rice cookies in 102 adults with diabetes found a significant total cholesterol reduction, but only among those not already taking statins, with no significant effects on LDL, HDL, or triglycerides; longer, properly randomized trials are needed [142]. Achieving substantial weight loss (at least 40% of excess weight over one year, through bariatric surgery or intensive medical treatment) was linked to MRI-visible increases in subcortical gray matter and preservation of Alzheimer's-vulnerable brain regions, though cognitive test scores themselves were unchanged at one year [143].

Underneath all of this sit metabolic mechanisms still being mapped. A multi-omics study integrating transcriptomic, genetic, and proteomic data across MASLD stages identified 39 candidate regulatory genes, with single-nucleus RNA sequencing revealing stage- and cell-type-specific expression patterns; in a lipid-overloaded hepatocyte model, one gene (MLIP) was confirmed as a functional driver of fat accumulation [144]. A bibliometric sweep of 725 publications on the Mediterranean diet and fatty liver disease found research output surging from 2014 onward, with Italy, Spain, and the US leading; the field has shifted from individual nutrients toward metabolic mechanisms and gut microbiota, with MASLD now replacing NAFLD as the central term [145]. Two stress-response hormones, FGF21 and GDF15, are both elevated in obesity, type 2 diabetes, fatty liver disease, and aging, sharing triggers that include nutrient imbalance, inflammation, and oxidative stress; a review frames them as complementary coordinators of energy balance and candidate therapeutic targets, while noting their effects depend heavily on context [146]. Branched-chain amino acids (BCAAs) are consistently elevated in insulin resistance and obesity, yet tissue-specific genetic animal models show that simply lowering circulating BCAA concentrations doesn't reliably improve insulin sensitivity; human evidence for effects on insulin sensitivity or appetite remains limited, and a review argues these amino acids function as part of a tissue-specific metabolic signaling network rather than acting as simple markers [147]. A machine-learning model predicted severe chemotherapy toxicity in 513 colorectal cancer patients with diabetic nerve damage with an AUC of 0.88, significantly outperforming standard regression, with poor glycemic control and high cumulative drug dose identified as the strongest predictors; the findings are associative and need prospective external validation before guiding clinical decisions [148]. In 459 patients assessed before a transcatheter aortic valve procedure, eight serum-based nutritional scoring tools frequently disagreed about who was at risk, with a principal component analysis revealing one underlying dimension explained most of the variance; most scores independently predicted mortality, but no single tool clearly outperformed the others [149].

A flurry of work is mapping the biology beneath insulin resistance. In European adults with type 2 diabetes, total ceramides were significantly elevated in those with the worst TyG scores, with nearly every ceramide species tracking the index closely [150]; across more than 5,000 U.S. adolescents, the same TyG index (alone or combined with body-composition measures) was strongly tied to prediabetes risk, with no composite version outperforming the standalone score [151]. Among postmenopausal women, SHBG stood out as the only sex hormone independently linked to TyG, with higher levels predicting lower insulin resistance [152]. A large genomic analysis identified over 100 shared risk loci for insulin resistance, clustering around fat-distribution genes and adipose tissue pathways [153], while in men with type 2 diabetes the protective protein omentin-1 dropped sharply with each step up in BMI, inversely tracking inflammatory markers like TNF-α, IL-6, and HOMA-IR [154]. A narrative review framed the whole picture as a "β-cell Stress Continuum," a spectrum in which immune, metabolic, and oxidative stressors chip away at insulin-producing cells differently depending on diabetes subtype [155]. The insulin resistance story extends to reproductive health: a review recast polycystic ovary syndrome as "polyendocrine metabolic ovarian syndrome," weaving together gut dysbiosis, chronic inflammation, and distinct molecular subtypes identified through multiomics [156]. Hormonal contraceptive choice also matters metabolically: across just four human studies that met inclusion criteria, levonorgestrel impaired glucose tolerance more than an etonogestrel vaginal ring, and estrogen-progestin combinations improved insulin sensitivity in lean women but worsened it in those with obesity [157]. On the mechanistic side, dietary fructose from sugary drinks is proposed to hijack a normally rate-limited liver pathway, driving unregulated fat synthesis and organellar stress in metabolic liver disease [158]. Sleeve gastrectomy, meanwhile, appears to suppress a stress enzyme called 11βHSD1 in fat tissue, reducing IL-6 and improving glucose handling even in lean mice that lost no weight, hinting at a metabolic benefit independent of the scale [159].

The cardiovascular picture is filling in from several directions at once. Long-term follow-up from the Bogalusa Heart Study shows that cumulative childhood exposure to high LDL, elevated blood pressure, and obesity independently predicts thicker carotid artery walls in adulthood, with adolescence singled out as a critical window for intervention [160]. That vascular damage can accumulate silently: in high-risk metabolic patients, nearly a quarter were in "false control," with LDL-c on target but ApoB still elevated, and 73% of them had detectable carotid plaque compared with 36% of those with true lipid control [161]. The 2026 ESC Congress added more ammunition, reporting that atorvastatin reduced major cardiovascular events in adults over 70 without established heart disease, plozasiran substantially cut triglycerides and pancreatitis risk in severe hypertriglyceridemia, and inclisiran outperformed bempedoic acid for LDL-C target attainment [162]. Despite these advances, calcific aortic valve disease remains a frustrating frontier: no pharmacological treatment tested in randomized trials, including statins, blood pressure drugs, bisphosphonates, and vitamin K, has shown consistent disease-modifying efficacy, though preclinical work shows senolytics (drugs that clear aging cells) reduce calcification in vascular models [163]. An intriguing small case-control study found that people who had a heart attack had a distinctly different oral microbiome from controls, with a four-metabolite saliva panel distinguishing MI patients from controls with an AUC of 0.92 to 0.94 [164]. In peripheral artery disease, better cardiovascular health scores independently predicted lower all-cause and cardiovascular mortality over roughly a decade, with smoking identified as the single most impactful modifiable factor [165]. Among over 1,400 stroke survivors, unemployment, low income, and lack of private insurance each independently raised the risk of death, with cumulative social disadvantage driving mortality upward in a dose-response pattern [166]. In Iranians with premature atherosclerotic cardiovascular disease, excess weight was present in more than 80% and metabolic syndrome affected up to 83%, and male sex was independently linked to lower Mediterranean diet adherence [167]. In breast cancer patients, the LDL-to-HDL ratio was elevated in older and postmenopausal women with higher BMI but did not independently predict hormone receptor status, as menopausal status alone explained the pattern [168]. A large UK cohort study linked two osteoporosis drugs to slightly elevated cardiovascular risks in women, with zoledronic acid associated with higher atrial fibrillation rates and ibandronate with higher MI rates, though both findings rested on small event counts and potential confounding [169].

The intervention landscape is similarly active. Fat cells that enter a state of irreversible stress, a process called adipocyte senescence, are now linked to obesity, type 2 diabetes, fatty liver, and cardiovascular disease; researchers are exploring senolytics, caloric restriction, and exercise as ways to clear or quiet them, with lipid prodrugs proposed as a way to concentrate drug delivery directly in adipose tissue [170]. Obesity's effects cut in unexpected directions: a review described the well-known survival paradox in renal cell carcinoma, alongside evidence that GLP-1 receptor agonists can reverse metabolic hypogonadism and slow chronic kidney disease progression [171]. In a 30-month randomized trial of 600 adults with overweight, a coaching-led digital weight-management program showed no meaningful difference from control at six months, but by 30 months the intervention group had significantly smaller BMI gains (0.13 versus 0.58 kg/m²), suggesting patience is part of the prescription [172]. Automated insulin delivery systems already improve time-in-range and cut hypoglycemia in type 1 diabetes, and available evidence suggests those benefits extend to adults over 65, though cognitive and digital literacy barriers in that group still warrant dedicated trials [173]. For people with diabetes and peripheral artery disease, a systematic review found that supervised exercise improved ankle-brachial index and blood flow while leaving walking performance measures inconsistent, and Mediterranean diet adherence was associated with better vascular outcomes on low-to-moderate quality evidence [174]. A small randomized trial in chronic kidney disease found that nightly melatonin significantly improved sleep quality, though its effect on urinary protein did not reach statistical significance despite a numerical reduction [175]. Dietary polysaccharides show lipid-lowering and anti-obesity effects in cell and rodent studies, potentially through gut microbiota changes and AMPK activation, but human clinical trial data is sparse and extrapolation to people remains premature [176]. In diabetic patients hospitalized with pulmonary tuberculosis, more than one in three (38.4%) had simultaneous extrapulmonary TB, most commonly in the pericardium and meninges, with the highest risk in those with multiple lung cavities [177]. Among teenagers with diabetes, average eating attitude scores fell below the standard clinical concern threshold, and no significant link appeared between eating attitudes and blood sugar control, though scores varied with BMI and treatment type [178]. And a carefully constructed Traditional Chinese Medicine knowledge graph for hypertension with emotional comorbidities did not improve clinical question-answering accuracy over model-only generation in a matched experiment, a useful reminder that rigorous validation must precede clinical use of AI-assisted tools [179].

Cardiovascular risk keeps revealing itself as a web rather than a chain. A UK Biobank analysis of nearly 3,000 adults found that lipids tend to drive arterial stiffness — ApoB predicted pulse wave changes in men and triglycerides predicted multiple stiffness markers in women — though both effects disappeared once blood pressure was added to the model, suggesting blood pressure may be the key intermediary rather than a downstream effect [180]. A separate genome-wide transcriptome study in almost 7,000 people found that triglyceride-related genes cluster in immune and allergy pathways as much as in classic fat metabolism, with novel variants linked to cardiovascular disease and triglyceride balance [181]. The layering of risk factors matters enormously: in over 313,000 UK Biobank participants followed for about 16 years, having both a fatty liver and an advanced cardiometabolic stage more than doubled the risk of a major cardiac event (HR 2.33) and raised the odds of a serious liver event fivefold (HR 5.09), with fatty liver accounting for 41% of the link between cardiometabolic stage and liver events [182]. A review of SGLT2 inhibitors found that beyond lowering blood sugar, these drugs appear to calm the heart's overactive nervous system — meta-analyses show modest but consistent reductions in atrial fibrillation, with preclinical work implicating several microRNAs and ion channel effects as the likely mechanisms [183]. A review explains that it's specifically visceral fat dysfunction — through impaired blood vessel growth and persistent low-oxygen stress — that most strongly drives insulin resistance and bodywide inflammation, with single-cell studies showing that even the same fat cell type behaves differently depending on where it sits [184]; an Egyptian expert consensus reinforces this shift away from BMI alone, recommending waist circumference, waist-to-height ratio, and body composition as front-line obesity tools alongside culturally adapted diet and exercise guidance [185]. A pilot study in kidney disease patients who carry high-risk APOL1 variants found that group had higher BMI, more central abdominal fat, and worse kidney function markers — framing excess body fat as a potentially modifiable precision nutrition target in this genetically at-risk group [186]. In a NHANES cohort of adults with peripheral artery disease, those with high functional vulnerability faced nearly 35% higher all-cause mortality even after adjusting for other cardiovascular risk factors [187]. A 4-week RCT of adults with elevated cholesterol found that triglycerides fell within the pumpkin seed and pumpkin seed oil groups but not the control group, though the differences between all three groups didn't reach statistical significance for any lipid measure [188]. A modeling exercise found that even a potassium-biofortified tomato at 600 mg per 100 g — a level no current cultivar reliably achieves — would supply only about 17% of the daily potassium target at a standard 100 g serving, too small an increment to reliably extrapolate cardiovascular benefit from existing potassium trial data [189].

The diabetes landscape is shifting on multiple fronts at once. Among 24 adults with type 1 diabetes who switched to a smart multiple daily injection system, time-in-range jumped from 56% to 66% over six months, with improvements appearing even among those not counting carbohydrates [190]. A study using large language models to parse free-text Chinese diet records found that LLM-derived nutrient estimates outperformed traditional embedding methods for predicting postprandial blood sugar in two real-world diabetic cohorts, cutting 3-hour forecasting error by about 2 mg/dL [191]. In 110 adults with type 2 diabetes wearing continuous glucose monitors during Ramadan, time-in-range rose from 61% to 65% and sensor glucose fell by 12 points — though most of those gains reversed after fasting ended [192]. A phase 2 RCT of acmopatide in 111 overweight adults with type 1 diabetes found it reduced HbA1c by 0.3 percentage points more than placebo and cut body weight by 3–7%, with no diabetic ketoacidosis or severe hypoglycemia [193]. A cautionary case report described a non-diabetic young woman who developed serious ketoacidosis after just five days of oral semaglutide prescribed off-label for weight loss at a normal BMI, with everything resolving after stopping the drug — a reminder that GLP-1 agonists carry risks outside their studied populations [194]. In a long-term follow-up of kidney transplant recipients who developed post-transplant diabetes, nearly 87% were still on glucose-lowering therapy at a median of six years out, and the persistent-treatment group showed a steeper drop in kidney function and more proteinuria — descriptive findings the authors flag as hypothesis-generating rather than causal [195]. Among Thai women with gestational diabetes, almost half had abnormal glucose tolerance at six weeks postpartum, but early post-delivery testing agreed poorly with the six-week result — many women who looked fine before discharge had problems six weeks later, and vice versa — underscoring how much the timing of postpartum screening matters [196]. A cross-sectional study of 295 adults with type 2 diabetes in South India found that Malayalam speakers had nearly double the diabetic retinopathy prevalence of Tamil speakers in the same geographic area (50% vs. 31%), alongside higher saturated fat intake and longer diabetes duration [197]. A meta-analysis of 11 RCTs found that social media–based diabetes education reduced HbA1c by about 0.44 percentage points on average — meaningful in direction but just shy of the 0.5% clinical threshold — with programs longer than three months working far better than shorter ones, though the evidence was highly heterogeneous [198]. Financial stress compounds things considerably: in 566 adults with elevated HbA1c, financial toxicity independently predicted higher diabetes distress even after controlling for biological and social factors, with psychological distress the strongest correlate overall [199]. A pharmacogenomics study found that neither the IRS1 nor pancreastatin genetic variant predicted how well patients responded to metformin plus sulfonylurea, though the IRS1 TT genotype did correlate with higher baseline cholesterol, triglycerides, and LDL [200]. A mechanistic review identified five key inflammatory signaling pathways at the root of PCOS and catalogued 18 traditional Chinese medicine compounds that target them — though it notes that clinical evidence for most of these compounds remains limited [201]. A cross-sectional study across two cohorts found that the metabolic score for insulin resistance (METS-IR) was independently and linearly linked to adolescent myopia, with obesity amplifying that association synergistically rather than simply adding to it [202].

On the intervention and nutrition science side, a small 20-patient study found that 48 hours after gastric bypass surgery both sodium excretion and blood pressure were essentially unchanged, suggesting early sodium handling probably doesn't explain the rapid blood pressure improvement that can follow the procedure [203]. A year-long RCT of 200 older hypertensive adults found that an AI-assisted management program raised blood pressure control rates from 65% to nearly 89%, with systolic pressure about 7 mmHg lower and meaningful gains in diet adherence, exercise, and quality of life [204]. Among 154 hypertensive adults at high altitude in Peru, overall diet quality was low, and in the treated subgroup each higher diet quality quartile was associated with about 4 mmHg lower systolic blood pressure — though the relationship wasn't significant in the full sample [205]. A 6-week pilot RCT comparing a web-based DASH program to DASH plus mindful eating found no meaningful differences between groups in blood pressure or cardiometabolic biomarkers, though the mindful eating group did show better cognitive dietary restraint [206]. A 4-week RCT in 68 women comparing 16:8 and 5:2 intermittent fasting found both produced nearly identical results — about 2.7 kg of weight loss and 1.7 kg of fat loss — with no meaningful differences in waist circumference or blood pressure between the two approaches [207]. In food science, researchers isolated a 36 kDa annexin protein from white kidney beans that inhibited the starch-digesting enzyme α-amylase in a concentration-dependent way in the lab, with molecular dynamics simulations confirming a stable complex — a bench-level finding with potential relevance to postprandial blood sugar [208]. And a 180-day feeding trial in cats found that a high-protein diet limited body weight loss compared to a low-protein one, with L-arginine emerging as the amino acid mediating this effect — the kind of mechanistic animal finding that may eventually inform how protein quality is understood in human nutrition research [209].

Your genes may shape how well a vitamin works for your heart. People who carry two copies of the MTHFR C677T variant — a quirk that impairs riboflavin-dependent folate metabolism — face a higher risk of high blood pressure, and randomized trials show that riboflavin supplements specifically bring that pressure down in this group, regardless of whether they're already on medication [210]. What makes this especially striking is how common this genotype is in some parts of the world: up to 66% in Guatemala, 32–44% in Mexico, and 24% in Northern China — making a cheap B vitamin a potentially powerful, targeted tool for hypertension prevention in those populations. Research into what lipoproteins actually carry is also reshaping how we think about heart protection: beyond shuttling cholesterol, these particles transport bioactive molecules — including sphingosine 1-phosphate, which travels with a protein called ApoM — that actively protect blood vessels, reduce clotting risk, and may guard kidney function, while clinical lipidomics work ties certain minor lipid passengers to acute coronary syndrome [211].

Two other vascular and metabolic pathways are attracting fresh attention. The amino acid tryptophan has a lesser-known breakdown route — driven by an enzyme called IDO1 — that produces metabolites influencing plaque stability, blood pressure, and even placental blood flow through mechanisms distinct from the more familiar nitric oxide system; dietary and drug strategies targeting this pathway are being explored, though sex-specific effects and the roles of related enzymes remain largely uncharted [212]. GLP-1 receptor agonists show anti-inflammatory and tissue-protective effects in experimental models related to diabetic foot ulcers, and observational data suggest favorable associations with fewer amputations and wound complications — though the evidence isn't uniform across comparative studies and unresolved questions remain about lean mass loss as a byproduct of the weight reduction these drugs produce [213]. In 49 children with an inherited high-cholesterol condition, those treated with statins or ezetimibe had effectively lower lipid levels yet still showed nominally elevated levels of a macrophage activation marker called YKL-40 compared to controls, suggesting the inflammatory side of artery disease may not be fully quieted by lipid-lowering drugs alone [214].

Zooming out to lifestyle and real-world data: a large analysis across nine U.S. metro areas and more than 15,000 census tracts found that more frequent greenspace visits were inversely linked to obesity rates in seven of the nine cities — Houston showing the strongest effect — and a separate clinical cohort of over a million patients confirmed the association across all BMI severity levels [215]. A real-world analysis of 25,742 people using an automated insulin delivery system across the Asia-Pacific region found that glycemic outcomes were clinically similar between Australia/New Zealand and the rest of the region, even though daily carbohydrate intake was markedly higher elsewhere (around 210 g vs. 147 g per day), with time in range actually improving in higher carbohydrate quartiles [216]. And in a two-year study of 671 people with HIV who switched to a long-acting injectable antiretroviral regimen, mean body weight was essentially stable overall (−0.18 kg, not statistically significant), though those with obesity lost a small but significantly greater amount; total cholesterol rose modestly while HDL increased too, leaving the total-to-HDL ratio unchanged [217].

Most of the molecular and mechanistic findings here — from ceramides to miRNAs to vesicle-mediated insulin resistance — are still early-stage biology that hasn't yet translated into actionable clinical advice, so resist the urge to overinterpret them. Worth watching: the EVOID-AS trial, which is testing whether a DPP-4 inhibitor can actually slow calcific aortic valve disease — a condition where every drug tried so far has failed — with results due in 2028.

Evidence for eating a wide variety of colorful plants keeps stacking up. In a cohort of nearly 4,600 older adults followed for 7.5 years, those with the highest intake and diversity of dietary bioactive pigments — think tea, berries, apples, peaches, and dark chocolate — had 37% lower all-cause mortality compared to those eating the least [1]. A Korean hospital-based case-control study found that a Prudent dietary pattern — vegetables, legumes, fish — was linked to roughly two-thirds lower colorectal cancer odds for both early- and late-onset patients, while the Western dietary pattern skewed more toward the younger cases [2]; a separate case-control study meanwhile found that eating fast food daily or weekly was associated with more than double the colorectal cancer odds compared to infrequent consumption, with behavioral exposure rather than simply living near a fast-food outlet driving the association [3]. A metabolomics analysis of two DASH feeding trials added biological detail to what had been mainly dietary advice, identifying specific blood metabolites — especially elevated N-methylproline and reduced theobromine — that track the diet's blood-pressure-lowering effect [4]. A controlled-feeding trial complicates the Mediterranean diet picture: it found that the caloric deficit this eating style typically creates may explain more of its anti-inflammatory effect than its distinctive food combinations do [5]. In chronic kidney disease patients followed for 15 years, a metabolomics study found plasma glycerophospholipids ran inversely to both ultra-processed food intake and mortality risk, with three other metabolites — C4-OH carnitine, myristoleate, and aconitate — rising alongside UPF consumption [6]. And a clinical review reminded us that most UK adults and children still fall short of fibre recommendations, with soluble, insoluble, resistant starch, and prebiotic subtypes each carrying distinct implications for gut, cardiovascular, and metabolic health [7].

The risks hiding in the food system itself deserve as much attention as what ends up on the plate. Drug-resistant bacterial infections already kill an estimated 1.27 million people a year globally, a toll projected to grow roughly tenfold by 2030, with antibiotic use in livestock and aquaculture, contaminated irrigation water, and post-harvest practices all implicated in spreading resistance through the food chain [8]. A systematic review of 29 studies across 18 countries found antibiotic residues in poultry in 28 of them, with a median study-level positivity close to 45%; in some Egyptian and UK products, fluoroquinolone levels reached hazard quotient values above 3 [9]. Ten years of food safety surveillance in Kosovo found 8.14% of animal-origin samples positive for Salmonella overall, with whole chicken products reaching 28.46% positivity [10]. There is also a subtler concern: heat kills bacteria, but it doesn't destroy their DNA — a review notes that antimicrobial resistance gene sequences persist after pasteurization, and while functional gene transfer from heat-killed foodborne material to gut bacteria has not been demonstrated in living systems, the authors propose a research index to track the risk going forward [11]. On the decontamination side, UV-C light can inactivate pathogens on ready-to-eat salads without compromising nutrients or flavor, and water-assisted delivery substantially outperforms direct UV-C alone [12]. Then there's what never reaches a plate at all: an estimated 22.7% of the U.S. edible aquatic food supply was lost or wasted between 2014 and 2018, a figure the authors translate into protein, long-chain omega-3s, and micronutrients that could meaningfully improve nutrition security if recovered [13].

What people eat is inseparable from the conditions they live in. A systematic review of 38 adolescent studies found that higher parental education was the most consistent predictor of better diet quality, with lower socioeconomic position linking reliably to more ultra-processed food, more breakfast skipping, and fewer fruits and vegetables [14]. In the U.S., Pandemic EBT benefits showed a modest but real effect: each extra $500 in annual benefits was associated with 3% higher food spending and meaningfully lower household food insecurity the following year [15]. A cluster randomized trial testing a mobile food market across subsidized housing sites found no overall improvement in diet quality scores, but it did cut sodium intake by roughly 400 mg per day — a potentially significant cardiovascular benefit at scale — even though fewer than half of participants shopped there regularly by the trial's end [16]. Latino farmworkers in California's Imperial Valley cited occupational time constraints, food insecurity, and limited grocery store access as the main barriers to healthy eating, and asked for on-site, culturally tailored programs rather than general advice [17]. In Northern Benin, secondary school students described most food available at and near their schools as energy-dense, high in sugar, and rarely including fresh produce — with hygiene concerns adding another layer of risk, particularly in rural settings [18]. There's a neurobiological dimension to children's vulnerability too: the prefrontal cortex doesn't finish maturing until around age 25, leaving kids and teens with limited impulse control and an amplified dopamine response to palatable foods — a gap that ultra-processed products are designed to exploit, feeding the pediatric obesity epidemic [19]. Among Latin American university students, nearly 4 in 10 skipped breakfast three or more times a week, and those students consistently scored lower on physical, psychological, and environmental quality-of-life measures [20]. A survey of Jordanian students found conscientiousness linked to healthier eating while higher negative emotionality tracked with poorer diet quality [21], and Chinese university students' frequency of eating light meals was driven primarily by specific dietary needs rather than by gender, spending, or campus supply [22]. Adults with spinal cord injury consumed about a third less energy than matched controls — driven by lower absolute intake rather than worse food choices, though over 90% still fell below vitamin D and vitamin E adequacy thresholds [23]. In young adults in Merida, Mexico, university students ate fast food roughly half as often as non-students (2.8 vs. 5.0 times per week), yet ultra-processed foods still made up about one-third of weekly intake in both groups [24]. On the production and technology side, eight processing innovations — including high-pressure processing, pulsed electric fields, and ozone treatment — can reduce antinutrients and shorten cooking times in legumes like lentils and chickpeas, though most remain at pilot rather than commercial scale [25]; a circular biorefinery concept using fruit-processing waste and CO₂/hydrogen gas fermentation achieved up to 74% protein in microbial biomass, though a fully integrated food-grade platform remains unrealized [26]. Consumer receptiveness to novel proteins like seaweed is uneven: across a cross-cultural survey in Ireland, Norway, Spain, and Turkey, "salty" dominated taste associations everywhere, while "metallic" and "chewy" were consistently the most off-putting descriptors [27]. AI-based dietary tools are advancing but carry real limits: two reviews found CNN-based food image recognition can match human accuracy for portion estimation under controlled conditions, and machine learning models integrating microbiome and clinical data show improved glycemic response prediction — but LLM chatbots show inaccuracies, micronutrient omissions, and lower empathic quality than registered dietitians, and neither review's evidence supports replacing nutrition professionals with AI [REF:56dd1hdb-2192-4405-b66c-40593df2923c][28]. Medical education is trying to close some of the cultural competency gap: a culinary medicine curriculum at a U.S. osteopathic medical school produced significant gains in students' self-assessed confidence in cross-cultural nutrition counseling [29], while a newly validated Mediterranean diet knowledge questionnaire showed strong reliability in adults — though its usefulness in children and adolescents is still being tested [30].

Food insecurity reaches further than most of us assume. 78.2% of Ghanaian university students were food insecure on campus, and among women, more than four in ten were anaemic — female sex was the strongest independent predictor, with an adjusted odds ratio of 7.05 [31]. Asylum-seeking families in England faced five layered barriers — insufficient income, culturally unsuitable food support, unaffordable transport, inadequate settlement services, and the mental and physical toll of all of the above — sometimes forced to choose between food and nappies [32]. A market survey in rural Bihar found that remote areas simply had less variety of nutrient-dense food available, not necessarily higher prices, pointing to supply and infrastructure as the levers to pull [33]. A mixed-methods study in rural South Korea found roughly 45% obesity prevalence with no real age-group differences, sodium over the limit across all ages, and geographic isolation flagged as a key structural driver [34]. Context shapes what works: the Samaki Salama community nutrition trial in coastal Kenya showed that social marketing through home visits and cooking demonstrations improved diets and child growth — but the clearest pathway was fishers keeping more of their catch for their own households, not families spending more on food [35]. Zoom out further and the trade-offs multiply: a DHS analysis across 38 lower- and middle-income countries found that women's education reduced the double burden of malnutrition in less globalized settings, but that protective effect reversed in more urbanized, economically globalized regions — a reminder that education alone can't counteract the nutrition risks that come with rapid modernization [36].

What people are actually eating reflects both their circumstances and the environments nudging their choices. Among Moroccan adolescents, 53.6% had low Mediterranean diet adherence and only 7.8% had optimal adherence, with girls scoring lower than boys [37]; Swedish youth on more restrictive plant-based diets were meanwhile falling short on vitamins D, B12, and selenium — with vegans also low on calcium — while getting more fiber and less saturated fat than omnivores [38]. An analysis of 1.2 million school lunch records from South Korea found seasonal variation was highest in kimchi and desserts, while main dishes stayed the most stable — the staple scaffolding of rice, noodles, and soups held firm even as individual items rotated [39]. The food environment shapes these patterns in powerful ways. Restaurant meals are well-documented as high in calories, saturated fat, and sodium, and a review of interventions found that quietly swapping the default side dish in children's meals to a healthier option consistently outperformed strategies that just gave parents more information [40]. Online delivery apps are pulling in a similar direction: a narrative review found they predominantly push energy-dense, nutrient-poor foods with limited regulatory oversight [41], and focus groups with 112 Australian adults confirmed that most people see meal delivery apps as a treat platform — with deals driving their use — not as a healthy eating tool [42]. Attempts to hold advertising accountable are running into structural problems too: a mystery-shopper audit of complaints to South African regulators found that none of 11 complaints were substantively resolved, with the self-regulatory body applying a "specifically directed to children" test too narrow to account for real-world exposure [43]. Labeling shows more promise: surveys of Mexican American adults in the US found that awareness of Mexico's front-of-package warning labels on beverages was associated with actually buying fewer sugary drinks, raising genuine questions about policy transferability [44]. The health stakes are real. In a prospective cohort of over 92,000 Korean women, eating high-sugar foods more than twice a week was linked to a 28% higher breast cancer risk — but fruit, which accounted for nearly 43% of total sugar intake in this group, showed no such association, suggesting sugar source matters more than total sugar [45]. In 210,839 UK Biobank participants, each one-point increase in an energy-adjusted dietary inflammatory index was tied to a 4% higher overall thyroid disease risk and a 10% higher hyperthyroidism risk, with inflammatory markers including C-reactive protein partially mediating those links [46]. A small psoriatic arthritis screening study found that biologic therapy combined with Mediterranean diet adherence produced the greatest pain reduction at one month compared with biologic treatment alone [47]. And a comprehensive review reinforced just how much context drives nutrient adequacy: disease, genetics, food matrix, and processing all shape how much of a nutrient actually reaches the body, and no single strategy works across all populations [48].

On the innovation side, the pipeline of new food options and delivery tools is active, if uneven. A scoping review found parents were more open to traditional plant-based alternatives like lentils, tofu, and beans than to novel processed products, while kids were often more receptive — especially when products looked like meat and were framed around sustainability and animal welfare [49]. A narrative review described hemp milk as rich in omega-3 and omega-6 fatty acids and potato milk as a low-fat, allergen-friendly option — though without clinical comparison data to show how either performs in practice [50]. Fermentation using Propionibacterium freudenreichii can synthesize vitamin B12 within plant-based foods, with new fungal-bacterial cofermentations reaching concentrations far above earlier attempts — but no controlled human trial has yet confirmed whether this B12 is actually absorbed, leaving nutritional claims unvalidated for now [51]. Cookies made with mushroom fiber from bio-residues reached 8.85 g fiber per 100 g at 12% substitution, with the highest antioxidant activity at that level — though sensory testing hasn't been done yet [52]. Food engineers working on a beef-based chip achieved crispiness scores significantly above the unoptimized version, and micro-CT imaging showed the pore structure closely resembling a commercial potato chip, with consumer and shelf-life testing still ahead [53]. A systems-level perspective proposed framing food science around a "Dietome" — connecting food structure to measurable biological responses including digestion and microbial metabolism — while flagging dietary microRNAs and long-term nutritional memory as promising but still-unvalidated pathways [54]. China's organic product certification program appears linked to more organic farmland in host provinces with positive spillovers to neighboring provinces, though the provincial-level analysis makes the evidence suggestive rather than definitive [55]. Technology is making inroads in dietary support too. In a small RCT of gastrointestinal cancer surgery patients, AI-assisted individualized nutritional guidance achieved significantly higher energy adequacy (66.7% vs. 40.0%) and protein adequacy (62.2% vs. 35.6%) at 30 days compared to standard discharge advice, with provider time reduced as well — though the trial can't separate the AI's contribution from the broader individualization [56]. A mobile health study with 15 Korean female students found that peer facilitation through a structured app turned self-monitoring into sustained behavior change, while participants without that social scaffolding struggled more when group members lapsed [57]. A "Food is Medicine" web app for breast cancer survivors received moderate usability scores — users found the meal-building guidance useful but wanted a more mobile-forward design [58]. An upcoming SWITCH trial will test whether a DASH-enhanced Portfolio diet built around high-UPF versus low-UPF soy protein makes a blood pressure difference in 300 adults with hypertension and obesity — with noninferiority of the ultra-processed soy option as a deliberately built-in hypothesis [59]. And a systematic review of 17 prospective cohort studies found no consistent evidence that meal timing patterns — when you eat, how often, how long you fast — link to cancer incidence or mortality, with the best available meta-analysis on eating frequency and colorectal cancer returning non-significant and rated very low quality [60].

The parts of produce we usually throw away pack more of a nutritional punch than most people realize. A study testing 12 types of fruits and vegetables found that the peels, skins, seeds, and stalks delivered more dietary fiber than the edible flesh in 10 of those 12 types, with fiber content ranging from 2.10 g/100 g in watermelon skin to 9.25 g/100 g in butternut squash skin and seeds, and focus group participants said nutritional benefits, particularly fiber, motivated them to try root-to-tip eating more than sustainability arguments did [61]. A review of edible insects in India documented over 300 species consumed across at least 14 states, some reaching 65.81% protein by dry weight, with roasting at 70–100°C preserving more of that protein than boiling, though the same review notes that no food safety surveys or species-specific regulatory standards exist yet [62]. A Norwegian dietary survey found that plant-based meat and dairy alternatives are still far from mainstream, with only 8% of adults consuming them at least twice a week, and while many products scored well on salt, sugar, and saturated fat, most unfortified versions had lower micronutrient content than the animal foods they replaced, so nutritional outcomes varied widely by product choice [63]. For the more than 500 million people who depend on cassava, sweet potato, yam, potato, taro, and plantains as dietary staples, a review highlights 30–40% post-harvest losses and food safety risks from antinutritional compounds (cyanogenic glycosides in cassava, glycoalkaloids in potato), while pointing to newer processing technologies like high-pressure processing and pulsed electric fields as better options for preserving heat-sensitive nutrients than traditional cooking [64].

Healthy dietary patterns keep earning their reputation, though the evidence is more nuanced than headlines often suggest. A large observational study tracking 8,716 cancer survivors in the UK Biobank for a median of 12.3 years found that those with the highest adherence to Mediterranean, AHEI-2010, or DASH-style eating had 18–37% lower cardiovascular disease risk, with an estimated 1.66 to 3.32 extra life-years at age 45 for the highest compared with lowest adherence [65]. A 20-year Swedish prospective cohort study of adults starting at age 70 found a higher Mediterranean Diet Score was associated with lower dementia risk in men (HR 0.83), though this association did not survive correction for multiple testing, was not seen in women, and no significant links to mortality, cardiovascular disease, or cancer emerged in either sex [66]. In the Loma Linda Blue Zone community, a cross-sectional survey found vegetarians had a significantly lower mean BMI (24.8 vs. 27.0 kg/m²) than non-vegetarians, but younger and non-Seventh-day Adventist residents were far more likely to be non-vegetarian, hinting at a generational drift away from the plant-based patterns the community is known for [67]. A cross-sectional study of 600 women with breast cancer found that each one-unit rise in Dietary Inflammatory Index was associated with meaningfully worse sleep quality scores, flagging dietary inflammatory potential as a modifiable factor for sleep in this population [68]. A scoping review of 78 studies found that rainfall variability was associated with child stunting and food insecurity, while higher mean temperatures and heatwaves were linked to lower weight-for-height, weight-for-age, and birth weight in children, with the evidence concentrated overwhelmingly in Africa and in children under five [69]. A cross-sectional study of 200 Indian adults found that more conscious eating correlated with greater dietary diversity, but the data suggested it emerged as a consequence of having a noncommunicable disease rather than as a preventive practice [70].

The food environment shapes choices in ways that go well beyond individual willpower, and some risks arrive without any label at all. A quasi-experimental study in Indonesian high schools found that traffic light labeling on beverage menus, combined with a brief educational session, produced significant reductions in energy, sugar, and fat from the drinks students actually purchased [71]. A study of 1,245 English adolescents across 222 schools found that having just one or two supermarkets within 400 meters of the school boundary was associated with 61% higher odds of purchasing food during school hours, a larger association than nearby takeaways or fast-food outlets, suggesting that restricting takeaways near schools alone may not fully address where older adolescents are actually buying food [72]. An integrative review of 29 studies on menu evaluation tools in food services found that fewer than 60% had undergone any validation and only about 1 in 10 were multidimensional, meaning the instruments many institutions use to assess their menus are likely incomplete [73]. A review of food-contact plastics found that everyday heating through microwaving, hot-liquid contact, and infant feeding drives the release of microplastics and nanoplastics via degradation processes including chain scission and surface oxidation, with infants identified as a particularly high-exposure group [74]. A global systematic review of dairy contamination found microplastic concentrations ranging up to roughly 20,200 particles per liter in milk, with infant formula averaging 827.75 particles per kilogram and human breast milk averaging 1,828.92 particles per liter, placing most countries in the highest contamination classification [75].

The biggest caveat running through almost everything here is that most of these studies are observational, meaning they can tell us what tends to travel together, not what actually causes what. As a practical step you can take today: stop microwaving food or formula in plastic containers and switch to glass or ceramic for anything you heat, since the research is consistent that heat is what drives plastic particle release most.

One of the clearest messages running through this batch is that nutritional status leaves measurable fingerprints at every level of care. Patients with IgA nephropathy in the lowest prognostic nutritional index category carried a nearly 18-fold higher risk of composite kidney outcomes compared to those with better nutritional scores [1], and a preoperative risk index built on low BMI, significant weight loss, and low albumin predicted which surgical patients would need post-hospital care with an AUC above 0.81 [2]. For people on home enteral tube feeding, the challenges are especially stark: a scoping review of 256 studies found that only 22 of 184 outcome instruments have been properly validated in this population [3], while a separate cohort study showed newly initiated home tube-feeding patients had more than three times the acute-care episode rate in the first 90 days, with higher albumin and caloric intake each independently linked to better survival [4]. Among hospitalized lupus and rheumatoid arthritis patients who died, there was notably less engagement with clinical nutrition procedures compared to survivors [5], and in hospice settings artificial nutrition was used more than twice as often in non-oncological patients than in those with cancer, despite similar lengths of stay [6]. On the diagnostic front, urinary USP2 achieved an AUC of 0.936 for detecting chronic kidney disease — outperforming established biomarkers — improving further to 0.972 when combined with age and sex [7]. In a small case series, three children with the rare metabolic disorder Fanconi-Bickel syndrome were able to discontinue or substantially reduce phosphate supplementation after starting empagliflozin, though the drug only partially corrected the underlying tubulopathy [8].

Zoom out to lifestyle and population health and the patterns are just as striking. Korean women who slept 6–8 hours a night reported meaningfully higher quality of life, while sleeping more than 9 hours actually amplified the harm of multiple chronic conditions rather than easing it [9]. A validated screening questionnaire across nearly 10,000 toddlers found that juice consumption, parents using screens during play, and parental worry about overeating each independently predicted higher BMI from age 1 to 5 — concrete early targets for intervention [10]. A trauma-informed physical activity program for women was handed from researchers to community leadership and maintained a median 91% delivery fidelity over a year; organizational support and facilitator continuity mattered more than the program design itself [11]. A narrative review confirmed that variants in BRCA1/2, MTHFR, and FTO do shape how the body handles folate, vitamin D, and fatty acids — but the evidence remains too fragmented and underpowered to support genotype-tailored dietary prescriptions yet [12]. Air pollutant exposure and lung cancer risk were found to share 17 overlapping plasma proteins in a matched case-control study of ever-smokers, with the inflammatory chemokines CX3CL1 and CXCL17 emerging as potential biological mediators of the pollutant-to-cancer link [13]. Clinically, 97% of patients who underwent direct oral drug challenges for low-risk allergy labels had no reaction, showing that allergy de-labelling can safely extend beyond penicillin to NSAIDs and cephalosporins in outpatient settings — though a validated risk tool for non-penicillin drugs is still needed [14]. In asthma patients continuing dupilumab for three years, 41% experienced significant FEV1 decline, with persistent elevated airway inflammation markers as the strongest independent predictor of that trajectory [15], and genetic profiling of patients with both nasal polyps and severe asthma found that the TNF-α GG genotype carried an odds ratio of 5.30 for disease, with clustering revealing three biologically distinct inflammatory phenotypes [16].

At the mechanistic end, researchers continue to map metabolism in new and surprising ways. A column-generation mathematical framework can now identify key metabolic pathways from sparse untargeted metabolomics data at genome scale, opening new windows onto how mammalian cells use nutrients under realistic conditions [17]. A review of neutrophil biology found that the same metabolic pathway can defend against infection in one context and drive pathological inflammation in another — a duality that seriously complicates therapeutic targeting [18]. In cancer, KRAS-mutant pancreatic tumors rely on a cellular scavenging process called macropinocytosis to feed themselves in nutrient-poor environments, and opposite strategies — supercharging or blocking this process — are both under investigation [19]. A review of the ANO1/TMEM16A chloride channel, amplified in head-and-neck, breast, and lung cancers, proposes a formal distinction between drugs that block the channel transiently versus those that degrade the protein itself, a mechanistic difference likely to matter enormously for therapeutic outcomes [20]. Viruses remodel lipid metabolism and membrane architecture to replicate, and a review of this ongoing host-pathogen conflict frames membrane-associated processes as promising broad-spectrum antiviral targets [21]. The crystal structure of a calcium-sensing protein in Arabidopsis was resolved at 2.1 Å, revealing an unexpected tetrameric assembly and providing the first structural model for how plant mitochondria regulate calcium import independently of a key animal cofactor [22]. In traditional medicine, the phytochemical profile of Dendrobium officinale varies significantly by province, with Zhejiang samples containing the highest flavonoid and polyphenol content, driven by differences in specific biosynthetic genes [23]. Aquaculture ponds are non-trivial greenhouse gas sources: fish ponds generated the highest CO2 and nitrous oxide emissions while crab ponds led on methane, with macrophyte coverage and nutrient loading identified as the dominant drivers by random forest analysis [24]. Soil lead at 180 mg/kg altered kale's volatile chemistry and disrupted insect-plant signaling in ways that differed by insect guild, with effects on jasmonate pathways and local amino acid pools [25]. Combined microplastic and aluminum stress in broad beans suppressed shoot biomass by over 40% and disrupted the flavonoid signals legumes use to recruit beneficial soil bacteria, while reshaping the broader soil microbial network [26]. In eggplants grown in lithium-contaminated soil, one chirality of selenium nanoparticle — but not its mirror-image form — successfully redirected lithium away from the fruit toward leaves and roots, via cascading effects through the soil microbiome and plant metabolism [27]. Uterine crowding and intrauterine position create within-litter birth weight differences in pigs, with downstream effects on survival and productive performance that have practical implications for improving litter uniformity [28]. An archival study recovered the work of economist Slavtcho Zagorov, who mapped food-energy balances across Danubian countries in the 1930s and 40s using biophysical rather than monetary measures — an approach that strikingly anticipates modern calls to rethink how food security is quantified [29].

Your gut microbiome is essentially a chemical factory, and the product list is longer than most people realize. A sweeping review mapping microbial metabolite research from 1985 to 2026 found that resident bacteria produce and transform SCFAs, secondary bile acids, indoles, and peptides that act on defined host receptors across metabolic diseases, cancers, immune regulation, and more [1]. Those same molecules — along with bacterial wall components like LPS and muramyl dipeptide — also regulate how the intestinal lining repairs itself after damage, pointing to potential new therapies for restoring gut homeostasis [2]. One illustration of just how much information is packed into those chemicals: in a study of 193 people spanning colorectal cancer, celiac disease, and obesity, serum SCFA models achieved 95% accuracy and a multiclass ROC-AUC of 1.00 in classifying disease, while fecal SCFA models hit only 59% — blood and stool appear to reflect largely non-redundant processes [3]. The microbiome's influence reaches even into the mouth; current evidence, though still largely associative, suggests oral microbial biofilms and metabolites may alter the chemical environment around taste receptors and subtly shape food preferences [4]. Children with geographic tongue offer a vivid example of oral microbial disruption — their tongue microbiota richness is markedly lower than healthy children's, with a characteristic shift away from Prevotella and Veillonella toward Neisseria and Streptococcus, alongside broad downregulation of metabolic pathways [5]. Looking beyond digestion, a systematic review of 13 studies found that the kynurenine-to-tryptophan ratio and immune activation markers were positively linked to liver stiffness and fibrosis, though no reproducible microbial taxonomic signature emerged [6]. Gut and intratumoral microbiota also shape cancer responses to immunotherapy and chemotherapy through inflammation and metabolic remodeling, though effects vary considerably by cancer type and associations don't yet establish causality [7]. Perhaps most striking is the emerging gut-brain picture: gastrointestinal α-synuclein pathology may actually precede neurological symptoms in Parkinson's disease, with a proposed framework in which seed formation, propagation efficiency, and neuronal vulnerability collectively determine whether gut pathology tips into neurodegeneration [8]. Animal and experimental models reinforce that the immune system and gut microbiome are deeply intertwined in brain development — disturbing either one perturbs the other, with microglia emerging as a recurring cellular go-between [9].

Gut-disrupting infections leave a surprisingly durable mark. A longitudinal Bangladeshi study found that Cryptosporidium infection — 96% of which was subclinical — still reduced microbial diversity and depleted beneficial genera like Roseburia and Prevotella, while Shigella abundance increased and persisted after infection cleared; post-infection diversity was also linked to lower weight-for-age scores, suggesting a connection to impaired child growth [10]. In a smaller Indonesian cohort, whipworm infection was associated with significantly lower Shannon diversity and distinct bacterial community composition, though no individual taxa survived multiple-comparison correction [11]. A nationwide Cuban survey of 19,000 children found intestinal parasites in nearly one in three, with Blastocystis and Giardia the most common, and risk factors as mundane as eating unwashed vegetables and walking barefoot [12]. Disease-specific microbiome findings are accumulating across unexpected areas too: tonsillar Pseudomonas enrichment predicted better remission outcomes after tonsillectomy in IgA nephropathy patients, with an AUC of 0.712 for complete remission at three years — connecting the tonsils to a kidney disease via microbial composition [13]. In children with celiac disease followed over 2020–2025, 89% had normalized tTG-IgA antibodies within 12 months of a gluten-free diet, with dietary nonadherence appearing in only 13% [14]. Pediatric fecal incontinence spans functional to neurodevelopmental to organic causes, and matching treatment to type matters — retentive forms respond to disimpaction and behavioral therapy, while children with ASD or ADHD require individually adapted programs [15]. Dupilumab's performance in 109 children with eosinophilic esophagitis was notable: 86% achieved combined clinical, endoscopic, and histologic remission at 12 months, with higher baseline eosinophil density the main predictor of a harder road [16]. In adults with compensated cirrhosis, a 30-day trial of rifamycin SV MMX found no significant enrichment of antimicrobial resistance genes versus placebo — a reassuring finding for a drug used in this vulnerable group [17]. In type 2 diabetes, a mechanistic discovery may reshape how we think about metformin failures: the microbial enzyme AdhE was identified as a metformin-degrading enzyme present in low-responders, opening a potential avenue for enzyme-targeted interventions to rescue the drug's effectiveness [18]. A single case report — which the authors themselves flag cannot establish causality — documented apparent clearance of clarithromycin-resistant H. pylori following a nutraceutical combining sulforaphane, curcumin, and L. acidophilus after bismuth quadruple therapy had failed, supporting further investigation [19]. In perimenopausal women, six months of menopausal hormone therapy reshaped vaginocervical and urinary microbiomes — boosting protective L. crispatus and reducing Gardnerella — and the response varied by baseline gut community: Phocaeicola vulgatus-dominated women showed greater hormonal responsiveness than Prevotella copri-dominated women [20].

The therapeutic frontier is expanding on multiple fronts at once. A systematic review of 35 studies found that FMT produced the strongest effects among microbiome-targeted therapies for pediatric autism, with pooled effect sizes of -2.71 for GI symptoms and -4.06 for social responsiveness, though benefits for core behavioral symptoms were smaller and inconsistent [21]. In bone marrow transplant recipients, the multi-strain live biotherapeutic SER-155 achieved full strain engraftment and was associated with a 77% relative risk reduction in bloodstream infections versus placebo in a phase 1b trial, though secondary endpoints didn't reach significance [22]. The challenge of recurrent C. difficile — where cumulative recurrence risk keeps rising with each episode and broad antibiotic exposure — reinforces why microbiota restoration strategies are now seen as the most evidence-backed prevention approach [23]. Looking further ahead, engineered probiotics are being designed to attack antibiotic-resistant pathogens including P. aeruginosa and C. difficile through pathogen-responsive antimicrobial production and biofilm degradation, though genetic stability, horizontal gene transfer risk, and regulatory requirements remain significant barriers to clinical use [24]. Cell-free supernatants of L. rhamnosus — the bacterial broth without the live microbes — show antibacterial, anti-inflammatory, and antitumor activity in lab studies, with potentially safer stability profiles than live preparations for functional food and medical applications [25]. Even formula formulation is moving forward: adding just 4.5% chickpea flour to milk-based formulations significantly boosted probiotic bacterial growth to 8 log CFU/mL and improved 28-day storage stability without affecting antioxidant potential [26]. In a randomized infant trial, L. reuteri DSM 17938 did briefly shift diversity metrics at 2 months, but those differences had disappeared by 4 months, with no significant differences in GI symptoms — a reminder that early microbiome effects don't always last [27]. Exercise type appears to matter for the gut: a 10-day study in 32 healthy males showed that normal-temperature training was associated with decreased Escherichia-Shigella and increased Blautia and Dorea, while each protocol produced its own metabolite and cytokine fingerprint — though the independent contributions of exercise modality, heat, and duration weren't isolated [28]. Dietary terpenoids show anti-inflammatory potential in gut models through NF-κB modulation, but the evidence base covers only a small subset of compounds, clinical trials remain limited by small cohorts, and how human gut bacteria actually metabolize terpenoids is largely unstudied [29]. Underpinning all of this is a bigger ambition: a proposed five-layer AI framework — observe, infer, predict, design, learn — aims to integrate multi-omics data with metabolic modeling and synthetic community design to engineer microbiomes deliberately, though compositional data biases and the gap between model performance and real-world ecosystem control remain formidable challenges [30].

A metagenomic aging clock built from 4,551 individuals' gut microbiomes could estimate biological age across the lifespan — though it stumbled in midlife, when the body's own metabolic machinery seems to buffer how much people's microbial communities diverge from one another; under high allostatic load, specific metabolite shifts were linked to accelerated systemic aging transition [31]. Much of that diversity is under sustained pressure from modern life: across globally diverse populations, industrialization consistently narrows microbial variety, destabilizes communities, elevates gut stress markers, and distorts IgA signaling — and because disease-prediction models trained on industrialized guts fail when applied to less-industrialized populations, the gap in our models is as striking as the gap in the microbiomes themselves [32]. At the genomic level, gut bacteria in industrialized populations have expanded their protein-coding repertoire and swapped genes rapidly with neighbors — parallel evolution driven by a shared modern environment [33]. Early life plants the seeds for all of this: a longitudinal cohort study found that fewer than a quarter of infants harbored starch-digesting bacteria by five months, but by one year those colonized with both a starch utilizer and Anaerobutyricum hallii produced significantly more gut butyrate — with lab experiments showing Ruminococcus bromii outperforming Bifidobacterium adolescentis at releasing fuel from resistant starch and enabling that butyrate boost [34]. The gut is also a fungal ecosystem, not just a bacterial one: a review describes how bacteria and fungi interact through nutrient sharing, iron competition, chemical warfare, and quorum-sensing disruption — a hidden layer of microbial complexity that AI-driven multi-omics approaches are only beginning to map [35]. Animal and in vitro studies raise concern that ingested microplastics can disrupt this ecosystem — perturbing the gut barrier and potentially promoting inflammation and metabolic dysfunction — though long-term human evidence at environmentally realistic exposure levels is still largely absent [36]. In a large U.S. cross-sectional survey of 7,431 adults, eating a diet that scores well for gut-microbiota support was linked to meaningfully lower odds of a chronic bronchitis diagnosis, with hints of an inflammatory-mediator pathway in between — though the observational design cannot establish cause [37]. A systematic review of computational methods noted that graph-based approaches — from microbial network modeling to machine-learning disease classifiers — are proliferating in this space, while standardized tooling and interpretable models remain lagging gaps [38].

The gut microbiome's fingerprints show up across a striking range of conditions, with some of the sharpest signals in cancer. A microbial analysis of colorectal tumors found that those harboring a polymicrobial trio — Peptostreptococcus stomatis, Fusobacterium nucleatum, and Parvimonas micra together — clustered toward the right colon, showed higher microsatellite instability, and were associated with poorer patient survival [39]; a narrative review links obesity-driven gut dysbiosis upstream of that process, arguing that depletion of SCFA-producing bacteria, enrichment of genotoxic pathogens, and a leaky gut synergize with systemic inflammation and insulin-IGF-1 dysregulation to create conditions favorable for colorectal cancer in people under 50 [40]. In a small metagenomic study of just 60 participants, a nine-taxon random forest model classified colorectal liver metastasis with 97.5% accuracy — a striking proof of concept that now needs prospective multicenter validation [41]. By contrast, the idea that the microbiome shapes how lung cancer spreads to the brain remains entirely hypothetical: a review found that no proposed mechanism had reached a high evidence tier, and all published observations rest on nucleic-acid detection alone with no experimental perturbation [42]. Neurological illness surfaces repeatedly: among 130 older post-acute stroke patients, cachexia — present in 15% — was independently tied to lower microbial diversity across three separate measures, though the cross-sectional design limits causal interpretation [43], and among a separate group of 362 stroke patients receiving tube feeding, nearly two-thirds developed constipation, with a machine learning model improving prediction substantially when full hospitalization data were available rather than just early-admission features [44]. An umbrella review of 45 systematic reviews on acupuncture for post-stroke swallowing difficulties found that most underlying evidence was critically low quality by AMSTAR 2, and patient-important outcomes like aspiration pneumonia and nutritional status were rarely even measured [45]. In people with anorexia nervosa, a review concludes that gut microbial changes are real but likely reflect starvation, dietary restriction, or medication rather than a disease-specific signature — and human data on fecal transplants for the condition remain limited to small uncontrolled studies and case reports, with no controlled efficacy data [46]. Among 18 bone marrow transplant recipients, those who developed moderate-to-severe acute graft-versus-host disease lost more butyrate-producing taxa and showed larger microbial community shifts before and after transplant than those who didn't [47]. A community household survey of 1,632 Nigerian adults found nearly one in four met Rome IV criteria for a gut-brain interaction disorder — women more affected than men, functional dyspepsia topping the list — a reminder that these functional conditions are common and consequential well beyond Western clinical populations [48]. Reviews this period also connected gut microbial metabolites — SCFAs, tryptophan derivatives, vitamin K — to bone remodeling through hormonal and immune pathways, with probiotics, fecal transplants, and bacterial extracellular vesicles proposed as future therapeutic levers [49]; a parallel review found probiotic interventions showing some improvements in psoriasis severity and inflammatory markers across clinical studies, but heterogeneous strains, doses, and outcome measures make firm conclusions premature [50]. In cholestatic patients struggling with intense itching, researchers traced the signal to a specific lipid: LPA 20:4 was the only elevated LPA species that correlated with both itch intensity and receptor activation, and blocking its upstream enzyme with an autotaxin inhibitor suppressed that activation — pointing to a potentially targetable pathway [51].

On the therapeutic side, some of the most practically useful findings are about nuance. A study in 249 rural Chinese adults found that butyrate's effect on blood glucose flips depending on fermentation context: in those with a carbohydrate fermentation phenotype, higher butyrate tracked with higher fasting glucose; in others, it trended the other way — a sharp caution against treating butyrate as uniformly beneficial [52]. Response to prebiotic fibers is similarly individual, and a review argues that systems biology and machine learning approaches will be essential to predict who actually benefits from which fiber [53]. A review of psychobiotics — specific probiotic strains proposed to support mental health by producing gut-derived neurotransmitters like GABA and serotonin — highlighted nanotechnology-enhanced delivery as a largely unexplored way to improve how reliably these strains survive and reach their target [54]. For children with short bowel syndrome and bacterial overgrowth, a Delphi process involving 55 international experts produced 21 consensus statements identifying metronidazole as the preferred first-line antibiotic and endorsing long-term cycling for recurrent cases [55]. In a propensity-matched analysis of 5,028 cirrhosis patients needing a feeding tube, the classic endoscopic approach outperformed fluoroscopic insertion on aspiration pneumonia risk, tube complications, and six-month mortality — useful data for a decision that often gets made quickly at the bedside [56]. A single case report described a 16-year-old who lost both their small intestine and pancreas and was restored to insulin independence and oral nutrition through a composite pancreas-intestine transplant using a carefully designed arterial and portal venous configuration [57]. Traditional Chinese Medicine preparations showed protective effects against radiation-induced gut injury in experimental models — operating through antioxidant, barrier-strengthening, and microbiome-modulatory pathways — but the supporting evidence is largely from acute single-dose animal studies, and clinical trial data remain limited by small samples, heterogeneous preparations, and inadequate follow-up [58]. A newly characterized Enterococcus faecium strain isolated from honey in the Brazilian semiarid region carried no acquired antibiotic-resistance genes or known virulence factors, survived simulated digestion, and had the metabolic toolkit to grow on prebiotic substrates — early groundwork for potential probiotic development, though no human evidence yet exists [59]. And in a phase 1 crossover study of 24 healthy participants, taking the acid-suppressor zastaprazan with food changed its absorption kinetics — peak drug levels fell but total exposure rose — yet the 24-hour window of stomach pH above 4 was virtually identical whether participants ate first or not (70.0% vs. 69.2%), supporting administration without regard to meals [60].

One of the clearest themes in this batch is how widely the gut microbiome's reach extends beyond digestion. A review framed chronic psychological stress as a promoter of tumor growth through neuroendocrine disruption, immunosuppression, and stress-driven gut dysbiosis, coining the term "gut-brain coherence" to describe how microbial and neural systems interlock, and proposed combining microbial, behavioral, and pharmacological strategies to restore balance [61]. Chronic alcohol exposure tells a similar story of downstream damage: a review showed gut dysbiosis feeding hepatic inflammation, steatosis, and neuroinflammation along the gut-liver-brain axis, with probiotics, FMT, and SCFAs showing mechanistic promise, though causal taxa and sex differences remain unresolved [62]. The gut-kidney connection got attention too, with a review positioning incretin hormones, particularly GLP-1, as key signals linking gut physiology to IgA nephropathy and CKD-related GI complications while uremic toxins loop back to damage the intestinal barrier [63]. A framework review proposed the Gut-Muscle-Joint axis, casting osteoarthritis as partly a microbiome-driven systemic disorder in which dysbiosis and intestinal permeability drive cartilage breakdown and sarcopenia [64], an idea that connects to a study of 217 Chinese children with Duchenne muscular dystrophy, where low bone density correlated with higher fecal Bacteroides vulgatus and lower Prevotella copri, pointing to gut microbiota as a potential target for glucocorticoid-induced bone loss [65]. In the respiratory system, a review noted that antibiotic-driven shifts in the lung microbiome may weaken colonization resistance against nontuberculous mycobacteria via gut-lung immune crosstalk, though microbiota-directed strategies for NTM remain experimental [66]; mycobiome profiling of 24 adults with asthma found that higher nasal and sputum Cladosporium abundance clustered with poorer asthma control scores (median ACT 15 vs. 18) [67], and a cross-sectional study of 60 people found that lower Neisseria perflava levels in both sputum and stool tracked consistently with psychological symptom severity in patients with asthma and comorbid depression [68]. Computational analysis of public databases linked gut microbial metabolites including butyrate, propionate, acetate, and TMAO to lung adenocarcinoma through JUN, IL6, and CXCL8 gene targets, though predicted hepatotoxicity signals call for cautious interpretation [69]. In the mouth, elevated arginase activity alongside oral dysbiosis may deplete L-arginine and suppress anti-tumor immunity in oral squamous cell carcinoma, with a review proposing the microbiome-arginine-immune axis as a framework for biomarker development [70]. Persistent high-risk HPV infection has been linked to reduced Lactobacillus dominance in the cervicovaginal microbiome, and a proposed two-phase "sequential microbiome therapy" would first break up dysbiotic biofilm before reseeding acid-producing Lactobacillus strains to support viral clearance [71]. A small phase II trial in 24 primary-resistant metastatic melanoma patients found that baseline gut microbiome ecosystem state, classified by TOPOSCORE, was not significantly associated with response to immune checkpoint inhibitor re-induction, with heterogeneous longitudinal patterns preventing firm conclusions [72].

Within the gut itself, functional disorders (IBS, chronic constipation, and functional diarrhea) affect roughly 20% of the global population, driven by disordered gut-brain axis signaling and visceral hypersensitivity, with treatment effectiveness remaining modest [73]. One striking finding comes from a nested case-control study: stool microbiome composition at around 12 months of age predicted IBS or abdominal pain diagnosed a mean of 11.8 years later, with future IBS risk linked to depleted SCFA producers and expanded mucosa-disruptive taxa in infancy [74]. For functional dyspepsia, a meta-analysis confirmed PPIs outperform placebo for global symptom relief, especially epigastric pain and burning, and also highlighted less-obvious effects including reduced duodenal eosinophil infiltration and gut microbiota modulation [75]; a pilot study in 11 FD patients found that gastric microbiota differed by symptom subtype, with Centipeda tracking postprandial distress and Collinsella, Holdemanella, and Paraprevotella tracking the epigastric pain variant [76]. In metabolic liver disease, a cine-MRI study of 15 MASLD patients found that small-intestinal motility correlated with specific gut taxa including Verrucomicrobia and Bacteroidetes species and with liver and adipose gene expression, while a 12-week exercise intervention had no effect on motility itself [77]. In IBD, fatigue affected 83% of patients regardless of disease activity, with higher rates in those with ulcerative colitis and those who were employed, while body composition and physical function measures showed no statistically significant link [78]; a review of mucosal glycosylation added another layer, describing how glycan modifications regulate barrier integrity and inflammasome activation while innate immune cytokines remodel the glycome in return [79]; and an Italian quality-improvement initiative used Lean A3 methodology to identify fragmented screening and regional access disparities as the root causes of nutritional care gaps in IBD, producing a standardized GLIM-based care pathway [80]. On enteral nutrition, a meta-analysis of 12 randomized trials involving 914 participants found no evidence that peptide-based formulas reduce diarrhea compared with polymeric formulas in hospitalized adults (RR 0.89, very low certainty), though two open-label trials of pectin-containing formulas did suggest lower risk [81]. A machine learning comparison of 319 patients found CatBoost the most accurate model for gallstone disease prediction (AUC 0.862), with CRP, vitamin D, and bone mass as the most influential variables and bioimpedance parameters alone providing substantial discriminative signal [82]. In a veterinary model, microbiome clustering of 56 dogs with chronic enteropathy showed that a dysbiotic cluster enriched with Streptococcus and Klebsiella and depleted of SCFA producers had remission rates of 38.9% compared with 83.3% in the healthier-microbiome cluster after treatment [83].

Diet and environment leave clear marks on which microbes thrive. An ex vivo fermentation study found that around 48 to 53% of the anthocyanin cyanidin-3-glucoside from jabuticaba peel was metabolized within 48 hours, with individual variation in SCFA production proving a more important factor than BMI group [84]; a review of preclinical evidence suggested that polyphenols including resveratrol, quercetin, and curcumin may reduce GI symptoms in autism spectrum disorder by tightening junctions and dampening NF-κB/NLRP3 signaling, though the authors note that clinical evidence in ASD patients is largely absent and favor low-FODMAP food matrices over isolated supplements [85]. From the other direction, synthetic chemicals matter: a cross-sectional study of 241 Chinese adults found bisphenol C negatively correlated with gut alpha-diversity, methylparaben negatively associated with species including Bacteroides salyersiae and Anaerostipes caccae, and triclosan upregulated pathways for aromatic compound degradation and mixed-acid fermentation [86]. Among 96 hemodialysis patients, higher Lachnospiraceae abundance independently associated with lower comorbidity scores and higher serum albumin; and counter to conventional thinking, a high Firmicutes/Bacteroidetes ratio in this cohort actually correlated with no prior-year hospitalization and a lower cardiac thoracic ratio [87]. Saliva samples from nine Tibetan dental caries patients were dominated by Bacillota and Actinomycetota, with multidrug-resistance annotations accounting for 53% of CARD hits alongside dense carbohydrate metabolism gene content [88]. At the taxonomy level, genome-scale analysis of Agathobaculum and Butyricicoccus resolved longstanding classification questions: two Agathobaculum species and B. faecihominis met thresholds for synonymization within Agathobaculum, while two other Butyricicoccus species were distinct enough to warrant recognition as an entirely new genus, Parabutyricicoccus gen. nov., within Oscillospiraceae [89]. For researchers wanting to go beyond sequencing-based snapshots, a protocol paper described a reproducible workflow for activity-based protein profiling of bacterial enzymes from stool using LC-MS/MS proteomics, designed to capture what the microbiome is actually doing enzymatically rather than just who is present [90].

Microbiome disruption shows up consistently across conditions that might not seem related at first glance. Reviews have found reduced diversity and altered bacterial communities to be a reliable feature of both type 1 and type 2 diabetes, with short-chain fatty acid signaling and gut barrier function as the strongest mechanistic threads, though large-scale randomized trials have not yet confirmed the interventions [91]. PCOS tells a similar story: studies link gut dysbiosis to insulin resistance, hormone imbalance, and reproductive symptoms [92], and a meta-analysis of 20 RCTs found that probiotics, prebiotics, or synbiotics together improved weight (SMD −1.21), insulin resistance, LDL cholesterol, and total testosterone (SMD −1.29) in women with the condition [93]. Genetics-based Mendelian randomization work adds another angle: higher Actinobacteria (OR 0.76) and Bifidobacterium angulatum (OR 0.88) appeared protective against endometriosis in genetic data, while Aneurinibacillaceae raised susceptibility (OR 1.50), with regulatory T cell and NKT cell pathways as key intermediaries [94]. The gut-liver relationship runs in both directions: microbial metabolites drive hepatic injury and fibrosis while liver bile acids in turn shape microbial ecology, a cycle documented across autoimmune, metabolic, and toxic liver conditions [95]. Recurrent Clostridioides difficile infection is perhaps the clearest proof that microbiome disruption can become self-perpetuating; a review highlights how FDA-approved microbiota-based therapies have transformed prevention by restoring the colonization resistance that repeated antibiotic courses strip away, with particular care needed for older, immunocompromised, and IBD patients [96]. In hematologic disorders, a review maps how microbial pathways including short-chain fatty acid production, bile acid transformation, tryptophan metabolism, and innate immune activation shape immune remodeling, marrow recovery, and transplant outcomes [97]; even in B-cell lymphoma patients receiving anti-CD20 chemoimmunotherapy, treatment mainly flattened microbial evenness and diversity without producing large compositional shifts [98]. The gut-brain axis keeps gaining texture too: a review describes how gut microbes modulate tryptophan metabolism through the kynurenine, serotonin, and indole pathways, with distinct metabolite profiles appearing across trauma-related, immunometabolic, and genetically defined subtypes of depression, positioning this axis as a possible framework for more personalized treatment [99].

Cancer research is increasingly focused on the microbiome, with results that range from promising to sobering. A review of gastric cancer traces how H. pylori infection, diet, genetics, and microbial metabolites combine to drive malignancy, with macrophage-targeted therapies emerging from that understanding [100]. Early-onset colorectal cancer, now rising in people under 50 worldwide, displays distinct immune microenvironment features tied to microbial mutational signatures and early-life exposures, informing new checkpoint blockade strategies [101]. An analysis of 1,190 tumor samples across 24 cancer types found that microbial epitopes inside tumors are more structurally stable than human epitopes, and that cross-reactive T cells triggered by both microbial and tumor antigens show enhanced antitumor activity—a potential foundation for microbial epitope vaccines [102]. Yet the picture stays complicated: a review concluded that no gut microbiome signature currently qualifies as a validated tool for selecting immune checkpoint therapy in gastrointestinal cancers, with response-linked microbial features varying by treatment type and lacking the clinical-utility evidence needed for practice [103]. The PANORAMIX phase II trial for metastatic pancreatic cancer is now testing whether ciprofloxacin can improve survival by targeting intratumoral Gammaproteobacteria that break down gemcitabine, running that question alongside a parallel maintenance chemotherapy comparison [104]. In a striking clinical finding, the gut microbiomes of 84 kidney transplant recipients were shown to substantially alter how their immunosuppressant was absorbed: high Eubacterium callanderi increased mycophenolate exposure by 29–63%, while high Faecalibacterium SGB15315 reduced it by 13–26%, meaning two patients on the same dose could have very different drug levels depending on who lives in their gut [105]. In nutrition interventions, among 650 adults with mild-to-moderate acute pancreatitis, starting enteral feeding within 48 hours versus later was associated with a shorter hospital stay (5.5 vs. 7.4 days) and lower feeding intolerance (8.7% vs. 18.6%), with every additional 12-hour delay adding 0.28 days to the stay [106]; a separate study in 63 patients with severe pancreatitis found that nasojejunal tube path length did not predict ICU length of stay [107]. In rectal cancer surgery, lower preoperative nutritional index was independently linked to higher anastomotic leakage, with leak rates of 19.0% in the lowest quartile versus 7.1% in the highest across nearly 2,500 patients, though the index works best as one input in a broader assessment [108]. A small pediatric Crohn's disease trial found that adding a Crohn's disease exclusion diet plus partial enteral nutrition to anti-TNF-α therapy produced earlier symptom relief compared with biologics alone, but did not accelerate normalization of fecal calprotectin or mucosal healing [109]. And a case report describes a child with Hoyeraal-Hreidarsson syndrome whose severe chronic enterocolitis went into remission on vedolizumab monotherapy sustained for two years, raising the gut-selective biologic as a potential option when systemic immunosuppression is contraindicated [110].

Behind the clinical stories, researchers are building better tools and testing new ideas about how the microbiome works at a mechanistic level. A new deep learning classifier called Taxonova reached species-level accuracy in the top range (median F-measures of 0.94 for short reads, 0.97 for long reads) and produced a median of 16.2×10⁻⁴ fewer false-positive species identifications than competing tools [111]. But even good tools need thoughtful users: a framework paper argues that AI literacy alone is insufficient for microbiome researchers because data leakage, ecological confounding, and unverified generative AI outputs can produce biologically misleading results, and proposes a five-capability competency framework culminating in "biological closure"—connecting computational predictions to independent evidence [112]. The oral microbiome is drawing more attention as a potential contributor to digestive disease: a review identifies clinical, metagenomic, and animal evidence suggesting that oral dysbiosis may seed the small bowel and contribute to SIBO, though direct clinical trial evidence for this link is still absent [113]. An oral mycobiome study in children and young adults found no overall difference in fungal diversity between type 1 diabetes patients and healthy controls, but Fusarium, Candida albicans, and several other fungal taxa were differentially abundant in T1D, and two taxa found exclusively in T1D subjects correlated with immune signaling molecules [114]. Researchers have now built the first detailed genome-scale metabolic model of Lacticaseibacillus rhamnosus GG, mapping its nutrient requirements and secretion products including lactate and indole-3-carboxaldehyde, providing a kind of metabolic blueprint applicable to other understudied gut bacteria [115]. The main clinical yeast probiotic, Saccharomyces boulardii, is better studied than ever but still not fully understood: a review finds that genome-scale models, flux balance analysis, and CRISPR-based engineering are emerging as ways to convert omics data into testable hypotheses, while related yeasts show interesting properties but limited direct human probiotic evidence [116]. In a creative engineering approach, adaptive laboratory evolution trained E. coli Nissle 1917 to grow on oxalate as its sole carbon source within approximately 400 generations, identifying genetic changes in aldehyde-dehydrogenase-associated modules as candidates for engineered bacteria targeting hyperoxaluria [117]. A systematic review of piglet trials found that N-acetylcysteine supplementation consistently raised reduced glutathione by 15–40% and lowered a marker of oxidative damage by 20–35%, while also enriching Lactobacillus and Bifidobacterium in the gut, with stronger growth benefits appearing under physiological challenge conditions [118]. An animal study in newborn calves showed that microencapsulated antibodies (IgY) combined with lactic acid bacteria improved daily weight gain, reduced diarrhea and fecal E. coli counts, and reshaped gut bacteria toward protective species like Akkermansia and Christensenellaceae while boosting fecal butyrate [119]. And on the more speculative end, a review introduces plant-derived exosome-like nanoparticles as tiny membrane-bound particles carrying small RNAs, proteins, and metabolites that might influence gut bacteria, the intestinal barrier, and mucosal immunity, though the evidence is predominantly preclinical and many fundamental questions about their fate and dosing in living systems remain open [120].

Almost everything here is still correlational, so it's worth resisting the urge to map any single finding to a specific supplement or food fix before the causal story is nailed down. That said, the emerging picture on personalized fiber responses is genuinely worth following — researchers are finding that which prebiotic fiber benefits you depends heavily on whether your particular microbial community has the right tools to ferment it, which may eventually make "eat more fiber" advice a lot more precise.

Tracking frailty at the population level reveals a quietly mounting problem: a large study of English adults aged 50 and over found that frailty prevalence crept from 15.5% in 2002 to 17.8% in 2022, adding more than a million people to the absolute count even as improvements in education and lifestyle partially held the rise in check, with projections suggesting over five million people could be frail in England alone by 2040 [1]. Understanding what shapes older adults' eating and health choices requires looking past the clinical view: a synthesis of 40 qualitative U.S. studies found that food and nutrition experiences are woven from six interconnected threads (social and cultural context, habits, environment, knowledge, economic constraints, and physiology), with notably thin coverage of racially and ethnically diverse older adults in the research so far [2]. The roots of healthy aging may stretch further back than we typically look: in a cohort of over 3,000 Chinese older adults, each additional favorable early-life factor such as education or family economic security raised the odds of reaching the healthiest aging category by 37% [3]. Frailty also blunts how well the immune system responds to vaccines, with research noting that the chronic inflammation and immune changes of frailty can reduce the effectiveness and durability of mRNA vaccines, while the adaptability of lipid nanoparticle platforms opens doors to formulations tailored for frail patients [4]. Oral health care is finding its way into the frailty conversation too: a cluster trial protocol describes a person-centered dental care model for frail older adults receiving home care, testing four flexible pathways from online consultation to mobile dental visits and tracking both oral health and quality of life over a year [5]. For older adults caught in humanitarian emergencies, a proposed rights-based framework called PARTICIPATE makes the case for five fundamental rights including visibility, non-discrimination, health, social protection, and autonomy as the foundation for reducing preventable mortality, disability, and care dependence [6]. Diet quality emerges as a meaningful lever across many of these dimensions: a systematic review of 11 studies found that closer adherence to Mediterranean-style eating was associated with better cognitive performance, slower memory decline, and favorable telomere and epigenetic age dynamics in some studies, though frailty and physical performance improvements mostly appeared when diet changes were combined with exercise [7]. Milk fat globule membrane (MFGM) supplementation paired with exercise improved physical function in older Japanese cohorts, but effects on body composition were modest and inconsistent, and variable phospholipid concentrations across products make it hard to know exactly what drove the benefits [8]. In overweight and obese individuals, higher diet quality measured by the Healthy Eating Index was cross-sectionally linked to better trabecular bone scores, higher bone mineral density at the spine and hip, and higher vitamin D levels, though prospective evidence is still missing [9]. A year-long study in active-duty service members found most falling short on vitamins K1 and K2, and exploratory proteomics pointed to connections between K2 and bone architecture, inflammation, and glucose pathways, though no changes in body composition emerged over the study period [10].

The bone-muscle relationship is increasingly understood as a two-way biological partnership that, when it fails, tends to fail together: a meta-analysis found that osteosarcopenia (osteoporosis and sarcopenia occurring simultaneously) affects roughly 1 in 5 older adults and is associated with more than double the fracture risk, a 54% higher odds of falls, and 75% higher mortality compared to neither condition, with the molecular crosstalk involving Wnt signaling, IGF-1, and constant chemical exchange between bone and muscle cells [11]. The perimenopause transition appears to be a key tipping point: the evidence for rapid bone loss at this stage is robust, and researchers are proposing a broader bone-brain-muscle axis driven by shared hormonal, inflammatory, and mitochondrial pathways, though direct evidence linking all three systems specifically during perimenopause is still limited [12]. The same estrogen withdrawal that accelerates bone loss is also written on the skin, with visibly reduced collagen, elasticity, and hydration that may signal broader internal tissue deterioration; hormonal therapies, SERMs, and plant-based compounds like isoflavones are discussed as potential interventions [13]. Estrogen may also explain striking sex differences in caloric restriction response: preliminary animal and human data suggest younger women are more resistant than men to fat loss from cutting calories, with this resistance fading after menopause, and a controlled feeding trial in 75 participants is under development to test whether hormone therapy can restore that responsiveness [14]. A bone-signaling protein called sclerostin, which damps bone formation, correlates with bone mineral density in population studies but is clinically complicated: it shifts with age, sex, kidney function, hormones, and metabolic disorders, and there is still no standardized assay for measuring it [15]. In clinical populations the stakes of muscle loss are stark: in a cohort of cirrhotic patients with gastric variceal hemorrhage, those with sarcopenia had three-year mortality of 41.1% versus 14.9% in non-sarcopenic patients, with sarcopenia independently predicting decompensation, mortality, and rebleeding [16]; in patients with chronic alcohol use disorder and sarcopenia, a simple blood ratio (red blood cell distribution width divided by albumin) independently predicted 12-month mortality with high accuracy (AUC 0.81), correlating closely with both lean mass and grip strength [17]. How sarcopenic obesity is defined also changes who gets flagged: in a Singapore cohort of 300 older adults, the BMI-based method was the only approach that detected a roughly tripled falls risk, though all three definition methods agreed on identifying low physical performance [18]. At the cellular level, long-lived proteins in the ovary, including cohesins that physically hold chromosomes together during cell division, gradually deplete with age and compromise the accuracy of egg development; researchers are now mapping this "long-lived proteome" in mammalian ovaries in search of targets relevant to understanding and treating reproductive aging [19]. And not all bone disease traces back to diet: a review highlights how non-nutritional rickets are frequently missed because genetic clues go unnoticed, with alopecia pointing to vitamin D-dependent rickets type 2A, cataracts to Lowe syndrome, and sensorineural hearing loss to X-linked hypophosphatemia; recognizing these patterns enables molecular confirmation and targeted treatments like burosumab that improve growth, radiographic healing, and function [20].

Under the hood, food's interaction with aging comes down to molecular switches: nutrients and metabolites directly modulate autophagy (the cellular process that clears out damaged proteins and organelles) by toggling energy-sensing proteins including mTOR and AMPK, and when this nutrient-autophagy crosstalk goes wrong it appears to contribute to metabolic imbalance and age-related disease [21]. One emerging target in muscle maintenance is an enzyme called spermine oxidase (SMOX), which regulates a family of small molecules called polyamines: in animal models, higher SMOX activity preserved muscle fiber size under three different atrophy-inducing conditions, and a small human study found that higher SMOX expression after strength training correlated with greater strength gains, though human evidence remains preliminary [22]. The popular supplements NR and NMN, designed to boost NAD⁺ (a molecule central to cellular energy and repair that declines with age), have not shown significant effects on muscle mass or strength in adults over 60 in recent meta-analyses, even though the underlying biology is real; combining them with exercise, which independently boosts NAD⁺ recycling, is proposed as the most testable next step [23]. Exercise itself keeps delivering at multiple levels: a 7-week moderate-intensity interval training program in 11 untrained young men increased skeletal muscle oxygen capacity by roughly 50% and power output at the lactate threshold by about 43 watts, driven by real gains in mitochondrial mass [24], and a scoping review of 141 studies (37 in animals, 104 in humans) confirmed that chronic training programs of at least six weeks consistently shifted the body toward a more protected oxidative state across healthy, athletic, and clinical populations [REF:558d75ac-03ae-420f-9799-19e4cdfadb58]. An unexpected cross-sectional finding suggests higher serum uric acid was independently associated with lower biological age acceleration in both men and women, with the effect particularly steep in men below a blood level of about 353 µmol/L, complicating the standard framing of uric acid as simply harmful [25]. On the metabolic afterlife of joint disease, a 7-year longitudinal cohort study found that total joint replacement partially normalized circulating fatty-acid transport markers, but persistent abnormalities and a significantly lagging free carnitine level in the surgery group suggested that the full metabolic footprint of osteoarthritis is not erased by replacing the joint [26]. At very high protein intakes (3.2 g per kilogram per day in 44 resistance-trained men over 16 weeks), some kidney biomarkers shifted in ways worth monitoring, but no statistically significant overall interactions were detected, and the small sample size means larger confirmatory studies are still needed [27]. At the rarer end of the aging spectrum, a 30-year-old carrying a LEMD2 gene variant presented with severe aortic stenosis, atrioventricular block, type 2 diabetes, and kidney disease (the most advanced metabolic picture yet described for this progeroid syndrome), strengthening the case for routine cardiac and metabolic surveillance in these patients [28]. And in a finding that upends assumptions about joint disease, more than 40% of people carrying certain non-classical HFE gene variants (linked to the iron-overload condition haemochromatosis) met formal criteria for arthropathy of the small hand and ankle joints even though their iron markers were entirely normal, suggesting these variants may damage joints through a mechanism that has nothing to do with iron [29].

The loss of strength with age turns out to be much more a nervous-system story than a muscle-size story. A study comparing older and younger recreationally active men found that despite similar thigh cross-sectional area, the older group showed 39% lower maximal force and 72% lower neural drive to the muscle [30]. Underneath that, a review explains that aging muscle suffers a kind of maintenance failure — protein synthesis slows while the breakdown systems ramp up, and that imbalance is identified as the primary driver of muscle wasting under catabolic conditions [31]. One specific nutrient that may matter more than current guidelines reflect is threonine: a study using the indicator amino acid oxidation method found that adults aged 70–79 needed 63% more dietary threonine per kilogram than those in their 60s, with no overlap in confidence intervals — suggesting our amino acid needs keep shifting meaningfully within the decades of old age, especially for people eating mostly plant proteins [32]. Reviews of dietary polyphenols argue they may support muscle repair and blunt atrophy by acting on the same mTOR and AMPK pathways that govern protein balance [33]. Exercise still delivers real gains: a meta-analysis of 11 randomized trials in older adults with type 2 diabetes found structured exercise produced moderate-to-large improvements in strength and physical performance even while lean mass barely moved [34]. For dialysis patients with sarcopenia, a 12-week nurse-led multicomponent program showed encouraging effect sizes for grip strength and gait speed, though the differences didn't survive correction for multiple comparisons in this small feasibility study [35]. Adding psychoeducation to exercise in nursing-home residents with sarcopenia improved mood and quality of life beyond exercise alone, again without any significant change in muscle mass [36]. A published trial protocol describes plans to test whether oral nutritional supplements combined with supervised exercise can lift physical function in malnourished hospitalized adults aged 75 and over — results are still to come [37].

Frailty trajectories are more fluid than many people assume: a meta-analysis in Chinese adults found that while 29% worsened over up to 11 years, 10% actually improved, and every 1% rise in the frailty index carried a 5% higher mortality risk [38]. In chronic kidney disease, the picture is similarly concrete — in two separate CKD cohorts, low handgrip strength roughly doubled mortality risk while abdominal obesity alone showed no significant association, suggesting that grip testing tells you more than measuring waist circumference [39]. In the same population, higher dietary acid load was linked to roughly three times the odds of poor lower-extremity function, though grip strength and muscle mass were unaffected after adjustment [40]. Nearly 60% of Chinese adults aged 60 and over in a large national survey already showed some decline in intrinsic capacity, with education and income as independent protective factors and comorbidity burden as a key driver [41]. For those who fracture a hip, the stakes are high: a quarter of 300 geriatric patients with proximal femur fractures died within one year, and a composite of three simple biomarkers — NLR, D-dimer, and albumin — showed an AUC of 0.86 for predicting who would, well above each marker alone [42]. Even after major cardiac interventions, independence is far from guaranteed: among older adults followed 36 months after a transcatheter valve procedure, those with the highest care needs faced more than three times the mortality of independent patients and costs roughly five times higher [43]. Nutritional status before surgery matters too: in lung cancer patients, even light malnutrition by CONUT score was independently associated with walking 36 metres less on the postoperative six-minute walk test, partly mediated through higher complication rates [44]. Among low-income older Korean adults, disadvantages compound dramatically — the odds of being unable to use chopsticks were 34 times higher than in general-income peers, with markedly lower intake of protein, fruits, and dairy [45]. A review links long-term proton pump inhibitor use to impaired absorption of calcium, magnesium, and vitamin B12 and to higher rates of fracture and impaired bone healing — a risk worth weighing carefully in anyone with existing musculoskeletal conditions [46]. Spinal kyphosis with age is tied more reliably to osteoporosis and trunk muscle dysfunction than to generalized sarcopenia, and a review recommends combining osteoporosis treatment, targeted exercise, posture training, and nutritional support — with a note that the causal relationships still need better longitudinal evidence [47]. Even measuring sarcopenia precisely is trickier than it looks: in 864 post-stroke patients, two widely used AWGS 2025 criteria disagreed in one in five cases, with albumin levels and phase angle predicting which classification a patient received [48].

The bigger picture of aging keeps widening. In a study of 414 hospitalized older adults, how well someone adapted psychologically to living with chronic illness explained a substantial share of what "successful aging" looked like — and dietary adherence was linked to that outcome primarily through adaptation rather than as a direct effect [49]. At the molecular level, a form of DNA modification called 5-hydroxymethylcytosine (5hmC) shifts in characteristic patterns during aging in ways that are partly independent of classic methylation, and a review suggests it may improve how epigenetic aging clocks are interpreted [50]. A new study protocol — the Super Movers Study — plans to compare fast-walking adults aged 80 and over against slower-moving peers using brain imaging, mobile EEG during walking, neurodegeneration biomarkers, and epigenetic aging clocks, to understand what the neural signatures of exceptional mobility actually look like [51]. A Mendelian randomization study found nominal associations between telomere length in different immune cell types and mixed hearing loss, but none survived correction for multiple comparisons — an intriguing signal that stops short of a finding [52]. In a double-blind trial, an oral supplement plus topical serum combination reduced grey hair count by 13% at 24 weeks compared to a 9.7% increase in the placebo group, a statistically significant difference confirmed by photo grading [53]. Among virally suppressed older adults living with HIV, lifestyle factors — smoking, diet, and substance use — rather than duration of infection appeared to be the main drivers of conditions like diabetes and cardiovascular disease, pointing toward the same modifiable levers as in the general aging population [54]. A systematic evidence map on intervertebral disc degeneration found that while cell and animal studies consistently implicate cholesterol loading and saturated fats in disc damage through ER stress and NLRP3 inflammasome activation, human observational data remain inconsistent and causality is unestablished [55]. A scoping review of nutrition education programs for Korean older adults found knowledge improved consistently across programs, but behavioral change was selective, most programs lacked an explicit theoretical framework, and fewer than a third ran longer than three months [56]. A new policy framework for Korea's 2026 community integrated care system proposes embedding structured nutrition screening — with triggered modules for malnutrition, frailty, sarcopenia, and dysphagia — directly into municipal care pathways, though the authors acknowledge field validation is still needed [57]. A survey of nearly 5,000 health and social care professionals found wide gaps across disciplines: physiotherapists led on falls and mobility knowledge, pharmacists on deprescribing, and social workers showed a striking mismatch between high interest and low self-rated knowledge — a finding with real implications for care team design [58]. A proposed Longevity-Oriented Nursing Framework explicitly designates biological-age clocks as adjunctive tools rather than primary outcomes, noting that their clinical validity remains unsettled pending prospective testing [59].

A long-running Australian cohort study tracked nearly 2,800 adults for over 16 years and found that never-smokers had 30% lower fracture hazard than smokers, and people with no muscle weakness had roughly half the fracture risk of those who did [60]; separately, a Danish cohort showed that hospitalization is itself a fracture risk event, with major fracture risk jumping 77% in the two weeks after admission compared to matched non-hospitalized adults and remaining elevated for a full year [61]. For postmenopausal women, a review makes the case that bone loss involves far more than estrogen — rising FSH, disruptions to the vitamin D-PTH axis, shifts in the gut microbiome, and immune dysregulation all conspire against bone, and current therapies carry safety trade-offs or limited long-term efficacy [62]. There is real reassurance for mothers, though: large prospective cohort data consistently show that pregnancy and even prolonged lactation don't raise long-term osteoporosis risk in healthy women, with adverse outcomes emerging mainly when nutritional deficiencies or high reproductive burden enter the picture [63]. The theory that uric acid might protect bone didn't survive scrutiny in a large NHANES analysis — any apparent bone signal disappeared once diet was accounted for [64] — but a combined BMI-and-blood-glucose index tracked osteoporosis odds remarkably well, with people in the worst quartile facing more than five times the risk of those at the top [65]. Deeper down, immune cells are emerging as key bone architects: a review shows that whether tissue-resident macrophages tip toward inflammatory or anti-inflammatory states directly governs the bone remodeling balance, with cholesterol efflux and fatty acid oxidation pathways proposed as intervention targets [66]. Mouse-based single-cell transcriptomics adds another layer, finding that a signaling receptor called Nrp2 ramps up steadily in periosteal stem cells as animals age while bone-forming progenitors dwindle — a vitamin D receptor–Nrp2 axis is proposed as a possible regenerative lever [67]. On the probiotic front, a bibliometric review found sparse publications before 2019 followed by rapid growth, with the field now centering on gut microbiome mechanisms and short-chain fatty acid signaling rather than simple calcium absorption [68].

Frailty turns out to be more readable from routine blood tests than many clinicians might expect: in nearly 1,500 Spanish older adults, standard lab values — particularly the liver enzyme GGT, albumin, and age — explained about 40% of frailty score variation, and a logistic model reached an AUC above 0.80 for predicting high frailty probability, though the researchers flag the need for external validation [69]. Adding a psychological dimension — resilience — to a clinical aging model in over 1,300 cancer patients receiving chemotherapy unlocked five distinct aging phenotypes instead of three, with quality of life dropping in stepwise fashion across them; being female, younger, and carrying more comorbidities pushed patients toward the worst profiles [70]. Oral health keeps appearing as an underappreciated frailty gateway: pooled international estimates suggest roughly one in three community-dwelling older adults has oral frailty, and it may precede physical frailty while capturing nutritional risk that conventional frailty tools miss [71]; in a cross-sectional study of older Beijing adults, oral frailty was independently linked to weaker grip strength, and the effect was substantially amplified in those with low body weight [72]. A scientometric analysis of nearly 1,150 gerodontology papers from 2007 to 2025 tracks the field's evolution from dentures and prosthetics toward frailty, nutrition, and dementia, with ageism and social determinants now entering the conversation [73]. In South Korea, about 4.6% of adults over 65 meet full frailty criteria and another 32% are pre-frail, a group where multidomain interventions have demonstrated reversibility [74] — the Korean Frailty and Aging Cohort Study, following 70-to-84-year-olds across ten hospitals, is generating much of that evidence base [75]. A local program in Busan that paired early screening with exercise, nutrition, cognitive, and social components showed significant improvements in grip strength, chair-stand performance, and reductions in depression and social isolation among 139 community participants [76]. Zooming out, a study of 18,581 older adults found that people in the lowest fifth of intrinsic capacity — the composite of physical, cognitive, and sensory function — faced over four times the risk of losing disability-free years compared to those at the top; notably, daily aspirin did nothing to slow IC decline and was linked to a small but unexpected worsening in women [77]. And in a historical curiosity, an analysis of Tang and Ming dynasty imperial eunuchs found only modest, inconsistent longevity differences compared to matched bureaucrats — with no evidence that earlier castration meant longer life — suggesting that testosterone's role in human aging is far more context-dependent than often assumed [78].

Muscle loss amplifies nearly every other health risk: a UK Biobank study of almost 440,000 adults found that combining fatty liver disease with low muscle strength raised cirrhosis hazard to more than seven times that of people without either condition, with stepwise increases also seen for heart disease, kidney disease, cancer, and all-cause mortality — replicated in a US validation cohort [79]. A meta-analysis of 35 observational studies found that type 2 diabetes carries 61% higher odds of sarcopenia compared to non-diabetic adults, while prediabetes showed no significant association, though observational design limits any causal reading [80]. In hospitalized older adults, sarcopenia shows a distinctive leg-heavy pattern — muscle deficit was significantly greater in the legs than the arms or trunk — suggesting that segmental assessment could add diagnostic value beyond the standard whole-body index [81]. A matched case-control study in adults aged 60 to 87 found that people with sarcopenia had distinctly lower blood levels of arginine, leucine, and a histidine-derived compound alongside disrupted lipid metabolism, with these patterns proposed as early detection candidates, though the metabolic signal was present but modest [82]. NHANES data show that men with the most appendicular muscle mass had nearly 40% lower odds of erectile dysfunction than those with the least, with monocytes potentially mediating a small share of that connection and vigorous physical activity independently associated with lower risk as well [83]. At the cellular level, spatial transcriptomics in patients with immune-mediated necrotising myopathy identified a specific fibroblast subtype — marked by SFRP4 expression, clustering around necrotic muscle, and carrying an inflammatory signature — proposed to drive the fibro-fatty replacement behind strength loss [84]. A review of the mitochondrial regulator Drp1 reveals it does far more than split mitochondria: it governs energy substrate use, calcium handling, and muscle adaptation through fission-independent mechanisms, with excess Drp1 activity linked to insulin resistance and deficiency linked to muscle wasting — positioning it as a potential target for both metabolic and neuromuscular disease [85]. For nutrition, a review of cereal-derived compounds including β-glucan and arabinoxylan finds preclinical evidence that they activate muscle protein synthesis pathways and suppress breakdown via the gut microbiota–short-chain fatty acid axis, though human intervention data remain limited [86]. On the protein front, a meta-analysis of five RCTs in untrained adults found that soy and pea protein combined with resistance training produced lean mass gains and fat loss comparable to whey, with no statistically significant difference between groups — chia-based protein was inconclusive given only a single study [87]. For endurance athletes, a review finds beta-alanine may help performance at the aerobic-anaerobic transition through carnosine buffering, and creatine may support late-race output through phosphocreatine availability, but evidence for improvements in core aerobic markers like VO2max is inconsistent and largely from untrained populations [88]. And in a cross-sectional study of older patients recovering from gastric cancer surgery, consuming 300–400 kcal/day of oral nutritional supplements was associated with roughly half the three-month body weight loss compared to those without supplements, though the cross-sectional design means causation can't be established [89].

One of the more counterintuitive findings across this batch: higher body weight doesn't protect your bones the way people assume. A review found that people with obesity face elevated peripheral fracture risk driven by visceral fat, bone marrow fat, and chronic low-grade inflammation, even when standard bone density scans look normal, and that weight-loss strategies like GLP-1 agonists and bariatric surgery may compound the problem if bone health isn't actively managed [90]. Bone complications also show up in unexpected places: a case series of seven patients with chronic wrist pain and documented low vitamin D found that all seven improved with supplementation and nutritional management alone, no surgery required [91]. A retrospective study of over 1,800 liver transplant recipients found that 3.5% developed femoral head osteonecrosis, and pre-transplant nutritional frailty was a stronger predictor than corticosteroid exposure [92]. Even the oral complications of bone-modifying medications get a nuanced reframe: a narrative review proposes that medication-related jaw osteonecrosis may involve a self-sustaining loop of impaired healing, microbial dysbiosis, and inflammation, though the authors note the framework is theoretical and derived from synthesis rather than primary data [93].

How you measure muscle matters as much as whether you measure it at all. A study in 475 healthy Thai adults showed that applying Western CT-based thresholds to this population overestimated sarcopenia prevalence, making the case for population-specific reference values [94]. In Parkinson's disease, a small comparative study found that sarcopenia is stage-dependent, becoming clinically meaningful mainly in moderate-stage disease rather than early on [95]. Among people with both obesity and low muscle mass, a large knee arthroplasty study found significantly higher central sensitization scores and lower pain thresholds compared to those with neither condition, suggesting the combination affects the nervous system in ways obesity alone does not [96]. For patients with cirrhosis, something as simple as bedside ultrasound of the thigh predicted hospitalization risk over the following year, with each unit increase in rectus femoris thickness linked to 22% lower odds of admission [97]. And in hospitalized older adults, poor chewing ability independently predicted worse functional status at discharge even after accounting for frailty and sarcopenia, suggesting masticatory assessment adds value to routine geriatric evaluation [98]. A review tying several of these threads together concludes that type 2 diabetes and sarcopenia are mutually reinforcing, each raising the risk of the other and together substantially increasing mortality risk compared with either condition alone [99].

On the intervention side, a few popular strategies don't hold up as well as hoped. A systematic review and meta-analysis found that exogenous ketone supplements produced no meaningful benefit for post-exercise muscle soreness, glycogen recovery, or lactate clearance, with mixed and limited evidence for cognitive recovery [100]. Creatine's role during forced rest is similarly murky: a systematic review of six small RCTs found it didn't consistently prevent muscle loss during limb immobilization, though two studies suggested faster recovery of quadriceps size, power, and strength once rehabilitation began [101]. What does hold up is structured exercise: a systematic review in frail older adults found two- to five-fold higher odds of frailty reversal in exercising groups, though the evidence for adding nutritional supplements on top of exercise remains inconclusive [102]. How someone exits the workforce also shapes how active they stay over the decades: a 17-year Finnish cohort study found that people who retired due to disability or unemployment showed steeper physical activity declines than those who retired at standard old age, with women in unemployment retirement losing 25.4 MET-hours per week by age 80 [103]. For cancer-related appetite loss, a review highlights that the problem runs deep at the molecular level, involving melanocortin-4 receptor, GDF-15, and ghrelin signaling pathways, and that multimodal strategies combining nutrition, pharmacology, and exercise are increasingly recognized as the preferred clinical framework [104]. Photobiomodulation using red and near-infrared light gets a wide-angle review reporting dose-dependent benefits across glucose metabolism, cardiovascular function, muscle regeneration, and vision, though standardized treatment protocols are still lacking [105]. A commentary on digital malnutrition screening in older adults pushes back on the tendency to stop at diagnostic accuracy, arguing that tools need to be validated in diverse populations, integrated with dietitian-led care, and evaluated on real outcomes like hospitalization and quality of life rather than risk scores alone [106]. Finally, a review on human placental extract concludes that while it may interact with the skin's KEAP1/NRF2 antioxidant pathway, the proposed mechanisms involving miRNA delivery remain hypothetical, and the profibrotic associations of one of the implicated microRNAs warrant safety evaluation before clinical translation [107].

Most of these findings are cross-sectional or from small trials, so the direction of cause and effect is often unclear — the "why" is still being worked out for many of these associations. Worth watching: the growing evidence that structured exercise does more for older adults than any single supplement, not by building obvious muscle bulk, but by keeping the nervous system's connection to muscle sharp — which may be the more important target all along.

What a mother eats during pregnancy can shape her own health for decades. Following 776 women from pregnancy to midlife, each one-standard-deviation improvement in DASH diet score during pregnancy corresponded to 3.3 points better cardiovascular health roughly 20 years later, with Mediterranean-style eating and anti-inflammatory dietary patterns showing comparable benefits [1]. Getting there requires attention to some easily overlooked nutrients: a community study in Northeast India found that about one in five pregnant and lactating women had suboptimal thiamine status, largely driven by stored rice, repeated pre-cooking washes, and salted tea — everyday habits that quietly deplete a B vitamin many assume is covered [2]. For women fighting anemia, a quasi-experimental Indonesian study found that adding red spinach-enriched snakehead fish floss to standard iron-folic acid supplementation produced a significantly larger hemoglobin gain over 21 days, suggesting food-to-food fortification can complement pills [3]. Supplemental vitamin C during pregnancy also showed an unexpected connection: in 302 women, it partially mediated the link between prenatal maternal distress and infant negative affect at six months, while dietary vitamin C intake alone did not have the same effect [4]. A scoping review of 48 studies from low- and middle-income countries found that women preferred receiving balanced energy and protein supplements at home alongside nutrition education over other delivery formats, a preference that may matter as programs try to improve uptake [5]. On the complications side, early-pregnancy insulin resistance more than doubled the odds of gestational diabetes in a retrospective cohort of 168 women with PCOS [6], and a secondary analysis of an RCT found that early metformin initiation significantly improved glycemic outcomes, with the greatest advantage in reducing the need for insulin [7]. A rare case report highlighted how poorly controlled pre-gestational type 2 diabetes can coincide with severe and multiple congenital anomalies [8], while another case showed that a woman with the glycosylation disorder PGM1-CDG navigated a full pregnancy by sustaining her galactose intake through a lactose-rich diet rather than pharmaceutical supplementation, with stable liver and cardiac function throughout [9]. A narrative review proposed an integrated omics framework to explain why the HIV drug dolutegravir has variable cardiometabolic effects in pregnancy, though the authors are careful to note these mechanisms remain hypotheses still awaiting pregnancy-specific validation [10]. Cord blood lipidomic profiling of pregnancies complicated by suspected preterm labor revealed distinct lipid signatures, particularly in phosphatidylcholines, sphingomyelins, and cholesterol-derived hormones, that may eventually help predict which pregnancies will deliver early [11]. A scoping review from Southeast Asia documented how environmental changes, including plantation agriculture expansion and industrial pollution, disrupt fertility, nutrition, and pregnancy outcomes through multiple pathways, with women facing disproportionate risks during extreme weather events [12]. A review of 74 studies on neural tube defects noted that while folic acid supplementation cut open NTD rates by around 30% following its landmark discovery in the early 1990s, closed NTD rates have not moved, pointing to genetic and other environmental contributors still being unraveled [13].

The first months of life bring their own set of nutrition challenges, especially for the most vulnerable newborns. A commentary summarized research showing that milk-derived osteopontin shapes the infant gut microbiome, which in turn directs early immune development in the respiratory airways, conferring protection against respiratory tract infections that can persist beyond infancy [14]. An umbrella review of seven systematic, scoping, and narrative reviews identified the Breastfeeding Self-Efficacy Scale Short Form and the Prenatal Breastfeeding Self-Efficacy Scale as having the strongest psychometric evidence, recommending a two-stage screening approach (prenatal, then postpartum) to target support where it is most needed [15]. A commentary proposed that informal community milk-sharing networks function as mutual-aid infrastructure filling real gaps left by formal milk banks, arguing that public health policy should develop evidence-informed frameworks to support the safety and equity of these practices rather than stigmatizing them [16]. In the NICU, a double-blind RCT of 109 babies born before 34 weeks found that lactase supplementation significantly reduced gastric residuals, abdominal distension, vomiting, and diarrhea, while also improving daily weight gain and cutting the incidence of necrotizing enterocolitis [17]. But what goes into IV lines carries its own risks: chemical analysis of parenteral nutrition passed through standard infusion equipment detected 18 contaminants, with estimated daily BPA intake exceeding health-based guidance values in premature infants whose immature detoxification systems cannot clear it quickly [18]. A look at real-world parenteral nutrition prescribing for 371 very-low-birthweight infants in Argentina found that while amino acid and glucose targets were broadly met, lipid provision fell short of the recommended minimum in nearly three-quarters of day-3 prescriptions, and amino acid delivery tracked fluid volume rather than individual weight-based targets [19]. A commentary on D-lactate cautioned that elevated levels after pediatric intestinal failure do not reliably confirm successful gut adaptation, since interpretation depends on the child's anatomy, microbial activity, and kidney function, and that current reference values lack sufficient validation to guide clinical decisions [20]. The Infancy-Childhood-Puberty growth model sheds light on why early nutrition matters so much: the infancy growth phase is driven by nutrition and IGF-I rather than growth hormone and represents a continuation of fetal growth through roughly the first six months of life, after which a distinct childhood growth pattern starts between 6 and 12 months alongside a marked rise in serum IGF-I [21]. A structured narrative review of 36 studies on cyanotic congenital heart disease found that these children consistently show appetite hormone disruption, impaired weight gain, and linear growth faltering, and that timely surgical correction is associated with partial recovery of growth velocity and anabolic signaling, though prolonged preoperative hypoxemia may limit full catch-up [22]. In children identified with benign transient hyperphosphatasemia within a vitamin D trial, alkaline phosphatase reached up to 11 times the upper reference limit, with both bone and liver isoforms elevated and evidence of altered glycosylation apparently driving the pronounced enzyme migration seen on laboratory testing [23].

School-age and community findings round out the picture. Among 315 Brazilian schoolchildren aged 7 to 10 who had biochemical testing, nearly nine in ten had at least one cardiometabolic risk factor, and eating meals with distractions was independently linked to nearly three times the odds of having multiple risk factors [24]. A study of 729 children aged 3 to 13 found that more than half did not meet water intake recommendations, and a urine osmolality cutoff of around 600 mmol/kg emerged as a practical pediatric threshold for detecting inadequate hydration, sitting slightly above the 500 mmol/kg adult standard [25]. A cross-sectional pilot in Chile found that most toddlers aged 2 to 5 did not meet dietary recommendations regardless of caregiver feeding style, though children of authoritative caregivers were more likely to eat fish or seafood at least once a week [26]. A published protocol describes a cluster RCT testing a 16-week responsive feeding intervention for rural family childcare home providers in Nebraska and Kansas, combining online learning modules with individualized coaching and video feedback, designed to improve fruit and vegetable intake among children aged 3 to 5 in informal care settings [27]. A 14-week gym-based health and nutrition program for Aboriginal youth aged 12 to 16 in Western Sydney showed strong feasibility, with 90% average session attendance in the first cohort and qualitative reports of cultural acceptability from both participants and families [28]. In New Zealand, universal continuous glucose monitor funding for children with type 1 diabetes triggered a ninefold jump in CGM initiation rates in the weeks after rollout, with increases seen across all major ethnic groups, though disparities in overall CGM use persisted by year-end and HbA1c distributions remained stable throughout 2024 [29]. LC-MS/MS profiling of cerebrospinal fluid from children with tuberculous meningitis found markedly elevated concentrations of most amino acids compared to both viral meningitis and non-meningitis controls, with glycine levels correlating with immune cell counts, suggesting that amino acid shifts in the CSF reflect the intensity of the inflammatory response [30].

Gestational diabetes sits at the center of a cluster of new findings. The condition touches roughly 14% of pregnancies worldwide, and a review describes how the supplement myo-inositol may support placental insulin signaling and reduce GDM risk — though the ideal dose and timing are still being worked out [31]. A related condition called polyendocrine metabolic ovarian syndrome (PMOS), found in about 1 in 6 women in a large prospective cohort, independently raised the odds of early GDM, adverse neonatal outcomes, and NICU admission [32]. How first-trimester blood sugar patterns play out matters too: in 150 pregnant women, insulin resistance predicted heavier babies while poor insulin secretion predicted higher maternal blood sugar after delivery — two mechanistically separate pathways with different consequences [33]. A meta-analysis of 10 studies found that applying stricter GDM diagnostic thresholds doubled diagnoses and pharmacotherapy use and increased neonatal hypoglycemia and mother-infant separation, without meaningfully improving most short-term outcomes [34]. Despite these stakes, qualitative research in rural Kenya found that high costs, supply shortages, and poor infrastructure remain the dominant barriers to GDM care, while family support and dietary counseling were the most consistent facilitators [35]. Meal kits don't offer an easy fix: a modeling study found that 64 menus from 10 US meal kit services averaged an HEI score of just 55.4 out of 100, with fiber, vitamin D, iron, and calcium all falling short of pregnancy recommendations and not a single recipe containing whole grains [36]. Digital GDM tools are multiplying fast — a scoping review of 62 studies found 77% were mobile apps — but most covered only the prenatal window and equity gaps around health literacy and technology access remained largely unaddressed [37]. Two large supplementation trials also delivered sobering results: a meta-analysis of 7 RCTs found no meaningful difference in infant cognitive or motor scores at up to 24 months when mothers took multiple micronutrient supplements instead of iron and folic acid alone [38], and a 1,568-infant factorial RCT in rural Nepal found that daily protein-energy supplementation during pregnancy or lactation left infant length-for-age z-scores unchanged at 6 and 12 months [39]. A striking case report described a 28-year-old woman who developed Wernicke's encephalopathy at 17 weeks of pregnancy after severe hyperemesis gravidarum depleted her thiamine — confirmed by characteristic thalamic MRI changes — underscoring how dangerously underdiagnosed this condition remains in pregnant women and why prompt parenteral thiamine is so critical [40]. On the more speculative end, a mechanistic hypothesis review raises the intriguing possibility that apigenin — a flavone found in parsley, chamomile, and celery — could theoretically amplify placental opioid signaling through several molecular pathways, while explicitly flagging that this is untested and that most supporting evidence comes from non-placental systems [41]. In a study of 175 mother-infant pairs, prenatal exposure to common household chemicals — phthalates, parabens, and phenols — was linked to over 2,000 metabolome-wide associations in umbilical cord plasma, with phenol and phthalate exposures particularly affecting fatty acid and energy metabolism pathways [42]. A case-series analysis found that multiple neural tube defects occurring at separate anatomical sites — rare even among NTD cases — tend to involve more spinal dysraphism than single NTDs, and surviving children generally showed less motor and cognitive impairment [43]; meanwhile a bibliometric sweep of the 100 most-cited preterm birth papers found US institutions produced 71% of articles and that the field has been moving from clinical risk factors toward molecular biology, the vaginal microbiome, and cervical assessment [44].

For the tiniest patients, a standout finding comes from six Dutch NICUs: in 481 extremely preterm infants under 28 weeks, a three-strain probiotic (ProPrems®) was associated with a 51% reduction in necrotizing enterocolitis odds, two fewer days to full feeds, and faster growth, with only one case of probiotic-related sepsis [45]. Gut health also features in congenital heart disease: a small study of 41 newborns found that formula feeding, feeding tube use, aortic cross-clamping during surgery, and greater socioeconomic deprivation were each associated with altered microbial diversity, while babies fed only human milk had a meaningfully different microbiome profile [46]. What's in that human milk matters, but not always in the expected direction: in 120 mother-infant pairs, higher levels of odd- and branched-chain fatty acids in breast milk were inversely associated with infant motor development scores at 8 months — a relationship that was stronger among infants born by cesarean, to younger mothers, or to mothers with excessive gestational weight gain [47]. In cystic fibrosis, a registry study of 10,008 US children found that those born with meconium ileus who also required a gastrostomy tube had the lowest early growth z-scores and lung function — a gap that narrowed with age but that flags this subgroup for closer follow-up [48]. In 33 pediatric liver transplant recipients, early tacrolimus trough levels in the first two weeks tracked closely with hemoglobin and creatinine values, while nutrition delivery method did not significantly affect drug levels [49]. For families managing cow's milk allergy, a study of 85 preschoolers who had failed an initial food challenge found that a casein-specific IgE below 3.71 kUA/L combined with a reaction that only appeared after the full protocol dose predicted successful future tolerance with nearly 93% negative predictive value — a practical signal for deciding when to retest [50]. In humanitarian settings, a systematic review of 53 documents across 20 countries found community-based nutrition programs reliably improved infant feeding practices and caregiver behaviors, though effects on child growth measures were inconsistent and evidence on long-term outcomes remains thin [51]; an ethics analysis of international emergency guidelines separately concluded that distributing infant formula beyond specific clinical indications — in particular simply because a mother prefers it — risks population-level harm and undermines breastfeeding support [52]. Low birth weight was the single strongest predictor of stunting, underweight, and wasting in 394 Indonesian children under age 5, raising stunting odds nearly fivefold [53]. And a creative pilot offering fruit-and-vegetable vouchers to 19 food-insecure pediatric kidney transplant recipients achieved 86% redemption and significantly raised serum bicarbonate — an important metabolic marker in this population — without a single episode of dangerous hyperkalemia [54].

Older children were the focus of several intervention studies and clinical reports. A 12-week school program in 1,200 Pakistani children and adolescents reduced overweight and obesity prevalence while it rose in controls, and pushed physical activity adherence from roughly one in four children to nearly three in four, with measurable improvements in screen time, sleep, fast-food consumption, and waist circumference [55]. Parent-involved digital health programs showed a small but statistically significant reduction in BMI-related outcomes in a meta-analysis of 22 RCTs — though the effect disappeared when compared against active rather than inactive controls, and evidence for changing diet or physical activity behavior directly remained limited [56]. A multi-omics study in 57 Mexican children found GGT to be the strongest hepatic obesity biomarker, outperforming ALT and AST, and catalogued more than 1,000 altered metabolites each in stool and blood in obese versus healthy-weight children, including disrupted short-chain-fatty-acid-producing bacteria with some strikingly high gut bacteria–metabolite correlations [57]. In 247 Indonesian children aged 3–24 months, developmental delays were suspected in up to a quarter of suburban children; longer screen time and postnatal complications raised the odds while higher maternal education was strongly protective [58]. Prader-Willi syndrome appeared in two distinct reports: a 3-year case follow-up of a boy with PWS showed promising early metabolic improvements on a structured diet but a characteristic weight rebound during puberty, supporting the need for developmentally adapted long-term monitoring [59], while a systematic review found that emerging dried bloodspot technologies could detect PWS at birth with high accuracy, but the absence of cost-effectiveness data and a curative treatment remain the main hurdles to adding it to universal newborn screening programs [60].

The story of what goes into a baby's first months of nutrition keeps getting more complex. A synthesis of more than 15 studies frames human milk as a dynamic biological system shaped by maternal endocrine status, diet, ethnicity, and lactation stage — with early-life programming of obesity, type 2 diabetes, and hypertension all running through gut microbiota as a key interface [61]. Many of its bioactive components — HMOs, sIgA, TGF-β, cytokines, fatty acids, and extracellular vesicles — have been mechanistically linked to immune tolerance and allergic disease, yet a narrative review concludes that no single component reliably predicts protection against eczema, food allergy, or wheezing in any given infant [62]. At the microbial level, gut bacteria in infants show distinct abilities to break down the two most abundant sialylated HMOs in breast milk, and breastfed and formula-fed infants already diverge in their profiles of these sialidase-producing bacteria before solid foods enter the picture [63]. For preterm babies, breast milk alone cannot meet their nutritional demands, making fortification essential — but a review of the evidence finds neither standard nor individualized fortification has demonstrated clear superiority, with osmolality, contamination risk, and emerging chrononutrition approaches all still unresolved [64]. In preterm infants under 34 weeks, serum phosphorus follows a U-shaped arc across gestational ages, dropping most steeply before about 32 weeks, then rebounding — a pattern relevant to mineral monitoring decisions in the NICU [65]. Umbilical venous catheters in preterm infants under 34 weeks were associated with later feeding starts, longer time to full feeds, and more frequent feeding intolerance while in place, with SGA infants showing notably lower splanchnic oxygenation in those early days [66]. For infants requiring NEC ileostomy closure, adding a transanal intestinal tube was linked to three fewer days in hospital and earlier enteral feeding initiation, though it shifted — rather than eliminated — complications [67]. A systematic review of six trials covering nearly 1,000 preterm infants found no evidence strong enough to guide timing or laxative choice for delayed meconium passage — a surprisingly open clinical question [68]. In Vietnamese mother-newborn pairs, the FIGO Nutrition Checklist outperformed the simpler MUAC measure for predicting small-for-gestational-age births, with an at-risk score independently linked to roughly three-to-four-fold higher odds of SGA by weight and length [69]. And for women with gestational diabetes, continuous glucose monitoring data in the 48 hours after delivery showed that better-controlled pregnancy glucose tended to predict lower postpartum glucose as well [70].

Early feeding habits leave marks that extend well past infancy. Among 40 Indian infants brought in for unexplained neurodevelopmental delays or feeding difficulties, nearly two-thirds had vitamin B12 deficiency, and those who received treatment showed significant improvements in both motor and mental development scores as well as weight and length gains — improvements not seen in infants who were already B12-sufficient [71]. In Yemeni preschoolers, nighttime bottle-feeding, sweetened pacifiers, and high-grain-and-sugar dietary patterns each showed strong associations with early childhood caries, while breastfed children had caries rates roughly three times lower than bottle-fed peers [72]. Australian infants tracked over their first year fell into distinct food avoidance trajectories, with the most avoidant babies significantly more likely to be fussy eaters at 12 months — though the avoidance pattern itself didn't predict vegetable intake [73]. Among South African preschoolers, eating meat three or more times weekly, seafood once or twice weekly, and vegetables three or more times weekly was each independently associated with roughly 70–75% lower odds of having ever wheezed [74]. A multi-omics study comparing children with kwashiorkor to those with marasmus and healthy controls found two kwashiorkor-specific molecular signatures — one involving proteins linked to extracellular matrix remodeling (lumican, gelsolin, tetranectin), the other enriched in sphingolipids — both correlated with edema severity and trending toward normalization after nutritional rehabilitation [75]. Among Nicaraguan children with dengue, those with obesity had nearly twice the binding antibody levels of normal-weight peers, but their neutralizing efficiency was 33% lower, suggesting adiposity skews the immune response toward quantity over quality [76]. Two pediatric cases of refractory iron deficiency anemia that turned out to be collagenous gastritis — confirmed by characteristic subepithelial collagen bands on biopsy — both responded to individualized management including dietary modification, iron replacement, and anti-inflammatory therapy [77]. A survey of gastroenterologists across 27 countries found generally high adherence to celiac disease diagnostic guidelines, but meaningful variation in biopsy practices at high serologic thresholds — with non-US providers significantly more likely to adopt biopsy-free approaches — and limited dietitian involvement across regions [78]. In a perioperative study of placenta previa caesarean sections, protein metabolism nutritional intervention combined with a surgical hemostasis technique achieved hemostasis in 95.5% of cases versus 70.6% in controls, with less bleeding, lower costs, and shorter hospital stays [79]. And across three pediatric ICUs, weekly proactive interdisciplinary rounding reduced serious hospital-acquired pressure injuries by 39% within a single year, with over 1,400 proactive interventions implemented [80].

What children eat — and what shapes those choices — is increasingly legible across a range of settings and ages. In Ethiopia, a cluster-RCT found that Health Belief Model-based nutrition counseling delivered to mothers nearly doubled appropriate complementary feeding rates, with significant gains in dietary diversity, meal frequency, and overall dietary quality [81]. A scoping review of 101 studies identified social norms, peer and family influence, and self-efficacy as the most prominent determinants of what adolescents eat, with social forces capable of nudging habits in either direction depending on the norms in play — though 41% of the studies lacked an explicit theoretical framework [82]. In Indonesian adolescents tracked across four national surveys from 2007 to 2023, tobacco and alcohol use declined, but insufficient fruit and vegetable intake rose above its 2007 baseline, with girls and older teens faring worst [83]. Analysis of over 1.2 million Chinese students from 2005 to 2019 showed overweight and obesity nearly doubling, while stunting fell and anemia remained persistently high at around 10%; ethnic inequalities widened, and the same child increasingly showed more than one nutritional problem simultaneously — complicating single-condition approaches [84]. A brief under-five-minute video on sugary drink harms and nutrition labels cut full-sugar drink selection by 21 percentage points among Chinese students in a cluster-RCT, with beverage profile and price together accounting for nearly 90% of preference formation [85]. Mouse-tracking experiments in 8-to-13-year-olds showed that food logos engage the same taste-driven, value-based decision processes as actual foods, and that successful self-control involved greater cognitive effort and earlier integration of health information relative to taste cues — for both real foods and logos [86]. A small Afrocentric food literacy program among 27 Canadian Grade 7 students saw whole-grain consumption more than double and non-starchy vegetable intake nearly double over 10 sessions, though the absence of a control group means these changes can't be attributed to the program alone [87]. In a cluster-RCT of Hispanic preschoolers along the Texas-Mexico border, a coordinated school health program improved health knowledge scores by 12 percentage points versus controls, with girls, older children, and those from higher-income and more-educated families scoring best [88]. A survey of 97 commercially available French baby foods found that heavy metals (Cd, Pb, Ni) all fell within EU limits and inorganic arsenic remained very low even in fish-based products, though tin levels were significantly higher in glass jars with metallic lids than in other packaging formats [89]. Finally, qualitative interviews with parents of early childhood cancer survivors in the first year after therapy found cost, time, and dietary restrictions as the top barriers to healthy eating — with families strongly preferring modular, access-focused nutrition support regardless of whether they were food-insecure, and reporting substantial unmet nutrition needs during early survivorship [90].

A large study of 807 women with gestational diabetes found that being overweight or obese before and during pregnancy significantly raised the odds of developing GDM — with obesity carrying more than double the risk of a healthy-weight pregnancy — and that pre-pregnancy BMI could predict GDM-related hypertensive complications with reasonable accuracy [91]. The same research showed that third-trimester triglyceride levels were tied to how the baby was delivered, neonatal birth weight, and blood loss at delivery, while HDL cholesterol had its own independent influence on fetal growth — a reminder that metabolic health in pregnancy is a web of interacting factors, not a single number on a scale [91].

For the smallest and most vulnerable patients — premature newborns — two findings point to both promise and persistent challenges. A review of probiotic use in preterm neonates found that strains of Lactobacillus, Bifidobacterium, and Saccharomyces show real potential for reducing dangerous conditions like necrotizing enterocolitis and sepsis, but that unresolved questions about which strains to use, at what dose, and how safely to give them to critically ill infants are keeping these findings from becoming standard care [92]. On the surgical side, a ten-year look at 431 pediatric gastrostomy procedures found that the laparoscopic-assisted approach (LAPEG) had the lowest overall complication rate at 24.5%, while open gastrostomy came in at a strikingly higher 58.3% — a difference that matters enormously when the patient is a child [93].

Older children face a different set of nutritional hurdles. Among 155 Saudi children with autism spectrum disorder, more than half were vitamin D deficient, over a quarter had low iron stores, and average daily energy intake reached only 68.7% of estimated needs — yet nearly a third were overweight and one in five was obese, coexisting with stunting in 14% of the group [94]. That paradox of simultaneous under- and over-nutrition underscores why BMI alone tells an incomplete story. Meanwhile, a study tracking 2,524 school lunch trays found that scheduling recess before lunch — a strategy sometimes promoted to improve eating behavior — did not meaningfully change overall diet quality or total calories consumed; kids with reverse recess did eat and waste slightly less fruit, but the broader hoped-for effect on what children choose to put on their trays simply didn't materialize [95].

Most of these studies are single-center, small, or drawn from specific populations, so results won't always translate directly to your situation or setting — the patterns are worth knowing, but rarely worth acting on without talking to a provider. Worth watching: the probiotic story in extremely preterm newborns is moving fast, with a Dutch NICU study now showing a 51% drop in necrotizing enterocolitis odds from a three-strain combination — if that holds up in broader use, it could become standard care sooner than expected.

Animal work this round mapped several routes by which metabolic disruption reaches the brain. In mice lacking the urea transporter UT-B, chronically elevated urea caused dose-dependent energy failure in amygdala oligodendrocytes—lower ATP, collapsed membrane potential—alongside anxiety-like behavior; supplementing with oxaloacetic acid partially reversed both [1]. A separate technique showed that a glucose-sensing biosensor injected into mouse optic nerves at ten days old can track oligodendrocyte metabolism live in intact tissue, opening a window on how these cells adapt under stress [2]. On the metabolic disease side, knocking out the long noncoding RNA H19 in diabetic rats silenced the NLRP3 inflammasome, dropped inflammatory markers ICAM-1 and VEGF, and reduced retinal injury—fingering H19 as an active driver of diabetic retinopathy rather than a bystander [3]. Nanostructured lipid carriers co-loaded with two diabetes drugs produced synergistic blood-sugar control and improved pancreatic tissue in streptozotocin-nicotinamide rats [4], while in prediabetic rats on a mild high-calorie diet, ACE1 was already elevated in fat surrounding the kidneys and blood vessels—and low-dose captopril corrected early vascular and kidney damage without touching blood pressure [5]. Five days of unacylated ghrelin injections in healthy rats improved pyruvate handling but left most other metabolic markers—muscle and liver fat, glucose uptake, AKT activation—unchanged, suggesting the hormone's short-term footprint is narrower than sometimes assumed [6]. A selective glucocorticoid receptor modulator cut liver fat within days in high-fat-diet mice, but the benefit reversed within a week of stopping, and stacking it with two other metabolic drugs added nothing [7]. In a mouse model of adolescent gender transition, puberty suppression reduced bone mass and raised body fat; estradiol restored bone but only partially normalized composition; and a synthetic progestin worsened glucose tolerance and drove hepatic fat accumulation more than natural progesterone did [8].

Insect and invertebrate studies showed just how tightly nutrition-sensing pathways control biology. In fruit flies, fat cells communicate with brain insulin-producing neurons via the hormone CCHa2—silence that signal in the fat body, and fed flies start sleeping like starved ones, with shallower rest and depleted glycogen stores [9]. In the horned dung beetle, suppressing the insulin-pathway enzyme Akt with RNAi shrank body size, horn length, and sex-specific ornamental structures, confirming Akt as a central switch for nutrition-driven developmental plasticity [10]. Bumblebees exposed to artificial light at night died earlier, lost sleep, and showed cognitive decline tied to a surge in reactive oxygen species; oral antioxidants and simple darkness both reversed the damage [11]. Heat stress cut the lethal dose of the insecticide thiamethoxam in bumblebees by roughly half, and lipid peroxidation persisted even after standard antioxidant markers had recovered [12]. Moving to aquaculture, sea cucumbers supplemented with 0.25% alginate oligosaccharides grew faster, fell ill less often after bacterial challenge, and showed improved gut structure and immune activity [13]. In weaned pigs, ear necrosis tracked with haptoglobin and IL-6 levels roughly two to three times higher than in unaffected animals, though no early-weaning marker reliably predicted which pens would develop problems later [14]. Gut microbiota turned out to explain an early growth disadvantage in cystic fibrosis mice: under germ-free conditions, the bone-length and IGF-1 gap between CF and wild-type pups vanished entirely [15]. A phage catalogue drawn from 25 non-human primate species found that evolutionary lineage shaped gut phage diversity more than diet did, with 78.5% of those phages also appearing in human guts—most commonly in nonindustrialized populations [16]. On the vitamin D front, cell work in prurigo nodularis showed that the VDR-AADAC protective axis is dismantled by oxidative stress and rebuilt by vitamin D—but only when the receptor itself is intact [17]. Two rare VDR mutations crippled receptor function, yet assembling a three-way complex with the co-receptor RXR and active vitamin D partially rescued transcriptional activity in a mutation-dependent way [18]. In vitamin D-deficient rats, 12 weeks of phytosterol supplementation slowed cancellous bone loss but raised abnormal sterols in skeletal muscle—a potential trade-off worth watching [19].

A thread running through several other papers is how environment and diet leave marks that outlast first exposure. Male mice inhaling concentrated urban PM2.5 five days a week for 22 weeks developed fatty liver and dyslipidemia—and so did their sons and grandsons—with matching DNA methylation changes at lipid-gene promoters in both sperm and offspring liver, suggesting air pollution can epigenetically reshape lipid metabolism across two generations [20]. In fission yeast, two chromatin regulators protect active promoters from inappropriate remodeling, and when nutrients run low a dedicated degradation pathway dismantles them on cue, neatly wiring nutrient status to genome-wide transcriptional reprogramming [21]. A review of rodent obesity models emphasized that early-life nutritional programming leaves epigenetic marks in fat tissue that set long-term metabolic trajectories, and that children's physiology diverges enough from adults' to limit what adult animal work can tell us [22]. In pain research, the cancer drug gefitinib directly activated a pain-sensing ion channel in sensory neurons and progressively worsened mechanical and thermal sensitivity over 28 days in mice; a traditional herbal formula partially reversed that sensitization through two of its active plant compounds [23]. Cell-based work on trigonelline—a compound found in coffee and fenugreek—predicted favorable docking to Alzheimer's-linked enzymes via network pharmacology and found improved survival of toxin-treated human neurons in culture, though those predicted molecular targets weren't directly validated in the cell experiments [24]. An herbal formula called Simiao Pill cut joint inflammation and reshaped gut microbial profiles toward aromatic amino acid and vitamin metabolism in arthritis mice; depleting the microbiota with antibiotics blunted those benefits, confirming the gut as a key mediator [25]. In a mouse model of hypertensive kidney disease, a specific macrophage subset drove tubular cell damage and fibrosis via IL-1β signaling; exogenous irisin suppressed that inflammatory population and improved kidney function without altering blood pressure [26]. Cardamonin improved motor activity, reduced oxidative stress, and raised brain dopamine in two mouse Parkinsonism models, though the study lacked neuron-specific markers to confirm direct dopaminergic cell preservation [27]. Baltic Sea bacteria were coaxed into producing two membrane-protective lipid molecules that made engineered E. coli more resistant to enzymatic cell-wall degradation and to hydrogen peroxide [28]. On the methods side, new ApoTracker fluorogenic probes enable wash-free labeling of dying cells across flow cytometry, live imaging, and live animal cancer models without requiring calcium—useful for chemotherapy drug screening in preclinical settings [29]—and in exercising horses, a standard infrared thermometer matched rectal temperature to within about 1°C on average, versus nearly 3°C off for a thermal imaging camera, with ambient temperature strongly skewing the camera readings [30].

A striking thread through this batch of studies is what happens in the gap between the endoplasmic reticulum and the mitochondria — two organelles that have to cooperate closely for cells to function. In rats fed a 60% fat diet for 15–16 weeks, coronary artery dysfunction traced back to a specific reactive-oxygen-generating enzyme (NADPH oxidase 1) that blunted mitochondrial respiration; tellingly, applying ER stress chemically to lean rats reproduced the same energy deficits, confirming that ER disruption alone can cause the mitochondrial impairment seen in obesity [31]. In muscle cells, overexpressing the circadian clock protein Nr1d1 multiplied the physical contact sites between the ER and mitochondria; under ER stress, those extra contacts funneled excess calcium into mitochondria and pushed cells toward death, identifying Nr1d1 as an unexpected co-pilot of that organelle junction [32]. A mouse model of PCOS combined with fatty liver found that blocking NK3 receptors quieted ER stress via the PERK-ATF4-CHOP signaling axis, cleared hepatic fat, and restored normal hormone cycling [33]. Thyroid hormone T3 strongly switched on thermogenic genes in brown and beige fat cells while barely moving the needle in white fat, pointing to hardwired, cell-lineage-specific responses to metabolic signals [34]. At finer resolution, reconstituted membrane experiments showed that a single amino-acid change at position 22 of the muscle peptide DWORF completely abolished its ability to activate the SERCA calcium pump, while mutations at the opposite end flipped DWORF from activator to inhibitor — a coordinated multi-domain mechanism [35]. In fission yeast, deleting the Atp12 protein shattered mitochondria into fragments and markedly shortened the organism's lifespan, effects largely reversed by boosting the fusion protein Fzo1 that Atp12 normally stabilizes, linking ATP-synthase assembly machinery to the aging clock [36]. In isolated mouse islets, the type 2 diabetes drug imeglimin at a clinically relevant dose enhanced insulin secretion and assembled mitochondria into higher-order supercomplex structures, while a dose one hundred times higher suppressed secretion instead — a vivid illustration of how non-linear these relationships can be in cell work [37]. Neonatal rat heart cells grown on medium-density nanofiber scaffolds showed four times the contraction force and twice the mitochondrial membrane potential of cells on denser substrates, the difference driven by mechanical signaling through YAP and PI3K-Akt [38]. In mice, a traditional Chinese herbal formula restored myocardial ATP and reduced cardiac scarring after heart attack, with multi-omics pinpointing the RNA-methylation eraser protein FTO as the central target — mice with one FTO gene copy knocked out lost all the formula's benefits [39]. And for researchers building lab-grown islets, layering calcium peroxide and catalase into a hydrogel kept oxygen levels elevated for 28 days in culture and supported beta-cell insulin secretion, though a fivefold higher peroxide dose turned cytotoxic over time [40].

The microbiome's reach extended into some surprising territory. Mice given an acute overdose of low-digestible sugars — arabinose, lactulose, and polyols — became dramatically more vulnerable to Salmonella: rapid fermentation acidified the gut, disrupted resident bacteria, and raised luminal amino acid levels to feed the pathogen, which then spread systemically via both of its main virulence gene clusters and even colonized the small intestine [41]. Structural biology work characterized the first carbohydrate-binding module from the gut bacterium Akkermansia muciniphila, finding it homes in on specific ganglioside sugar structures — a molecular window into how this symbiont may navigate the mucosal surface [REF:b21c5aac-ad5e-4908-aa4f-0b324c17ab11]. In Parkinson's disease mice, gut dysbiosis went hand-in-hand with lower circulating arachidonic acid; fecal transplants from healthy donors restored both the fatty acid and motor performance, while giving arachidonic acid directly also reduced neuroinflammation, tracing a potential gut–lipid–brain signaling axis [42]. A mechanistically distinct gut-to-liver route for cancer emerged from work showing that Bacteroides fragilis can translocate from gut to liver and promote hepatocellular carcinoma development by using its own enolase enzyme to latch on to hepatocyte vimentin [43]. Orally delivered mangiferin in liposomal nanoparticles increased cartilage thickness, raised subchondral bone density by 27%, and cut colonic histopathology scores by 65% in an osteoarthritis mouse model, with gut microbiome sequencing showing partial restoration of the Firmicutes-to-Bacteroidetes balance [44]. Maternal gum disease in mice reduced offspring gut microbiome diversity and produced measurable shifts in social behavior and locomotion, while cerebellar gene expression changed and DNA methylation was altered as early as embryonic day 18.5 — pointing to oral dysbiosis as an unexpected epigenetic influence on fetal brain development [45]. On the food-compound side, an Aspergillus niger fermentation broth of oysters produced strong antioxidant activity and reduced oxidative damage in cell culture [46], and luteolin-loaded chitosan nanoparticles at 50–100 mg/kg protected heat-stressed growing rabbits by cutting inflammatory markers including NF-κB, TNF-α, and several interleukins in a dose-dependent pattern [47]. An extract of Jatropha integerrima showed activity against human coronavirus HCoV-229E in cell culture and, formulated as nanoparticles, reduced viral lung damage and shifted immune responses toward Th1 and NK cell profiles in intranasally infected mice [48]. Green tea's EGCG formed protective assemblies with undigested gliadin peptides that limited how far those peptides penetrated intestinal mucus, with the assemblies associated with lower IL-8 inflammatory signaling in a gut cell coculture compared with free peptides [49]. Acorn extracts from two oak species survived simulated stomach digestion with their enzyme-inhibiting activity intact — in some cases stronger afterward — and ellagic acid released by digestion showed high predicted binding for fat-breakdown and blood-sugar enzymes in molecular docking [REF:69d35bb0-1d66-4f5c-b456-4a972fbe470]. In largemouth bass, a mixture of Astragalus and Codonopsis root extracts at 0.1% of the diet improved growth, immunity, and antioxidant enzyme activity via Nrf2 signaling, while the double dose reversed those gains — underscoring a narrow therapeutic window [50]. And the plant compound salidroside improved learning and memory in an Alzheimer's disease mouse model by restoring glutathione metabolism and activating Nrf2, an effect cancelled in cell culture when Nrf2 was pharmacologically blocked [51].

Several findings range across reproduction, neurology, and other disease models. In zebrafish, paternal exposure to the flame retardant DBDPE damaged sperm and caused eye malformations in F2 grandoffspring even at low doses, with transcriptome analysis tracing the multi-generational harm to progressive disruption of vitamin D3 synthesis across generations; paternal vitamin D3 supplementation during exposure protected both sperm quality and offspring development [52]. An analysis integrating rumen microbiome data, metabolomics, and genomics in Holstein bulls found that Fibrobacter abundance was positively linked to sperm motility and density, with machine learning shortlisting Fibrobacter and the metabolite thromboxane B2 as candidate indicators of semen quality [53]. Rat models of hypothyroidism developed depressive behaviors within six weeks and worsening spatial memory over 14 weeks, while hippocampal GLUT4 protein rose nearly twofold without a matching change in its gene — apparently a post-translational compensation for impaired glucose metabolism — with all changes reversing on levothyroxine [54]. In head and neck cancer cells, chemotherapy triggered cGAS-STING signaling that paradoxically fueled autophagy and drug resistance through paracrine TNF; elevated ATG9A serine-654 phosphorylation correlated with poor drug response in patient samples, and TNF blockade improved outcomes whether chemotherapy was given alone or combined with immune checkpoint inhibitors [55]. In a bowel pain model, the cytokines IL-6 and Oncostatin M triggered calcium responses in colon sensory neurons that were dampened by inhibiting TYK2 kinase or the ion channels TRPV1 and TRPA1, identifying TYK2 as a downstream pain mediator potentially relevant to IBD-associated pain [56]. Overexpressing ANGPTL3 in transgenic chickens triggered pronounced hepatic fat accumulation and oxidative stress, implicating this protein as a key driver of fatty liver hemorrhagic syndrome in laying hens [57]. And for researchers studying neurodegeneration, a new protocol describes isolating lipid droplets from neurons — organelles thought to play roles in neurodegenerative disorders but previously too small and sparse in neurons to capture cleanly — by using a lipase inhibitor to enlarge them before separating them by sucrose-gradient flotation [58].

The relationship between our gut microbes and the rest of the body kept emerging as a throughline across this batch of studies. Blueberry's protective effect on blood vessels turned out to depend entirely on the microbiome — in mice, germ-free or antibiotic-treated animals lost both the vascular protection and the blueberry-derived plasma metabolites (like hippuric acid) that normally accompany it [59]. In a separate mouse model, a transient gut infection in newborns — but not in adults — caused lasting hippocampal damage and cognitive deficits, with the metabolite D-lactate appearing as a key culprit during what seems to be a critical early window [60]. The gut bacterium Faecalibacterium prausnitzii, markedly depleted in human sepsis patients, improved survival and reduced organ injury in septic mice, apparently via a metabolite called 18β-glycyrrhetinic acid that quieted inflammatory signaling [61]. In the liver, a serum metabolomics study in 222 NAFLD patients identified classifiers that distinguished disease subgroups with AUROCs up to 0.93, and separately, supplementing a bacterium called Dialister invisus in overweight mice reduced weight, liver enzymes, and blood fats [62]. Senescent liver cells amplified both fat accumulation and inflammatory crosstalk with nearby macrophages; delivering a senolytic drug via nano-cell vesicles cleared those aged cells in a mouse fatty liver model without lowering platelets or hemoglobin [63]. A compound called TDQ-Cl reversed scar-forming activation in liver stellate cells and also improved gut barrier integrity and partially restored gut microbial composition in mice with chemical liver injury [64]. Lycopene — the red pigment from tomatoes — quieted inflammatory and cholesterol-metabolism pathways in liver cells under conditions mimicking parenteral nutrition-associated liver disease, and a lycopene-loaded albumin nanoparticle remained chemically stable in five different PN formulations [65]. Meanwhile, polystyrene nanoplastics made metabolic syndrome measurably worse in mice already on a high-fat diet, worsening blood sugar control, insulin resistance, and gut microbial diversity beyond what high fat alone produced [66].

Several studies drilled into how cells handle fats, proteins, and energy in ways that ripple into disease. Work in yeast showed that lipid droplets act as literal "garbage trucks," physically transporting clumped, misfolded proteins to the cell's recycling compartment — with the fat composition of those droplets controlling how well the job gets done [67]. In obese mice, elevated circulating FABP4 — a fat-transport protein released by fat cells — promoted breast cancer lung metastasis by activating signaling cascades in tumor cells, and both genetic deletion and a neutralizing antibody markedly reduced spread [68]. A selective autophagy route called Golgiphagy was linked to breast tumor suppression: under nutrient stress, an enzyme called USP28 travels to the Golgi to stabilize a protein governing how sugars attach to other proteins, and disrupting this pathway slowed tumor growth [69]. The DNA-sensing protein cGAS, usually cast as an immune sentinel, turns out to regulate cholesterol balance; in mice lacking it, cholesterol accumulated in the liver and xenografted tumors grew faster — effects largely reversible by an Akt inhibitor [70]. A berberine-rhein nanoemulsion shrank tumors in a triple-negative breast cancer mouse model by rewiring fat metabolism inside the tumor, and the effect was further amplified when paired with anti-PD-L1 immunotherapy with no detectable organ toxicity [71]. The flavonoid baicalein enhanced the killing effect of radiation in cervical cancer cells by targeting the lipid enzyme ALOX15 and reducing fat droplet accumulation [72]. Most unexpectedly, the amino acid aspartate was found to directly inhibit the growth-promoting kinase mTORC1 — uniquely among all amino acids tested — and cell-permeable aspartate analogs suppressed reactivation of latent HIV in T cells [73]. In Alzheimer mouse models, oral iron boride nanostructures that generate hydrogen gas under stomach acid improved learning and memory and reduced both amyloid and tau pathology [74], while separate work in the same disease model mapped how amyloid-beta remodels the blood-brain barrier's nutrient transport proteins [75].

A third cluster covers practical food risks, therapeutic delivery, and the nuts and bolts of nutritional measurement. 5-HMF — the browning compound formed when you heat sugar in baked goods, coffee, or anything roasted — significantly worsened lung fibrosis in mice, with network analysis and machine learning identifying seven candidate molecular targets [76]. In a Brazilian reservoir, cyanobacterial toxin concentrations exceeded safety thresholds in every season, and zebrafish exposed to that water showed disrupted reproductive hormone pathways and reduced sperm production [77]. The ulcer-causing bacterium H. pylori was shown to survive inside dental S. mutans biofilms and worsen cavity progression in a rat model; a light- and sound-activated hydrogel disrupted those mixed biofilms while a copper-calcium compound addressed both the bacteria and enamel repair [78]. For infectious disease, a chitosan nanoparticle co-delivering rifampicin and vitamin D3 directly to alveolar macrophages achieved effective killing of drug-resistant tuberculosis at a dose four times lower than standard treatment [79]. In neonatal piglets on parenteral nutrition, adding vitamins E and C significantly cut liver fat accumulation and lipid peroxidation [80], and sustained-release microspheres co-delivering lutein and myo-inositol restored ovarian architecture in a rat PCOS model while sharply reducing oxidative stress markers [81]. In Pacific white shrimp, a gut-lining protein called PvPT-L1 helped a beneficial probiotic stick to intestinal cells, and silencing it dysregulated nearly 500 genes involved in gut barrier defense and antioxidant function [82]. Black soldier fly larvae meal supported anteater nutrition at up to 54% diet inclusion without affecting most health markers, though higher doses raised eosinophil counts — a signal worth tracking [83]. Pig genetics and metabolism intersected in a comparison of fat Min pigs and lean commercial breeds, where integrated proteomics and metabolomics tied higher intramuscular fat to enhanced short-chain fatty acid metabolism and mitochondrial energy pathways [84]. In human cartilage cells, green tea's EGCG cut a key inflammatory breakdown axis by over 80% at the protein level, with PAR-2 identified as the main upstream switch [85]. A new skin peptide called FMdEG-KTTKS stimulated fibroblasts to produce more than 200% more collagen per cell than conventional stimulants and also reduced inflammation in macrophage experiments [86], while engineered hybrids linking an anti-aging cosmetic peptide to an antimicrobial sequence killed both S. aureus and E. coli rapidly through shared membrane-disruption mechanisms [87]. And in a methodological note with real implications for nutrition science: a mouse study on the doubly labelled water technique — the gold standard for measuring energy burn in free-living animals — found that applying proper isotope-specific corrections cut calculation error nearly threefold, and that one widely used correction variant produced physiologically impossible energy estimates in 13 of 15 animals [88].

One of the more striking themes running through this batch of animal and cell work is how rapidly the brain rewires itself in response to diet. In just one day on a high-fat diet, male mice showed increased excitability in hypothalamic glutamatergic neurons alongside reduced excitatory input, while female mice showed unchanged excitability but selectively weakened inhibitory tone; when those circuits were experimentally forced into an active state, males resisted weight gain and females actually lost weight — a clean demonstration of sex-specific wiring [89]. The aging theme ran deep across several models. In Alzheimer's mouse work, the beta-amyloid fragment Aβ40 — but not Aβ42 — blocked a ceramide-based signal that normally clears damaged mitochondria, and an intranasal nanoparticle designed to restore it reduced plaque burden and improved behavior in aged mice [90]. A triterpenoid from Sanguisorba officinalis called Ziyu glycoside I extended lifespan in C. elegans and reduced functional decline in aging mice by physically stabilizing the enzyme LDHA to keep lactate production running, with lactate supplementation alone rescuing senescence in LDHA-depleted cells [91]. A data-mining sweep of a German regulatory rodent toxicology archive found 27 of 154 tested substances (18%) significantly extended survival by at least 10%; roughly half of those candidates disrupted mitochondrial oxygen consumption in mammalian cells, with bromoxynil emerging as a mitochondrial uncoupler that also improved multiple healthspan markers in C. elegans [92]. In human fibroblasts aged in culture and then converted to neurons — a model that preserves biological age — metformin broadly dampened both transcriptomic and epigenetic aging signatures while rapamycin showed limited effect [93]. Growth hormone improved spatial memory and cut hippocampal oxidative damage in a rat methylmalonic aciduria model by activating NRF2/HO-1 signaling, confirmed through rescue experiments in both rats and cell culture [94]. In streptozotocin-diabetic mice, adding vitamin D3 to metformin outperformed either drug alone, bringing LDL to roughly 29 mg/dL and triglycerides to 120 mg/dL while also preserving pancreatic islet structure [95]. A new auraptene analog called SU5 reduced steatosis, inflammation, and fibrosis in a mouse MASH model more effectively than auraptene itself — which degrades quickly metabolically — by activating FXR and suppressing lipogenic genes [96]. Fluoride in diabetic mice produced opposing effects by dose: high doses reduced serum triglycerides and VLDL while low doses raised LDL, with proteomic analysis showing mostly inverse shifts in liver lipid metabolism proteins at the two doses [97]. A network pharmacology analysis identified 210 target overlaps between lycopene and traumatic brain injury — with strong predicted binding to EGFR, PPARγ, and TP53 — though the finding is computational and the authors call for in vitro and in vivo follow-up before drawing conclusions [98]. And a broad preclinical review of Alpinia oxyphylla and its active compounds (diphenylheptanoids, polysaccharides, flavonoids, terpenoids) found multi-pathway activity in animal models of Alzheimer's, Parkinson's, and diabetes, while stressing that no robust human evidence yet exists and bioavailability remains a key hurdle [99].

The microbiome work in this batch reaches from infant guts to wild primates to aquatic herbivores. A crystal structure study of a Bifidobacterium bifidum enzyme revealed it uses a distinctive ten-strand β-sheet cradle to cleave N-glycans preferentially from glycopeptides rather than whole proteins — explaining at the molecular level how infant gut bifidobacteria unlock nutrients in breast milk glycoproteins [100]. A genomic atlas of 47 manatees yielded over 1,200 non-redundant microbial genomes and uncovered a layered toolkit for plant cell wall deconstruction — free enzymes, cellulosomes, and enzyme-enriched outer membrane vesicles — plus a previously unknown pathway in one bacterial group for accessing a carbohydrate most microbes cannot process [101]. The connection between gut bacteria and immune defense came through clearly in an insect model: antibiotic depletion made Spodoptera frugiperda larvae far more vulnerable to a baculovirus, partly by weakening the gut's protective peritrophic matrix, while restoring a single symbiont — Glutamicibacter soli — reversed those effects; RNAi silencing of one matrix protein alone was enough to increase susceptibility, nailing the mechanism [102]. A commentary described a related but odder twist: some animal hosts appear to hijack a prophage inside their bacterial symbiont, triggering bacterial lysis to extract nutrients — host-microbiome mutualism that is simultaneously a form of exploitation [103]. In E. coli-infected mice, cholic acid at 10–30 mg/kg dose-dependently reduced intestinal and hepatic inflammation, raised short-chain fatty acid levels, and partially restored beneficial genera like Gordonibacter and Enterorhabdus while cutting opportunistic pathogens [104]. In wild long-tailed macaques, social rank and grooming network centrality were the strongest predictors of gut bacterial composition, outweighing demographic and environmental factors, with bacterial communities showing nested rather than modular structure [105]. Polystyrene microplastics at medium and high doses depleted the oral microbiome in mice — reducing Gemella and Lactobacillus while enriching Streptococcus and Rodentibacter — with hundreds of differential gingival metabolites at both doses [106]. Lacticaseibacillus casei BL23 releases small extracellular vesicles (~113 nm) packed with probiotic proteins including GAPDH and enolase; in cell culture these bound to mucin and intestinal epithelial cells and crossed polarized monolayers within four hours, pointing to a postbiotic communication route that doesn't require live bacteria [107]. In a seven-week broiler trial, Arthrospira platensis and Chlorella vulgaris extracts improved immune organ development and intestinal morphology at the doses tested, but combined supplementation triggered significant hepatic steatosis and renal tubular degeneration, and individual doses altered bone microarchitecture — dose and combination clearly matter [108]. And in rats restricted to a low-sodium diet for one week, the kidneys upregulated all three ENaC sodium channel subunits as well as Na/K-ATPase, while the heart responded by downregulating the natriuretic peptides ANP and BNP — the two organs pulling in opposite directions, with opposing gene ontology enrichment patterns for growth and development pathways [109].

The remaining findings land all over the map — from agricultural chemicals and stress biology to bone health and fundamental cell mechanics. The pyrethroid metabolite 3-phenoxybenzoic acid (3-PBA) suppressed viability in differentiating muscle cells, boosted atrophy markers Atrogin-1 and MuRF1, dropped ATP, and elevated oxidative stress in cell culture; machine learning analysis pointed to five hub genes linking it to energy metabolism disruption and sarcopenia-relevant pathways [110]. In C. elegans, maternal caffeine exposure reduced a key chromatin mark (H3K4me3), raised eggshell permeability from about 10% to nearly 28%, and roughly doubled embryonic death rates — effects methionine supplementation could rescue — while offspring of caffeine-exposed mothers showed enhanced oxidative stress resistance, suggesting epigenetic changes were transmitted rather than simply corrected [111]. Temperature stress in narrow-clawed crayfish sharply expanded Hafnia-Obesumbacterium, Enterobacter, and Raoultella in the gut while cutting dominant Prevotella and Agathobacter, alongside upregulation of apoptosis and immune signaling and downregulation of metabolic pathways [112]; and in hibernating plateau frogs, acute heat exposure caused hepatocyte damage and triggered 17 amino acids to fall by 29–65%, with 720 differentially expressed genes enriched in retinol metabolism and lipid pathways [113]. In spontaneously hypertensive rats, the structural assemblies organizing the mitochondrial electron transport chain (N- and Q-respirasomes) were preserved despite sustained high blood pressure, but cytochrome c oxidase exerted only limited control over respiratory flux — structural stability without kinetic optimization [114]. In doxorubicin-treated sarcoma mice, adding alfacalcidol to alendronate produced greater gains in trabecular bone volume, thickness, and number than alendronate alone at four weeks, with both agents suppressing osteoclast activity [115]. SPAK-knockout mice showed no protection against adriamycin-induced kidney injury — in fact they had worse baseline mitochondrial health and greater apoptosis under injury conditions than wild-type mice, suggesting SPAK plays a protective role in the glomerulus that wasn't previously appreciated [116]. In a synthetic chemistry screen, one compound from a coumarin-pyrazole-indolinone hybrid series matched ascorbic acid for antioxidant potency and potently inhibited both acetylcholinesterase and butyrylcholinesterase in cell-free assays — with molecular docking confirming active-site binding [117]. And in fission yeast, dormant spores require an adequate level of reactive oxygen species to begin germinating at all — artificially lowering ROS blocked germination initiation — while later stages depend on the antioxidant enzyme Sod1 to bring ROS back down, without which development stalls, suggesting oxidative signaling acts as both a starter and a timer in the germination program [118].

The gut keeps turning up as an unexpected middleman for all kinds of health problems in animals. In mice, polystyrene microplastics caused measurable bone loss through the gut microbiome — when researchers transferred feces from exposed mice to unexposed ones, the bone damage traveled with it, and glycine supplementation during that transfer blunted the effect [119]. The gut-brain axis got attention too: a water extract of Corni Fructus reduced depression-like behaviors in stressed mice, lowered inflammatory cytokines, and boosted microbial diversity [120], while Morinda officinalis oligosaccharides improved post-stroke depression-like behaviors in mice by raising fecal butyrate and dialing down a brain enzyme called Pla2g4a — transferring the treated mice's microbiome to naïve animals carried some of that benefit along [121]. Butyrate is proving itself a versatile molecule: in diabetic mice, the fiber inulin was fermented into butyrate, and that butyrate stabilized a key protein that protects heart cells from iron overload and ferroptosis [122]. An engineered strain of the probiotic E. coli Nissle 1917 degraded uric acid under low-oxygen conditions and, in hyperuricemic mice, brought down serum urate, kidney markers, and inflammatory cytokines while enriching the gut with helpful bacteria [123]. In rodent colitis models, preclinical work shows propolis and its active compounds reduce inflammatory signaling and restore the gut lining — though the researchers note human clinical evidence is still absent and propolis compositions vary widely between products [124]. In Sunit sheep, feeding coated mannitol didn't change weight gain but shifted rumen fermentation and boosted antioxidant and immune markers in blood [125]. And a comparison of cows and goats fed the same diet found the two species harbor dramatically different gut fungal communities regardless of what they eat, suggesting the animal's evolutionary history shapes its gut mycobiome independent of diet [126].

Animal studies on the heart, bones, and muscle are surfacing intriguing molecular handles. The plant compound gossypin improved lipid profiles, cardiac biomarkers, and inflammatory markers in atherosclerotic rats through the PI3K/AKT/mTOR pathway [127]. Aromadendrin appeared in two separate rat studies: in dexamethasone-induced osteoporosis it improved bone density and altered the bone-remodeling RANKL/OPG ratio over 20 weeks [128], and in isoproterenol-induced heart injury it normalized hemodynamic and antioxidant markers through the MAPK/Nrf2 pathway [129]. In diabetic mouse hearts, reduced lactylation of a protein called Cryab worsened cardiac dysfunction, hypertrophy, and fibrosis, while restoring that chemical modification protected the heart by stabilizing a chaperone protein and muting a stress-signaling cascade [130]. Chronic alcohol feeding in mice pointed to a less familiar mechanism of heart damage: ethanol drove copper overload in heart cells, triggering a form of copper-dependent cell death called cuproptosis that a copper chelator reversed [131]. In a 40-week high-fat, high-cholesterol mouse experiment, males developed worse obesity, greater mitochondrial dysfunction, and more severe muscle wasting than females, with females maintaining better gut microbial health throughout [132]. A traditional Chinese formula called Bazi Bushen restored muscle mass and grip strength in ovariectomized mice by suppressing FGFR1/ERK signaling and reducing atrophy markers [133]. On the longevity side, mice lacking the protein MKP-2 lived longer and showed better insulin sensitivity alongside protective shifts in fat tissue lipid profiles [134]. In a large human dataset of nearly 11,000 NHANES participants, EGCG intake was associated with slower biological aging and lower mortality, and mechanistic work in C. elegans and senescent liver cells traced the effect to activation of peroxisome biogenesis — knocking out the relevant genes abolished the benefit [135]. Meanwhile, Drosophila experiments challenged the popular idea that the male Y chromosome shortens lifespan by accumulating harmful transposable elements — replacing the Y did shorten male fly lifespan, but the culprit appeared to be specific genetic variants and epistatic interactions rather than any overall rise in transposable element levels [136].

A cluster of cell and animal studies explored how compounds disrupt cancer cells and other disease mechanisms at the molecular level. Platinum nanoparticles grown from Coleus barbatus leaf extract killed MCF-7 breast cancer cells with an IC50 of 2.28, while also showing antibacterial activity against E. coli and S. aureus [137]. Oleuropein and punicic acid both damaged MCF-7 cells by ramping up mitochondrial oxidative stress in cell cultures; punicic acid was more potent at lower concentrations, and silencing peroxiredoxin proteins made cells more vulnerable to both [138]. A light-activated iridium complex disrupted cancer cell antioxidant defenses by oxidizing GSH, NADH, and NADPH and generating reactive oxygen species under white LED illumination, suggesting a phototherapy approach [139]. Seven synthesized thiosemicarbazones showed antioxidant activity and inhibited both urease and xanthine oxidase in cell-free assays, with one compound standing out as the most potent radical scavenger [140]. In DMH-induced colorectal cancer rats, pinoresinol diglucoside reduced tumor markers and improved colon architecture over 15 weeks by suppressing NF-κB/iNOS/COX-2 signaling and restoring the gut microbiome's bacterial balance [141]. In a striking mouse genetics experiment, animals engineered so that neurons lacked the cilia protein ARL13B became obese and insulin-resistant, and restoring that protein to cilia in young mutant mice fully reversed the obesity, placing ciliary signaling in neurons at the center of energy balance [142]. Mice exposed to a gradual 8-hour heat ramp from 20°C to 38°C showed changes in blood cytokines, a shift in lung immune gene expression toward B-cell activation pathways, and modest disruption of amino acid metabolism including glycine and serine pathways [143]. In pigs infected with a respiratory virus, high-resilience animals had distinct metabolite profiles in lung and lymph node tissue with carnitine-related metabolites enriched, and a compound called deoxyadenosine elevated in those pigs also promoted immune cell proliferation in lab assays [144]. A hydrolyzed yeast protein protected against alcohol-induced stomach lining damage in both cell cultures and live animals, with the amino acid methionine identified as the active player working through suppression of an inflammatory signaling pathway [145]. In a mouse model of sepsis-related brain injury, an overactive immune protein called STING suppressed a key metabolic enzyme in neurons, impairing energy production and memory — clearing STING through a cellular recycling pathway restored cognitive function [146]. Bacteria-derived xanthine turned up as a driver of smell loss in allergic rhinitis: S. aureus xanthine promoted an inflammatory immune response in the nasal tissue of mice, and blocking the downstream signal IL-17A reversed the olfactory impairment [147]. Finally, Nile tilapia chronically exposed to low-level mercury suffered stunted growth and tissue damage, but dietary selenium nanoparticles or vitamin E largely reversed the harm, restoring weight gain, blood markers, and tissue architecture [148].

A handful of studies this round reexamined how we measure and understand antioxidant defense — including one worth noting for researchers. Standard isolation techniques for extracellular vesicles (EVs) were found to dramatically overestimate antioxidant activity due to non-vesicular contaminants; stricter purification revealed measurable antioxidant activity in bacterial EVs for the first time and showed that a dietary intervention can shift EV antioxidant capacity in humans [149]. In fruit fly larvae, Moringa oleifera leaf extract dose-dependently rescued antioxidant enzymes (catalase, SOD, glutathione, GST) disrupted by chemical stress, with flavonoids, phenolic acids, and terpenoids likely responsible [150]. In rats chronically exposed to aluminum chloride, bromelain (250 mg/kg orally) partially reversed sharp drops in calcium, iron, magnesium, selenium, and other minerals while improving the overall redox balance [151] — though a note of caution came from another rat study where melatonin pretreatment failed to curb splenic lipid peroxidation or restore blood counts in hemolytic anemia, even as oxidative damage tracked tightly with falling hemoglobin (r = −0.84) [152]. The antioxidant master-regulator Nrf got attention in two model organisms: in C. elegans, different isoforms of the Nrf equivalent SKN-1 handle distinct jobs — longevity, oxidative defense, detoxification — with mTOR as a central control switch, and conservation to mammalian Nrf proteins suggests this division of labor may apply broadly [153]; meanwhile, losing the protein PRMT-7 (responsible for ~30% of a key protein modification in worms) extended lifespan without hurting reproduction, though those mutants coped less well with heat stress — a reminder that living longer and tolerating stress are not the same program [154]. From the sea, a marine-bacterial carotenoid called Marinophyll quenched ROS in stressed skin cells, activated protective pathways including Nrf2, HO-1, and SOD2, dialed down inflammatory signals, and boosted filaggrin expression in human skin tissue, supporting improved barrier function [155].

The gut-body axis continued to surface in unexpected places. In mice recovering from ischemic stroke, Akkermansia muciniphila improved neurological recovery without changing infarct size — apparently by raising circulating isorhamnetin, which prompts microglia to release a repair signal (PSAP) that activates the GPR37-ERK pathway in brain white matter cells; blocking GPR37 with AAV erased the benefit entirely [156]. Bone health offered a parallel story: selenium nanoparticles derived from Cordyceps sinensis boosted bone mass and architecture in growing mice, but wiping out the gut microbiome with antibiotics completely abolished the effect — the nanoparticles appear to work by raising kynurenic acid and trehalose, metabolites that push bone cells toward building and away from breakdown [157]. In alcohol-fed middle-aged mice, daily sesaminol (a sesame lignan, 1.2 mg by gavage) restored a healthier microbial community, raised fecal butyrate, and repaired intestinal barrier proteins eroded by chronic drinking [158]. On the metabolic front, mice lacking the mitochondrial enzyme NNT showed impaired glucose tolerance at both 6 and 24 months — with lower glucose-stimulated insulin secretion in young males and older females — despite identical body weights and energy expenditure to controls, pointing to a metabolic role for NNT that is separate from obesity [159]. A crocin-rich Gardenia jasminoides extract (GJ-4, 50 mg/kg, 5 weeks) improved glucose tolerance and lowered triglycerides, total cholesterol, and LDL in metabolic-syndrome mice by activating hepatic PPARα to simultaneously suppress glucose production and ramp up fatty acid oxidation [160]. In a propensity-score-matched cohort of over 42,000 patients per arm with MASLD and type 2 diabetes, GLP-1 receptor agonists were associated with a 13% lower risk of composite cardiovascular events versus sulfonylureas, and in Western-diet-fed mice the same drug class reduced cardiomyocyte hypertrophy and expression of fibrosis markers [161]. Hamsters engineered to lack ABCA1 — a key cholesterol transporter — had almost no detectable HDL on normal chow, developed severe atherosclerosis and massive hepatic xanthomatosis on a high-fat diet, and appeared to recapitulate human ABCA1-deficiency disease more faithfully than existing mouse models [162]. Swimming exercise protected the hearts of diabetic mice dose-dependently, reducing fibrosis and improving glucose control by suppressing FABP4, a protein that otherwise triggers ubiquitin-proteasomal degradation of the cardioprotective factor CTRP3 [163]. In fish nutrition work, gilthead sea bream fed a low-fishmeal diet and subjected to inflammatory challenge showed improved liver metabolism and balanced immune gene expression when given a microalgae- and yeast-based supplement (LB-IMMUNOboost), which also partially preserved intestinal architecture [164]. On the brain side, β-caryophyllene (a compound found in many spices) reduced anxiety and compulsive behavior in a mouse PTSD model, lowering amygdalar glutamate and stress hormones — with every benefit blocked by the CB2 receptor antagonist AM630, confirming the mechanism is CB2-dependent [165]. In mice with cognitive damage from carbon monoxide poisoning, NBP treatment improved maze performance, reduced hippocampal injury, and shifted the inflammatory balance (lower TLR4, TNF-α, IL-6; higher IL-10), with worse TLR4 signaling correlating with worse memory outcomes [166]. And a traditional Chinese herbal formula (Huanglian Jiedu Decoction) improved behavior and neuropathology in 5xFAD Alzheimer's mice apparently by working through the liver: knocking out PPAR-γ specifically in hepatocytes blunted the formula's ability to reduce microglial inflammation, suggesting a hepatocyte-to-brain communication axis [167].

A run of cancer, bone, and environmental findings rounds out the picture. In cell work, exopolysaccharides from vaginal Lactobacillus strains showed strain-specific antibacterial and antibiofilm effects, and two strains' extracts dose-dependently reduced triple-negative breast cancer (TNBC) cell viability with maximal inhibition at 85 µg/mL [168]. An experimental nanoplatform built on FeSe2 nanosheets generated ROS under ultrasound, exploited the tumor's own hydrogen peroxide and glutathione to amplify killing, and simultaneously targeted bacteria inside TNBC tumors to recruit T-cell immunity — suppressing metastatic colonization in animal models [169]. In colorectal cancer models, a traditional herbal formula (Xianlian Jiedu Decoction) reduced tumor growth and shrank cancer stem-cell populations by dismantling the CRYAB-STC1 molecular axis that sustains self-renewal [170]. A dual-degrader compound (S8588) simultaneously destroyed two fat-synthesis enzymes (ACSS2 and ACLY) in oral squamous cell carcinoma cells, draining the acetyl-CoA supply and slowing tumor growth in vitro and in vivo — with the effect reversed by supplementing acetate or citrate, confirming the mechanism [171]. In bone biology, human stem cells undergoing bone formation were found to rely on mitochondria physically fragmenting into ~450 nm pieces to encapsulate and clear calcium phosphate; blocking this fragmentation cut ATP to 59% of normal and mineralization area to 37%, with matching defects seen in zebrafish given Drp1 inhibitors [172]. Separately, phosphorus-deficient zebrafish lost bone and dentin mineral but showed completely unaffected enamel mineralization, apparently because enamel-forming cells carry their own phosphate importer (slc34a2b) that sustains mineralization independently of systemic phosphorus availability [173]. Circadian disruption showed metabolic consequences without lifespan consequences in mice: a compressed 22-hour light-dark cycle produced quicker weight gain and worse body composition than a 24-hour cycle, yet overall survival and maximum lifespan were identical across all T-cycle groups [174]. An environmental finding worth flagging: the plasticizer TOTM (used in some PVC products) disrupted thyroid hormones and caused locomotor abnormalities in zebrafish larvae at concentrations below 0.047 mg/L, while adult males showed cholesterol and sex hormone disruption at similarly low levels — with effects differing by life stage in ways that complicate standard risk assessment [175]. A cell-culture toxicology study found that combining two liver-toxic compounds — a steatosis inducer (triphenyl phosphate) and a phospholipidosis inducer (haloperidol) — produced non-additive effects on fat accumulation but synergistic cytotoxicity due to their interactions affecting drug-metabolism enzymes, underscoring that mixture toxicity cannot be predicted from individual compound profiles [176]. A maternal diet study in mice found that high-fat feeding during pregnancy flipped the direction of cardiac microRNA-493-3p in adult offspring depending on sex — upregulated in sons, downregulated in daughters, with estrogen (shown via ovariectomy) appearing to drive the female suppression; in cardiomyocytes, overexpressing this microRNA activated a hypertrophic growth program via PI3K/AKT/mTOR [177]. Finally, an experimental nanoliposome (A@Clip) combining ROS-scavenging phospholipids with an anti-inflammatory drug simultaneously imaged colitis by MRI and reduced disease progression and gut microbiome disruption in a murine ulcerative colitis model, without detectable systemic toxicity — an integrated diagnostics-plus-treatment approach [178].

A wave of animal and cell work this cycle zeroed in on how the gut maintains its defenses and how that barrier can be disrupted or reinforced. The colon itself responds dynamically to pressure: when stool distends the wall, all three types of junction protein simultaneously tighten in a response driven by a motor protein called nonmuscle myosin II, and switching that protein off caused the barrier to fail under ordinary physiological load [179]. Gut bacteria also do heavy lifting here: citrulline fermentation by the microbiome produced short-chain fatty acids and activated an immune-balancing pathway (AhR/IL-22) that reduced inflammation and improved barrier integrity in a mouse sepsis model, with both antibiotics and pathway blockers wiping out the benefit [180]. Less encouragingly, feeding mice a heat-processed whey-and-glucose mixture loaded with Maillard reaction products damaged the colon lining, shrank the crypts, and shifted the microbiome away from protective species like Akkermansia [181]. In zebrafish larvae, Ligilactobacillus salivarius cells physically bound to human norovirus and reduced its replication by over a log; the bacteria's spent broth had no effect at all, confirming that direct cell contact rather than secreted compounds is the active mechanism [182]. A comparison of wild and captive Bengal tigers found that the wild animals carried a richer, more diverse gut microbiome, with habitat rather than sex being the dominant driver of community composition [183]. Side-by-side testing of four human liver cell systems showed that 3D spheroids and micro-organoids best modeled the slow fat buildup relevant to metabolic disease, while simpler 2D cultures were only suited for rapid short-term screening [REF:6b585db7-d7d6-4bc4-90e9-e06b04d0f29a]. In bovine mammary cells, combining heat stress with a Klebsiella infection synergistically amplified inflammation and simultaneously suppressed the genes responsible for milk fat synthesis [184]. A phage-lipid nanoparticle system designed against drug-resistant Pseudomonas aeruginosa achieved a thousand-fold reduction in bacterial burden at a thousand-fold lower dose than free antibiotic, while also sparing the gut microbiome from collateral damage in mice [185]. Probiotic-derived extracellular vesicles from Lactobacillus plantarum were likewise shown to preserve organelle structure, delay DNA damage signaling, and suppress NF-κB-driven inflammation in UV-irradiated skin cells [186].

Several studies sharpened the picture of how blood sugar is controlled and how insulin-producing cells might be preserved. The amino acid cysteine turns out to be a key trigger for glucagon release: short-term cysteine depletion quickly muted the glucagon response to low blood sugar in both human and mouse islets, and restoring it or applying a reducing agent brought the response back, with the mechanism running through the electrical state of voltage-gated sodium channels in glucagon-secreting alpha cells [187]. A modified form of the stress hormone urocortin 2 selectively shifted body composition in obese rats and minipigs, reducing fat mass and increasing muscle weight while improving insulin sensitivity but without meaningfully lowering total body weight [188]. Mice missing the GIP receptor in a specific population of glutamate-signaling neurons showed better glucose tolerance but normal weight gain, confirming that the receptor's weight-related effects run through separate neural circuits [189]. Two transplantation strategies also showed promise in diabetic mice: delivering rapamycin locally inside polymer microparticles prolonged islet graft survival, and adding a low-dose immune checkpoint agent (CTLA-4-Ig) to that strategy achieved 100% graft survival past 200 days without systemic immunosuppression [190]; separately, co-transplanting islets with extracellular vesicles from umbilical cord stem cells significantly improved blood sugar control, with a single microRNA (miR-182-5p) identified as the active cargo that reduces stress inside beta cells [191]. In mouse brain imaging, hypothalamic oxytocin neurons fired precisely at the transition from rest to activity, and optogenetically stimulating them in that resting state first triggered brown fat thermogenesis, then behavioral arousal, placing them at the intersection of body temperature and sleep-wake control [192]. Spatial metabolomics of mouse tooth pulp revealed that stem cells in the growing tip run on fat oxidation while rapidly dividing cells nearby use the standard TCA cycle, a metabolic division of labor that likely helps maintain the stem cell state [193]. And in a captive colony study, male Northern tree shrews lived longer on average than females, though maximum lifespan and overall reproductive aging were comparable between sexes [194].

The remaining work spans neuroprotection, cancer biology, musculoskeletal health, and natural compounds. Polystyrene microplastics fed to fruit flies at just 10 parts per million disrupted locomotion and sleep rhythms, cut antioxidant enzyme activity by as much as 46%, impaired mitochondria, and lowered dopamine [195]. Heat-killed Lactobacillus murinus improved memory and reduced brain cell death in an Alzheimer's rat model, with the team tracing the effect to a pentose phosphate pathway metabolite called 6-phosphogluconic acid that bolsters antioxidant defenses [196]. In a rat stroke model, astragaloside IV reduced harmful neutrophil trap formation and improved blood flow to damaged brain tissue, with purine metabolism identified as the main pathway affected [197]. In gastric cancer, a cholesterol-derived oxysterol produced by tumor-associated stromal cells was found to push immune cells toward a suppressive Treg state via the GPR183 receptor; higher GPR183 expression correlated with worse outcomes in patients, and deleting the receptor in mice restored cancer-fighting immune activity [198]. A systematic review of 26 preclinical studies on agents that clear or suppress senescent cells found consistent protective signals across osteoarthritis, osteoporosis, and sarcopenia models, though the authors flag significant heterogeneity and no established path to clinical translation [199]. Six weeks of a whey protein hydrolysate rich in branched-chain peptides improved running endurance, grip strength, and muscle fiber size in older mice, alongside better mitochondrial function and lower oxidative stress [200]. In an ovariectomized mouse model of estrogen-loss bone thinning, supplementing with the purine metabolite adenine at a low dietary dose thickened trabecular bone and activated bone-building while suppressing bone-breakdown signaling in cell experiments [201]. Calcium oxalate triggered both oxidative stress and ferroptosis cell death pathways in kidney tubule cells, with pharmacological blockade of either the NOX or PI3K pathway partially reversing the damage [202]. The effects of a Chinese herbal formula on nasopharyngeal cancer in animals were mapped through metabolomics and lipidomics, pointing to glycerophospholipid metabolism as the most consistently altered pathway, though only three of 597 candidate lipid changes survived statistical correction [203]. An epigenetics study found that the demethylase KDM3B is essential for hair follicle stem cell maturation in mice, acting through a molecular chain (mTORC1 to LARP1 to ribosomes) that ramps up protein synthesis during differentiation [204]. Two new antioxidant molecules, fluoindeneacids A and B, were isolated from an enzyme-triggered chemical reaction and shown to protect cells from oxidative damage in lab tests [205]. A soil fungus, Aspergillus terreus, blocked a competing mold's growth and mycotoxin production while itself producing simvastatin as a natural secondary metabolite, with green tea broth yielding the highest output [206]. And leaf extracts from Ziziphus oenopolia showed strong antioxidant and anti-inflammatory activity in lab assays, with molecular docking pointing to binding of the plant's key compounds to COX-2 and related inflammation targets [207].

The gut microbiome keeps turning up as a long-reach regulator, with new preclinical work mapping several of its routes. Missing just one human milk sugar — 3'-sialyllactose — in neonatal mice derailed intestinal development, stunted growth, worsened jaundice, and left the animals more vulnerable to colitis damage as adults [208]. An entirely different gut-to-organ pathway emerged in mice lacking the intestinal receptor GPR128: they retained more of the beneficial microbe Akkermansia muciniphila, whose enzyme activity freed a plant-derived compound that — through a chain of molecular steps — shielded the liver from acetaminophen damage [209]. In a colitis model, an engineered oral immunotherapy targeting Ruminococcus gnavus — a bacterium linked to oxidative stress and inflammation in ulcerative colitis patients — outperformed a standard medication and restored microbial, epithelial, and immune balance simultaneously [210]. Reviews of plant compounds paint an encouraging but incomplete picture: phytosterols, steroidal sapogenins, and pentacyclic triterpenoids consistently tamed inflammation and partially repaired the gut lining in rodent colitis models, but the reviewers are frank that clinical evidence, standardized doses, and long-term safety data are all missing [211]. A honey from Castanopsis fissa trees reduced colitis severity in mice and rebalanced their microbiome, with metabolomics and machine learning identifying three characteristic biomarker molecules — including apigenin — as likely contributors [212]. In catfish deliberately exposed to toxic copper levels, a high dose of caffeic acid phenethyl ester (a compound from propolis and some plant foods) strengthened gut barrier proteins, cut liver fat, and boosted antioxidant capacity — effects the low dose failed to replicate [213]. Wild rodent comparisons added an evolutionary lens: herb-eating voles completely rewired their fermentation-focused microbiome in step with seasonal grass shifts, while seed-eating gerbils kept stable metabolic outputs despite large dietary swings, suggesting microbial flexibility tracks what an animal eats more than the environment it shares with its neighbors [214]. In goats, 60 days of heat stress raised expression of seven toll-like receptor genes in immune tissue; a herbal supplement brought all seven back down, though the functional meaning of that shift remains to be determined [215]. A review of herbal feed additives for camels found the evidence too thin at every level — controlled camel studies, related ruminants, broader animal models — to support routine use, and called for proper dose-response trials before that changes [216]. In a cross-kingdom discovery more relevant to soil science than nutrition, a fungal crop pathogen was found to harbor bacterial hitchhikers inside itself that reprogram the fungus to produce a selective toxin against beneficial soil bacteria, letting it undermine root-zone protection from within [217].

The brain and peripheral nervous system featured heavily in this batch, with several animal studies tracking how metabolic signals reach neural tissue. In rats subjected to a stroke model, brief controlled circulation restriction in a limb — called remote ischemic preconditioning — reduced infarct volume and improved neurological outcomes by flooding the brain with lactate, which activated an AMPK/ULK1 signaling cascade restoring protective autophagy; blocking lactate transport blunted the whole effect [218]. A preclinical review noted that exercise consistently improves outcomes after cerebral ischemia and points toward mitophagy as a protective mechanism via PINK1/Parkin and related pathways, but cautions that most studies rely on static molecular markers rather than confirmed flux measurements — so the causal chain is suggestive, not settled [219]. In a rat chronic pain model, electroacupuncture eased both mechanical hypersensitivity and depression-like behavior by reshaping the gut microbiome (raising SCFA-producing bacteria, suppressing pathobionts) and restoring excitatory/inhibitory balance in the prefrontal cortex, with a specific gut metabolite — pipecolic acid — identified as a meaningful statistical mediator of both improvements [220]. In chronic migraine mice, overactive TREM1 in brain immune cells drove lipid droplet buildup, inflammatory polarization, and central sensitization; blocking TREM1 reversed all of this, pointing to the TREM1-NF-κB axis as a driver of migraine chronification [221]. Different selenium compounds did different jobs in a mouse neuroinflammation model: one form cut amyloid accumulation by 69% while another suppressed glial activation — and the type of selenium mattered more than the protein it was packaged in [222]. In diabetic mice, berberine improved memory and cognition by reducing oxidative damage and restoring insulin signaling in the hippocampus, also lowering tau phosphorylation along the way [223]. A separate diabetic neuropathy study found that stem-cell-derived extracellular vesicles mostly accumulated in the liver, where their microRNA cargo quieted an inflammatory signaling pathway; that liver-level change then translated into measurable improvements in peripheral nerve structure and function in diabetic mice [224]. Biodegradable nanoparticles that slowly release beta-hydroxybutyrate improved survival, restored immune function, and preserved cognition in septic mice — and produced similar immune rescue in blood cells taken from a small group of human sepsis patients [225]. In monocytic cells, pairing vitamin D with TGF-β synergistically activated a broader immune gene program than either signal alone, requiring intact vitamin D receptor signaling and sensitive to several epigenetic and kinase inhibitors [226]. A review of light therapy (photobiomodulation) on preclinical heart models found consistent reductions in infarct size and improvements in cardiac function, primarily by boosting mitochondrial energy production and promoting repair cell recruitment; human data hint at modest benefits, but protocols vary too widely for firm conclusions [227].

The final cluster spans metabolism, cancer biology, and some eye-opening cell-biology observations. Pancreatic cancer cells were caught stealing cholesterol directly from the membranes of surrounding support cells through a physical membrane-transfer process driven by a protein called ANO6; blocking ANO6 reduced tumor growth and also relieved some immune suppression in the tumor's vicinity [228]. In renal cancer models treated with CAR-T cells, an epigenetic regulator called BAZ2A drove resistance by loading the tumor microenvironment with palmitic acid, which then impaired CAR-T cell mitochondria and blunted their attack; inhibiting BAZ2A restored the therapy's effectiveness in mice [229]. Spermidine, often celebrated for potential anti-aging effects on immunity, produced the opposite result in older mice: in a specific age-accumulated subset of CD8+ T cells, it suppressed mitochondrial activity, depleted antioxidant reserves, and reduced the cells' capacity to fight infection — effects not seen in younger animals [230]. Cell mechanics yielded their own surprise: human corneal cells grown on softer substrates piled up excess cholesterol and fatty acids by turning on synthesis genes and turning off removal pathways, and the same lipid gene signatures appeared in tissue from patients with Fuchs corneal dystrophy — suggesting that mechanical changes in the aging cornea may drive metabolic dysfunction [231]. Insulin-secreting beta-cells, long treated as a uniform population, resolved into three functional subtypes in mouse work — one handling baseline secretion, one fine-tuning post-meal glucose, and one built for high-output peak-glucose management — with high-fat feeding shifting the whole islet population toward the high-output profile [232]. In obese female mice, combining tirzepatide with time-restricted feeding and resistance training brought body weight nearly to control levels and improved insulin sensitivity more than any single intervention, while resistance training specifically protected muscle mass during drug-induced weight loss [233]. Citrulline malate supplementation in rats improved vascular relaxation and reduced artery wall thickening only in females, with no measurable vascular effect in males — a clean sex difference the authors attribute to differences in nitric oxide handling or hormonal regulation [234]. A physics-driven cell study used hydrostatic pressure to adjust lipid membrane curvature without touching its chemistry, and found a clean linear relationship between curvature and the energy barrier to membrane fusion — results the authors say support the leading "stalk hypothesis" for how cell membranes merge [235]. Oral nicotine pouches disrupted bone-cell development in human embryonic stem cells in a concentration-dependent way, with single-cell sequencing showing the wintergreen 6 mg formulation caused among the greatest disruption to the bone-lineage developmental trajectory [236]. And a new semi-automated tool for studying aging in fruit flies tracked motor decline continuously across a lifespan using video analysis, detecting age-related slowdowns reliably in both normal flies and flies engineered to accumulate amyloid — a potentially useful platform for future preclinical aging and neurodegeneration research [237].

A flurry of animal and cell-culture work this period drills into how bodies handle fuel, finding the clock matters as much as the food. The circadian gene DBP turns out to be the master switch for day-night swings in muscle insulin sensitivity in mice, with its absence erasing the normal rhythm and locking gastrocnemius muscle into a state of heightened glucose uptake at the start of the inactive phase [238]. Immunotherapy targeting an endogenous retrovirus (IAPE) in a mouse model of accelerated type 2 diabetes improved fasting glucose, reduced islet senescence markers, and shrank adipocytes; because the human counterpart HERV-K lit up in cytokine-exposed human islets, the finding may have translational relevance [239]. In the liver, mice lacking hepatic Fam172a developed worse high-fat-diet steatosis by shifting which PPARγ isoform dominated, and restoring the splicing factor SRSF3 partially rescued fat accumulation in cells [240]. The traditional herbal formula Yinchenhao decoction tackled alcoholic steatohepatitis in both cell and animal models by dialing down M1 macrophage activation through the COX-2/PI3K/Akt pathway, with acacetin, apigenin, and fisetin flagged as likely active players [241]. A multi-omics study of diabetic kidney disease used Mendelian randomization to identify 60 plasma metabolites with causal links to the condition and built a machine-learning model reaching an AUC of 0.963, with the enzyme CTH, found in proximal tubular cells and suppressed under high glucose, emerging as a standout biomarker candidate [242]. In hepatocytes, Pseudomonas aeruginosa infection ramped up APOC3 expression, triggered ferroptosis-like mitochondrial damage, and accumulated lipid peroxidation products, and knocking down APOC3 reversed every one of those effects [243]. Even after hepatitis C virus is cleared with antivirals, treated liver spheroid cells still showed actin protrusions in 25% of cells versus just 2.5% in controls, with markers of partial cell-state transition persisting in both the lab model and real patient biopsies taken at end of treatment [244]. On the gut-immune axis, mice engineered to lack VEGFR-1 in T cells developed defective gut IgA, lost control of a taurine-depleting pathobiont called Taurinivorans, and spontaneously became obese; oral IgA supplementation reversed the weight gain [245]. In a test-tube fermentation using pooled human microbiota, longan polysaccharide selectively fed Bacteroides and Prevotella species while boosting short-chain fatty acids and immune-relevant metabolites like GABA and taurine [246]. And in an equine nutrition study, switching horses from grass-only hay to a 50:50 grass-alfalfa mix raised fecal ammonia while lowering total nitrogen output, showing that the form of dietary protein, not just the total amount, shapes what gets excreted [247].

Inflammation research this period spans itchy skin, nerve signals, and the recovering brain. A plant-based formula (Feining Granules) given orally for a week before an inflammatory challenge reduced four key lung injury cytokines in mice and cut cell death in mouse lung epithelial cells from roughly 12% down to 7% [248], while a pectic polysaccharide from honeysuckle (WLJP-025p) calmed atopic dermatitis-like lesions in mice by suppressing JAK2/STAT3 signaling, lowering IgE, and reshaping the gut microbiome at the same time [249]. A striking discovery ties chronic itch to a diet-derived signal: EKODE, a breakdown product of linoleic acid (the omega-6 fat in most vegetable oils), activates a receptor called GPR35 on sensory neurons, driving itch and heat hypersensitivity in mice, and blocking that receptor significantly reduced scratching in both psoriasis and atopic dermatitis models [250]. Cell studies of kidney-stone injury found that a small RNA called miR-4284 normally keeps the protein MMP10 in check; when calcium oxalate crystals suppress miR-4284, MMP10 rises, tight junctions fall apart, and tubular cells suffer, but restoring the microRNA rescued those cells in culture [251]. In mouse hippocampus, lycopene activated a PPAR-γ-to-Nrf2 signaling chain, cutting neuroinflammation and restoring synaptic transmission weakened by chronic stress [252], while dissolving quercetin in a choline-based deep eutectic solvent dramatically raised its water solubility and boosted its ability to block the protein aggregation linked to Parkinson's disease in cell experiments [253]. In the lung vasculature, the plant sterol stigmasterol bound directly to the inflammatory chemokine CCL5 and, in mice with surgically induced pulmonary hypertension, suppressed smooth muscle cell overgrowth through a CCL5-to-taurocholate signaling cascade [254]. Combining crocin (a saffron pigment) with 8 weeks of treadmill exercise in diabetic rats cut cardiac TNF-α by 55% and more than tripled NRF2 protein, with the pairing outperforming either treatment alone [255]. An exploratory single-cell sequencing study in mice after ischemic stroke (n=1 per condition, flagged by the authors as requiring independent replication) found preliminary associations between intranasal stem cell treatment and a shift in microglia toward more homeostatic states, along with altered neuronal gene expression involving mitochondrial pathways [256]. A new high-throughput gut receptor screening platform identified the microbe-derived molecule 6-hydroxynicotinic acid as a GPR35 activator, found that an IBD-risk variant of GPR35 responds to it abnormally, and noted that a bacterium enriched in IBD patients produces unusually high levels of that same molecule [257]. In a rat preeclampsia model, 142 microRNAs shifted in the placenta, with the most downregulated ones tied to lipid metabolism, angiogenesis, and immune regulation [258].

The bench also delivered results on environmental exposures, reproductive aging, and a few genuinely unexpected findings. Perinatal exposure to the flame retardant PBDE-47 disrupted organ glucose metabolism in rats in sex-opposite ways: male offspring showed increased heart uptake but less in brain and kidney, while females flipped the pattern, with network toxicology pointing to insulin-resistance and endocrine signaling hubs as likely drivers [259]. A PFOA replacement chemical (HFPO-TA) impaired liver cell development from human stem cells even at an environmentally relevant concentration of 3 µM, raising triglycerides and LDL while dropping HDL and damaging mitochondria, apparently through PPAR signaling [260]. On reproductive biology, a protein called OMC1 turns out to be a chromosome-axis guardian in mouse oocytes: without it, the molecular glue holding chromosomes together degrades ahead of schedule, accelerating the age-related rise in egg aneuploidy that underlies fertility decline [261]. On the safety front, synthetic GM3 ganglioside (chemically identical to the form in human breast milk) showed no mutagenicity or adverse effects in juvenile rats at doses up to 1,300 mg/kg body weight per day for 90 days, establishing a NOAEL that supports its use as an infant formula ingredient [262]. An ecology experiment found that water fleas (Daphnia) can grow and reproduce in a completely inorganic, mineral-only environment, but only when fine sediment is present to harbor microorganisms, consistent with the idea that sediment bacteria synthesize B-vitamins that travel up through the food web [263]. A careful virological investigation overturned a long-held assumption: picobirnaviruses, previously thought to infect vertebrates, are actually RNA bacteriophages that infect gut bacteria, establishing only the third known clade of RNA phages alongside leviviruses and cystoviruses [264]. From the traditional Indian fermented food Akhuni, researchers isolated a Pediococcus strain (FSG6) that survived gut-like stress conditions and potently disrupted Pseudomonas aeruginosa biofilms, among the first such reports for this genus from that food [265]. Fish-derived collagen peptides produced with ginger protease improved survival of silkworm larvae infected with P. aeruginosa and boosted levels of the antimicrobial peptide Cecropin B in their blood, suggesting oral collagen hydrolysates can reinforce innate immunity even in an invertebrate model [266]. Finally, detailed SEM mapping of healthy mouse femur bone charted osteocyte lacunae averaging 6.3 µm wide, canaliculi around 150 nm across, and calcium-to-phosphorus ratios of 1.70 to 1.79, giving researchers clean reference measurements for distinguishing diseased bone and designing better bone-mimicking scaffolds [267].

Findings from mouse and cell models keep reshaping what we think we know about immune regulation. Basal autophagy in alveolar macrophages quietly suppresses IL-1α, acting as a brake on innate immune priming; when researchers disabled it in mice, neutrophils became more aggressive — and overexpressing IL-1α alone was enough to protect against both Staphylococcus aureus and influenza A virus [268]. Separately, mouse experiments showed that pre-exposure to typhoid toxin can flip an otherwise-resistant animal toward lethal intestinal perforation at Peyer's patches after oral Salmonella Typhi infection, and that masking the toxin's vascular receptor completely blocked the disease [269]. There is also a striking finding linking heart disease to cancer immunity: atherosclerotic plaques in mice depleted PPARα from NK cells, leaving them exhausted with elevated immune-checkpoint markers; in patients, advanced coronary stenosis (≥50%) tracked with lower NK-cell IFN-γ production, and the fatty-acid signal oleoylethanolamide could restore antitumor killing in melanoma and ovarian cancer mouse models [270]. At the gut level, Bacteroidaceae commensals suppressed Clostridium perfringens by competing for amino acids and carbon in co-culture, blunting the pathogen's virulence toolkit [271], while in colorectal-cancer mice thioproline reshaped microbial communities and elevated linoleic acid levels, easing intestinal inflammation on histology [272]. Two plant-derived treatments targeted gut inflammation from different directions: an ultrasound-optimized adlay seed polyphenol extract — with a 61% higher phenolic yield than conventional extraction — cut pro-inflammatory Escherichia-Shigella by 57% and dampened PI3K-Akt signaling in colitis mice [273], and tiny ~3 nm carbon dots synthesized from naringenin and citric acid outperformed the equivalent free-molecule mixture at repairing mucosal damage and restoring microbial balance in DSS-induced colitis, suggesting the nanostructure itself is doing the work [274]. In a lupus mouse model, four weeks of oral omega-3 PUFAs matched the necroptosis-blocking drug Nec-1 in cutting kidney immune-complex deposition, anti-dsDNA antibodies, and creatinine [275], and in the heart, caffeic acid cut macrophage-driven fibrosis and inflammatory cytokines after ischemia-reperfusion in mice by suppressing the MAPKs/CREB axis — an effect comparable to genetically deleting MAPK14 [276].

Metabolic and cardiovascular research this round offered a mix of encouraging signals and cautionary tales. In a sepsis mouse model, elevated lactate drove white adipose tissue to "brown" through GPR81 receptor signaling, activating UCP1; mice lacking UCP1 were substantially protected from the resulting muscle wasting and insulin resistance [277]. A chromatin-level story showed that deleting Ube3a specifically in hypothalamic AgRP neurons was sufficient to trigger obesity and impaired glucose handling in mice on a high-fat diet, because an unchecked histone demethylase erases a repressive chromatin mark — a defect that a small-molecule KDM6-family inhibitor could partially correct [278]. In pancreatic beta cells, curcumin partially reversed palmitic-acid-induced senescence, restoring insulin secretion and cutting ROS, with molecular docking pointing to NOX4 — binding energy −8.4 kcal/mol — as the mechanistic target [279]. In obese rats fed a high-sugar diet, a 30% caloric restriction beat time-restricted feeding on nearly every metabolic marker — weight, insulin resistance, leptin, adipocyte size — while time restriction mainly improved depressive-like behavior in swim tests, an interesting divergence in what each approach actually fixes [280]. One note of caution: olvanil tested in a mouse fatty-liver model did reduce body weight and fat accumulation but also raised liver ALT, IL-6, and oxidative stress markers and worsened steatosis on histology, suggesting that lipolysis-driven free fatty acid flux into the liver may offset any peripheral benefit [281]. PTH and abaloparatide selectively increased alveolar bone formation in type 2 diabetic mice — a net anabolic gain not seen in non-diabetic animals — via osteocytic PTH1R and Wnt pathway activation [282]. In a cell culture study, human podocytes were found to stockpile glycogen under high glucose and mobilize it rapidly when glucose drops, placing glycogen regulation squarely on the map for diabetic kidney disease [283]. In early Sjögren's syndrome patients, salivary citrate was markedly lower than in controls despite normal calcium and phosphate levels; the deficit traced to a zinc–ACO2 dysregulation in salivary gland tissue, and zinc repletion in the lab restored citrate and dentin remineralization capacity [284]. Blue mussel-derived peptides PIISVYWK and FSVVPSPK fed to atherogenic-diet mice lowered LDL, total cholesterol, and triglycerides while raising HDL, reducing arterial lesion development alongside lower ICAM-1, VCAM-1, and liver enzymes [285]. In rats, (-)-epicatechin at 20 mg/kg/day for eight weeks prevented high-fructose-driven rises in blood pressure, insulin resistance, and perivascular fat expansion by suppressing NF-κB-driven oxidative stress in the aortic fat tissue [286]. And in nulliparous rabbits, a combined linseed-plus-Padina pavonica supplement raised thyroid T3 and T3/T4 ratios while lowering leptin at parturition and NEFA at insemination, suggesting reduced early lipid mobilization [287].

Brain and nervous-system findings ranged from dietary fructose to Down syndrome therapeutics. In Down syndrome neurospheres, synthetic DHA derivative DHA-H and its metabolite HPA boosted neural stem-cell and neuronal differentiation markers, with HPA restoring several markers to wild-type levels; both compounds also raised BDNF and activated TrkB in the hippocampal dentate gyrus when given to live animals [288]. In diabetic, sleep-deprived mice, combined vitamins C and E together outperformed either vitamin alone in preserving hippocampal neuron density and spatial learning, while simultaneously increasing BDNF, Nrf2, and HO-1 and cutting inflammatory markers [289]. In an Alzheimer's mouse model, 15 weeks of TSA improved maze performance and reduced hippocampal Aβ and glial activation, with lipidomic profiling revealing changes across 41 lipid species including suppressed glycerides and elevated plant-type lipids, suggesting inflammation-linked lipid metabolism as the route [290]. Less reassuring for anyone who enjoys sweetened drinks: dietary fructose significantly promoted brain metastatic growth in mice, with mutations in fructose-metabolism genes (Khk, Pfkfb2, Pfkfb3) enriched in the brain-colonizing subpopulation of lung cancer cells — and a KHK inhibitor attenuated that growth [291]. A skin disease study combining spatial transcriptomics, single-cell sequencing, and metabolomics found that the Th2 cytokine IL-4 degrades the antioxidant enzyme GPX4 in sebaceous gland cells via TRIM15-mediated ubiquitination, triggering ferroptosis and gland dysfunction in atopic dermatitis mice; topical ferrostatin-1 and the biologic dupilumab both reversed the damage [292]. In an early-stage discovery, endophytic Alternaria fungi isolated from Reseda pruinosa leaves — the first such report from that plant — produced extracts with anticancer activity against breast cancer cells (IC50 ~96–117 µg/ml) alongside antioxidant, antibacterial, and antifungal effects [293]. A survey of 422 companion ferrets found that animals over age four (adjusted OR 3.85) and those in the USA or Canada (adjusted OR 5.06) had higher odds of owner-reported adrenal disease, with regional differences in diet and housing noted though causality was not established [294]. At the microbiome frontier, four generations of tetracycline exposure in fruit flies permanently reduced wing size even after microbial recovery via fecal reinoculation, hinting at lasting gene-expression consequences of early antibiotic disruption that microbial restoration alone could not fully reverse [295]. Researchers formally described a new butyrate-producing gut bacterium — Senimuribacter muris sp. nov. — found exclusively in C57BL/6J mice from a specific vendor and showing a positive correlation with host age in metagenomic data [296]. Finally, in juvenile large yellow croaker fish, boat noise reduced behavioral lateralization toward zero, impaired swimming speed and reaction time, raised oxygen consumption, and lowered gut microbial diversity while increasing short-chain fatty acid concentrations, with microbiome shifts correlating with lateralization strength [297].

A striking finding from insect research shows that dietary sulforaphane altered the activity of over 1,600 genes and reshaped the entire chromatin landscape in caterpillars, with some of those changes persisting in offspring that never ate the compound [298]. That kind of heritable epigenetic reach is unusual for a dietary compound, and it adds weight to the idea that what a parent eats can influence the biology of the next generation. On the metabolic front, animal work turned up several encouraging leads: an RNA-binding protein called CLUH was found to be suppressed in a mouse model of fatty liver disease, and restoring it improved fat accumulation, scarring, and liver enzyme levels by supporting mitochondrial and cellular health [299]; a silk fibroin and probiotic synbiotic nanoemulsion dramatically reduced cholesterol, triglycerides, and inflammatory markers in obese mice while improving tissue architecture across multiple organs [300]; and a polysaccharide called botryosphaeran given to obese pregnant rat dams not only corrected the mothers' blood sugar and lipid levels but also reversed metabolic dysfunction in their offspring [301]. In aging mice, the natural sugar trehalose reduced oxidative senescence markers and reversed the buildup of aging-related proteins P16, P21, and P53 across liver, lung, and kidney [302], while twelve weeks of soybean polysaccharide supplementation in older mice restored blood vessel function by nurturing butyrate-producing gut bacteria — and giving butyrate directly reproduced the same vascular results [303]. A plant polysaccharide from Polygonatum odoratum was linked to reduced brain oxidative stress and gut microbiome shifts in D-galactose-treated mice, though functional studies are still needed to show whether those changes actually drive the brain benefits [304]. In a scopolamine-induced rat model of Alzheimer's disease, resveratrol restored circadian clock gene expression in the brain's master timekeeping region and improved spatial memory, though whether the clock restoration caused the memory gains remains an open question [305]. Stepping back to the population level, a meta-analysis of 31 controlled animal studies found that food-derived polysaccharides boosted exercise endurance by an average factor of 1.7 — but the prediction interval touched zero and variability between studies was extremely high, which means this doesn't yet translate cleanly into functional food claims [306].

Gut health and inflammation generated a rich body of preclinical work. A specific strain of Bifidobacterium animalis significantly eased colitis in mice, lifting body weight, colon health scores, and anti-inflammatory cytokines, with metabolomics showing it reshaped purine and vitamin B6 pathways in the gut [307]. A Streptococcus fermentation supernatant reduced lung inflammation and improved airway function in mice exposed to both air pollution particles and an asthma trigger [308], and in nursery pigs challenged with a gut pathogen, a blend of inulin, yeast extract, essential oils, and lactic acid reduced intestinal inflammation, reinforced the gut lining, and restored villus structure without hurting growth [309]. An oral casein hydrolyzate reduced constipation, visceral pain, and gut inflammation in IBS-prone mice through the gut's cGMP signaling system, and one isolated peptide — PFPGPIPN — independently reproduced those benefits in vivo [310]. A novel polysaccharide extracted from shiitake mushroom residue shut down multiple inflammatory signals in macrophage cultures and also reduced inflammation markers in zebrafish [311], while a yeast isolated from traditional fermented yak milk carried genes for synthesizing several B vitamins and suppressed three major pro-inflammatory cytokines in stimulated immune cells [312]. Rainbow trout fed diets high in soybean meal showed intestinal damage, reduced tight-junction gene expression, and impaired growth signaling compared to fishmeal-fed fish, and adding dried fish solubles to soy-heavy diets partially repaired the intestinal damage [313]. In a pilot in vitro study using immune cells from lupus patients, EPA reduced a key inflammatory messenger by nearly half in mercury-challenged cells, and DHA showed a similar trend — suggesting omega-3 fatty acids might dampen metal-triggered immune flares in SLE, though the small sample of 15 patients per group limits any firm conclusion [314]. An aronia berry extract protected rat kidneys from drug-induced damage by cutting oxidative stress, lowering inflammatory proteins, and reducing expression of an apoptosis trigger [315]. On the infectious disease side, researchers found that a female-specific RNA-binding protein in Cryptosporidium — a waterborne gut parasite — is essential for producing infectious offspring; removing it rapidly cured infected animals by generating non-invasive sporozoites, flagging it as a potential drug target [316].

Several studies explored how nutrients and plant compounds can be made to work harder through novel delivery systems, and what they can do in cancer, neurological, and cardiovascular contexts. A smart food-grade nanocapsule that contracts in the stomach and expands in the intestine achieved 1.8-fold higher systemic exposure for vitamin C compared to the free supplement, retained over 90% of its cargo after 80 days, and worked across 12 different vitamin formulations [317]. A curcumin nanoassembly delivered through the nose reduced brain injury volume and improved neurological outcomes in stroke-model rats, with RNA sequencing identifying dopamine receptor signaling as a key pathway involved [318]. In a rat colorectal cancer model, chitosan nanoparticles carrying the plant polyphenol protocatechuic acid sped drug absorption dramatically — time to peak blood levels shrank from 8 hours to under 30 minutes — while also reducing oxidative stress and inflammation in the colon [319]. Adding the active form of vitamin D to oxaliplatin treatment in human colon cancer cell cultures reduced the concentration needed to kill cells by more than fivefold, while simultaneously suppressing multiple cancer survival pathways [320]. An experimental microsphere system combining calcium carbonate with metabolic disruptors suppressed liver tumor growth in mice and enhanced the effect of immunotherapy by remodeling the tumor's immune environment [321]. In preclinical models, quercetin consistently lowered both systolic and diastolic blood pressure, improved cholesterol profiles, and reduced cardiac damage markers through several protective molecular pathways, though well-designed human trials are still needed to confirm whether these benefits translate [322]. A systematic review of 33 in vitro studies across multiple cell types found that toxic clusters of alpha-synuclein consistently damaged mitochondria, impairing energy production and triggering fragmentation before cells even began to die — a consistent mechanistic pattern with implications for Parkinson's research [323]. Cynarin, a compound from artichokes, was found to block the entry receptor used by RSV and independently dampen macrophage activation; in infected mice, it cut lung viral load and inflammation, and worked considerably better as a preventive than as a treatment given after infection [324]. A wound dressing built from tannic acid — a polyphenol found in many plant foods — reduced oxidative stress, calmed early inflammation, and significantly sped healing of both clean and diabetic wounds in animals by reshaping the macrophage response [325]. In UVB-irradiated mice, oral Rosa rugosa root extract reduced wrinkle formation and collagen breakdown by blocking two distinct inflammatory signaling cascades [326]. Finally, a mouse model of salt-sensitive hypertension revealed that the initial blood pressure spike occurred during a phase of potassium and water loss rather than sodium overload, and oral potassium supplementation was identified as a potential causal remedy for both the dehydration and the pressure rise [327].

Animal and livestock models continued to reveal how diet reshapes metabolism from the inside out. In high-fat diet-fed mice, eight weeks of NMN supplementation trimmed body weight, hepatic steatosis, LDL, triglycerides, and fasting blood glucose while lifting HDL [328], and the herbal compound atractylenolide III protected the liver in MASLD mice through PTEN activation, cutting lipid synthesis and hepatocyte death [329]. Feeding mice a high-cholesterol diet drove metabolic liver disease through the AGE/ALE-RAGE signaling axis, and pharmacological RAGE blockade reversed both steatosis and fibrosis [330]. The common plasticizer DEHP produced liver fibrosis in mice by coaxing hepatic stellate cells to burn stored lipid droplets through lipophagy as an activation fuel; blocking autophagy at any of several points rescued the cells [331]. Perhaps the most striking everyday-diet message: just four days on a high-fat diet in mice, timed to the onset of acute skin inflammation, locked in an exaggerated inflammatory response that persisted even after the animals returned to normal eating, encoded via neutrophil-NLRP3-IL-1β signaling as durable tissue immune memory [332]. In lambs, 4% flaxseed oil in a liquid diet raised ALA and total n-3 PUFAs in muscle while reducing the n-6/n-3 ratio and thrombogenicity index, and adding niacinamide further trimmed intramuscular fat [333]. High-concentrate feeding in lambs disrupted cecal pH, damaged the mucosal lining, and elevated TNF-α and IL-1β, while 0.5% yeast culture supplementation partly restored barrier gene expression and shifted metabolites toward bile acid pathways [334]. Eimeria parasitic infection in lambs increased drip loss and reduced cooking yield, and Clostridium butyricum supplementation partly reversed these meat quality changes; metabolomics tied the shifts to thiamine pathway disruption [335]. A combined proteomics and metabolomics study of mastitis in sheep identified 25 differentially abundant proteins—including sharply lower HHIPL2 and SERPINA6—spanning immune, lysosomal, and metabolic pathways, alongside 151 candidate lipid and organic acid features, though none of the metabolite hits survived feature-level FDR correction [336]. Chronic low-level lead exposure in Alzheimer's-model mice shortened gut villi, depleted goblet cells, lowered calcium, copper, and magnesium concentrations, and reduced microbial diversity, raising questions about how environmental contaminants interact with disease-associated gut changes [337].

The gut-immune axis produced a tightly interconnected cluster of mechanistic findings across mouse and rat models. In a mouse model of gestational metabolic disorders, combining Polygonatum sibiricum polysaccharide with probiotics restored sialylated milk oligosaccharides better than either alone, by correcting mammary mitochondrial energy deficits and upregulating a key sialyltransferase—pointing to a gut-mammary signaling relay [338]. A peony root polysaccharide, BP-1, eased arthritis severity and colonic injury in rats by quieting TLR4/MyD88/NF-κB signaling and shifting the gut microbiota [339]. Twelve weeks of dietary fiber in mice alleviated hyperglycemia and insulin resistance through a precisely traced chain: cecal propionate activated colonic ILC3 immune cells via FFAR2-ERK/STAT3 signaling, boosting IL-22 and tightening the intestinal barrier [340]. A histone-methylation regulator called Wdr82 proved essential for regulatory T cell differentiation in mice; deleting it sparked microbiota-dependent intestinal inflammation that wild-type Treg transfer prevented [341]. Age-related findings from the lung were similarly clarifying: in aged mice it is the fibroblast niche—not the progenitor cells themselves—that fails, with mTORC1-activated, autophagy-impaired old fibroblasts dramatically suppressing organoid formation even when lung progenitors were present [342]. In intervertebral disc tissue, low levels of the serine-synthesis enzyme PHGDH triggered a cascade—lowering α-ketoglutarate, spreading repressive H3K27me3 marks across the Rap1b promoter, blocking autophagy, and depleting glutathione—that accelerated disc degeneration; AAV-delivered PHGDH overexpression in live rats reduced puncture-induced damage, while a serine-deficient diet made it worse [343]. In cancer immunology, intermittent fasting conditions shifted CD8⁺ T cells toward a long-lived memory phenotype by promoting fatty acid oxidation, and those metabolically imprinted cells delivered more durable antitumor control in adoptive-transfer mouse experiments [344]. In fasted mice, orexin neurons were found to rapidly suppress AgRP/NPY hunger-promoting neurons, and sensory stimuli recruited a pupil dilation pathway that did the same—identifying pupil dilation as a non-invasive proxy for arousal-driven hunger suppression [345]. A ZIF-8-based nanomedicine that simultaneously blocked glycolysis, mitochondrial respiration, and lipid metabolism in tumor cells while rerouting lipid droplets to cancer-associated fibroblasts via gap junctions strongly amplified antitumor immunity and suppressed both subcutaneous and orthotopic tumors in mice [346]. In skin cancer cell work, UVB radiation dose-dependently enhanced melanoma cell migration by inducing ROS and calcium release in co-cultured keratinocytes, which then secreted TGF-β1 that upregulated the pro-migratory protein YB-1; blocking calcium release with NAC broke the entire chain [347].

Mycotoxins, polyphenols, and emerging biotechnology rounded out the picture. The T-2 mycotoxin was shown in pig kidney cells to directly bind the mitochondrial selenoprotein TXNRD2—occupying its FAD/NADPH pocket, flooding cells with ROS, and disrupting ATP production; selenomethionine restored enzyme activity and cut ROS overproduction by roughly 39%, and TXNRD2 knockdown abolished the rescue entirely [348]. A second fungal toxin, zearalenone, acted as a molecular glue in mice at just 0.5 mg/kg over five days, targeting PPARγ for proteasomal destruction and blunting glucose metabolism; the anthocyanin cyanidin-3-O-glucoside competed for the same binding site, blocked the ubiquitination, and restored glucose handling including the efficacy of the PPARγ agonist rosiglitazone [349]—and in separate cell-free experiments, that same anthocyanin covalently inhibited α-glucosidase enzymes by forming stable thiol adducts through its electrophilic flavylium scaffold [350]. In a blood-brain barrier cell model, linoleic acid increased uptake of two environmental carcinogens by roughly 18–20% and nearly doubled their elimination half-lives, an effect implicating the CD36 fatty acid transporter [351]. Kanzan cherry blossom extract protected human skin fibroblasts from methylglyoxal-induced senescence by suppressing RAGE/NF-κB, reducing intracellular ROS, and restoring collagen gene expression; two constituent compounds drove the anti-glycation and enzyme-inhibiting activity respectively [352]. A pH-responsive alginate hydrogel loaded with solubilized ellagic acid kept nearly 90% intact through simulated digestion and produced 36.86 μg/mL of urolithin A at 48 hours with the right gut microbiota—the highest conversion among conditions tested, suggesting that formulation design can meaningfully determine whether ellagic acid reaches its bioactive form [353]. A multi-component nanoplatform (TSCA@OL) combining cholesterol synthesis inhibition, efflux promotion, redox restoration, and anti-inflammatory action reduced aortic plaque burden by 62.97% in ApoE⁻/⁻ mice relative to high-fat diet controls while suppressing pro-inflammatory macrophage polarization [354]. On the biotech side, encapsulating single yeast cells in hollow hydrogel microparticles (PicoShells) enabled fluorescence-based screening of natural product producers at over 30,000 colonies per hour, achieving roughly tenfold enrichment of serpentine-producing strains without engineered reporters [355], and a separately engineered Saccharomyces cerevisiae strain produced 4.39 g/L ergosterol in a 5-liter bioreactor—a scalable yield for this vitamin D2 precursor [356]. And in the ocean, the microbiome of juvenile angelsharks was clearly distinct from surrounding seawater and sediment from early life onward, with Pseudoalteromonadaceae abundance correlating positively with individual growth—a rare window into how early-life microbial communities may support development in a critically endangered species [357].

Several animal and cell studies in this batch zeroed in on the brain, with a throughline of metabolic signals shaping cognition and neuronal health. A microbial metabolite of coffee compounds called dihydrocaffeic acid (DHCA), given daily to aging APOE4 mice for three weeks, improved object recognition and spatial memory, reduced amyloid plaques and tau tangles, and nudged astrocytes into a more neuroprotective state [358]—a vivid reminder that gut microbes, via the compounds they produce, can reach all the way into the brain. On a more alarming note, ADP-ribose, a byproduct of DNA repair activity, was found to trigger a form of iron-driven neuronal self-destruction (ferroptosis) through a cascade involving oxidative enzymes—and blocking that cascade reversed cognitive damage in mice after brain hemorrhage [359]. In rats engineered to develop Alzheimer's disease, brain scans revealed an unexpected early spike in cerebral glucose metabolism—peaking at nine months and driven by astrocytes rather than neurons—before the familiar metabolic crash of late disease set in [360]. Separately, in a mouse model of chronic sinus disease, a deficiency of the mitochondrial regulator SIRT3 in macrophages worsened olfactory neuron loss by pushing immune cells toward an inflammatory, glycolysis-heavy state [361]. On the protective side, novel saponins extracted from the herb Gynostemma longipes shielded neuronal cells from glutamate-induced death in lab tests [362], and regular exercise in mice strengthened the brain's response to nutrient delivery through a previously unknown brainstem neuronal population tagged by FIBCD1—one that genetics data suggest may matter for body-weight regulation in humans too [363]. Zooming all the way out to insects, work in Drosophila found that insulin signaling drives production of juvenile hormone, which then acts as the central regulator of aging and lifespan; the insulin–juvenile hormone axis is decoupled in long-lived social insect queens, and analogous features appear in worms, hinting that comparable systems may exist in mammals [364].

The gut and its microbial tenants figured heavily across several lines of research. In accelerated-aging rats, fecal microbiota transplants (FMT) from healthy donors markedly improved spatial learning, memory, and organ health in the heart, hippocampus, and colon—with antibiotic pretreatment blunting the effect, suggesting the recipient's gut environment shapes how well a transplant takes [365]. A novel bile acid analog called CCD052 killed all 115 tested clinical strains of C. difficile within two hours, then in mice prevented death and diarrhea, reduced spore shedding, and—crucially—preserved beneficial gut bacteria while shifting bile acid profiles in a protective direction [366]. A traditional Chinese preparation called Siwu Paste restored blood cell production and intestinal barrier function in blood-deficient rats, effects that were partially transferable by FMT and partially blocked by antibiotics, pointing to a gut-to-spleen metabolic axis as the key mechanism [367]. In obese rats, the dual-drug combination CagriSema achieved its weight loss almost entirely by cutting food intake (86% of efficacy) rather than raising energy burn—and once stopped, weight came rushing back within roughly a week [368]. Diet-induced (but not genetically) obese mice showed elevated TRPV4 in the hypothalamic neurons responsible for suppressing appetite (POMC neurons), and removing TRPV4 specifically from those neurons worsened high-fat diet obesity by impairing them through a mitophagy cascade [369]. In obese mice with insulin resistance, a fat-tissue kinase called MKK3 choked off insulin-driven glucose uptake in subcutaneous fat by blocking the delivery of GLUT4 transporters to the cell surface; MKK3 is elevated in human obesity and correlates positively with BMI [370]. A gut-bacteria-derived fat molecule called glycine lipid L1256, produced by Bacteroidota and found in the muscles of diet-fed obese mice, enhanced mitochondrial respiration, boosted antioxidant defenses, and preserved muscle fiber size—while a structurally related molecule (L654) that didn't accumulate in tissue failed to do the same [371]. In hybrid fish, eight weeks of Clostridium butyricum supplementation improved growth and reshaped gut microbial communities in ways linked to better glycerophospholipid metabolism [372]. And in a striking example of cross-species metabolic hijacking, tiny RNA molecules encoded by a parasitoid wasp's bracovirus suppressed the host insect's fat-making machinery to redirect nutrients toward developing larvae—with symbiotic success dropping when the suppression was artificially prolonged, disrupting the host's energy balance [373].

A final cluster of findings spanned the heart, cancer, and infection. In diabetic rats, an ion channel called P2X7R drove atrial fibrillation susceptibility through fibrosis and electrical remodeling; silencing it with gene therapy reversed those changes, and recreating P2X7R overactivity in healthy rats reproduced the diabetic heart's arrhythmia profile—confirming it as a causal driver rather than a bystander [374]. A surprise in heart muscle revealed that the lactate transporter MCT1 also lives inside the inner mitochondrial membrane, converting lactate directly into fuel for the electron transport chain—a parallel carbohydrate pathway whose loss accelerated heart failure and death after cardiac stress in mice [375]. An engineered nanoparticle combining an iron porphyrin scaffold with curcumin released its cargo specifically at acidic plaque sites, outperforming free curcumin at reducing plaque burden and inflammation in atherosclerosis-prone mice [376]. Three naturally occurring human variants of the fat-scavenger receptor CD36 all showed impaired oxidized LDL uptake and shorter protein lifespans—not because the receptor got stuck in a particular compartment, but because it couldn't complete normal maturation [377]. In liver cancer cells, a chemical modification called SUMOylation on a metabolic enzyme (TIGAR) supercharged glycolysis and tumor growth, with cells lacking that modification forming significantly smaller and lighter tumors in a tissue assay [378]. In a related finding, platelets were found to funnel leucine into liver tumor cells, triggering a growth-promoting signaling cascade (leucine–S6K1) that dietary leucine restriction disrupted in a mouse xenograft model [379]. On the infection front, a Clostridium perfringens toxin (Delta toxin) was identified in the guts of infants with severe necrotizing enterocolitis and shown in mice to breach the blood-brain barrier and cause multi-organ injury through inflammasome activation—with both a genetic knockout and a neutralizing antibody providing protection [380]. And in the fungal pathogen Candida albicans, a protein complex (CaUbc8-GID) that responds to nutrient and copper stress proved essential for survival under those conditions, flagging it as a potential drug target for a notoriously difficult-to-treat infection [381].

Almost everything here comes from mice, rats, and cell cultures, so direct human translation is a long way off for most of these findings. That said, the blueberry gut-microbiome result is worth watching: if the vessel-protective effects of berries really do depend on a healthy microbiome to unlock them, that would put gut health at the center of why whole-food benefits so often outperform isolated supplements in human trials.